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ABSTRACT
Glutamate, substance P (SP) and neurokinin A (NKA) are all found in fine
primary afferent fibres and can be released upon noxious stimulation of the
corresponding cutaneous receptive field. The possibility of a role in nociception for
the metabotropic class of glutamate receptors (mGluRs) as well as those at which SP
and NKA preferentially act (NKj and NK2), was investigated in the present study.
Since protein kinase C (PKC) has been shown to be important in the mediation of
noxious, but not non-nociceptive inputs, the potential role of this and several other
signal transduction pathways in sensory inputs was assessed here, especially in the
context of actions via mGluRs.
(a) Extracellular recordings were made from single dorsal horn neurons
(laminae III-V) in the spinal cords of chloralose/urethane anaesthetised rats. Activity
evoked by innocuous brushing of the cutaneous receptive field was not reduced by
ionophoresis of mGluR antagonists L-l-amino-3-phosphopropionic acid (AP3),
(R,S)- or (S)-4-carboxy-3-hydroxyphenylglycine (CHPG). However, sustained
elevated firing evoked by the application of the C-fibre selective chemical irritant
mustard oil was significantly attenuated by L (but not D)-AP3 and (R,S)-CHPG.
Approximately one fifth of dorsal horn neurons could be excited by ionophoresis of
the mGluR agonist (lS,3R)-l-aminocyclopentane-l-3-dicarboxylic acid (ACPD), and
this evoked activity was similarly reduced by L (but not D)-AP3 and (R,S)-CHPG.
(b) Inhibitors of calmodulin/Ca++-dependent kinase (CamKII), phospholipase
A2 (PLA2), protein kinase A (PKA) and non-receptor tyrosine kinases were
ionophoresed during brush- and mustard oil-evoked activity. CamKII and PLA2
inhibitors were less effective in reducing innocuous rather than noxious inputs.
Inhibitors of PKA and tyrosine kinases were equally effective in reducing all evoked
activity. All of these antagonists, as well as two PKC inhibitors significantly
decreased activity elicited by the ionophoresis of (1S,3R)-ACPD.
(c) The behaviour of conscious rats in response to noxious mechanical and
thermal stimulation of one hindpaw (non-inflamed or inflamed by an intraplantar
injection of carrageenan) was monitored following an intrathecal injection of mGluR
antagonists L-AP3 and (S)-CHPG, as well as GR82334 and L659,874, antagonists at
NK] and NK2 receptors respectively. (S)-CHPG significantly increased withdrawal
responses in each model to both mechanical and thermal stimulation, whereas L-AP3
was only effective in the inflamed paw. L659,874 was antinociceptive in thermal,
but not mechanical, tests in the non-inflamed and inflamed paws. GR82334 did not
alter latencies in any tests. However, a co-injection of GR82334 or L659,874 with
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each mGluR antagonist resulted in an apparent reversal of the analgesic effects
observed when the mGluR antagonists were administered alone.
This investigation demonstrates a role for spinal cord mGluRs in the
transmission of sustained nociception, possibly mediated by PKC, CamKII and
PLA2. NK2 receptors appear to have a selective role in thermal inputs to the spinal
cord, whereas this study provided no evidence for an overt role of NK] receptors in
the nociceptive models assessed. It is possible that NK] receptors play a greater role
in more prolonged or severe nociceptive inputs. The present data suggest however
that not only NK2, but also NK] receptors exhibit a functional interaction with the
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Pain is the perceptual counterpart of the body's response to stimuli that threaten the
integrity of its tissues.
(Treede et al, 1992).
1.1. General Introduction
In order to reach the brain somatosensory information is first relayed
from peripheral receptors to the spinal cord (or in certain cases, the brainstem) by
means of primary afferent fibres. Included in this barrage of information are signals
contributing to the sensation of pain. During the past century there have been several
major theories as to how painful (sensory) information is transferred to the central
nervous system from the cutaneous surface of the body. These include the intensity
theory (Goldscheider, 1884), which hypothesised that nociception occurred due to
low-threshold receptors receiving a high enough intensity of stimulus to encode pain,
and the pattern theory (Nafe, 1927), which claimed that a noxious stimulus gave rise
to the appropriate pattern of discharges which was decoded centrally. The theory of
specificity (Miiller, 1842 and supported by Von Frey, 1895), differed markedly from
the others in that it postulated the existence of receptors designed to selectively
transmit painful information - nociceptors. Although this theory was correct in
hypothesising a receptor responsible for nociception, it did not consider the variety of
nociceptors, and their dynamic properties, that we are now familiar with.
1.1.2. Cutaneous Nociception
There are various groups of primary afferent fibres, classified according
to their size and conduction velocity, and whether they are myelinated or not. Aa
(group I) are the largest class of myelinated fibres and are found in muscle afferents,
but not those innervating the skin. Non-noxious inputs from the cutaneous surface
are mediated principally by large myelinated A(3 (group II) fibres which have
conduction velocities of greater than 30 metres per second (m/sec). Noxious inputs
are mediated by fine afferent fibres, both myelinated A8 (group III) and unmyelinated
C (group IV) fibres, with average conduction velocities of 5 - 30 m/sec and 0.5 - 2
m/sec respectively (Willis & Coggeshall, 1991).
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Two types of receptors mediate sensory cutaneous inputs - corpuscle
receptors and free nerve endings. The former include slowly and rapidly adapting
touch receptors which mediate tactile sensations. In glabrous skin there are two types
of rapidly adapting (Meissner's and Pacinian corpuscles) as well as two types of
slowly adapting (Merkel receptor and Ruffini corpuscle) touch receptors. Hairy skin
has all of these, with the exception of Meissner's corpuscle, and also contains hair
follicle receptors. Some of these, type D hair follicles, are innervated by A5 fibres,
therefore not all non-nociceptive inputs are A(3 fibre-mediated. The free nerve
ending group of cutaneous receptors includes nociceptors, of which there are several
classes derived from both A8 and C fibres. Not all free nerve endings are exclusively
nociceptive however, as warming and cooling of the skin is also detected by A8 and
C fibres (Iggo, 1959; 1969). Since most nociceptors have been located in a manner
whereby their responses to mechanical and heat stimuli have been characterised, they
are often referred to as A and C mechano-heat sensitive fibres (AMH and CMH):
(a) A8 Fibre Nociceptors: Two types of AMH nociceptors have been
reported. The first, found mainly in glabrous skin, responds to high-intensity thermal
stimuli, typically greater than 53°C, as well as noxious mechanical stimuli
(Adriansen et al, 1983; Torebjork, 1985). The second type however is found only in
hairy skin and is responsive to lower thresholds of mechanical/heat stimulation, as
well as responding to chemical irritation (Adriansen et al, 1983). Around 50% of A8
nociceptors have very high mechanical thresholds, or do not respond to noxious
mechanical stimuli at all, these are commonly referred to as mechanically-insensitive
afferents (MIAs, Meyer et al, 1991; Davis et al, 1993).
(b) C Fibre Nociceptors: C mechano-heat nociceptors (also commonly
known as C polymodal nociceptors) respond to high-intensity mechanical, heat (and
cold) and chemical stimuli. The response characteristics of CMH receptors in a
variety of species, including human, monkey and cat, are highly uniform (Bessou &
Perl, 1969; Torebjork, 1974; Beitel & Dubner, 1976; Kumazawa & Perl, 1977). Heat
thresholds can range from 38°C to 50°C for these receptors (though they are typically
above 41 °C), with the response tending to depend on the previous experience of the
unit (Torebjork, 1993). Sensitisation, whereby a repeated electrical or natural
stimulus evokes an increased response from the neuron, has been reported for C
fibres, with up to ten minutes of no further stimulation being required for responses
to return to control levels (Meyer et al, 1994). As well as polymodal C fibres, there
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are also around 30% of C fibre nociceptors which belong to the MIA group
(Handwerker et al, 1991; Meyer et al, 1991; Kress et al, 1992; Davis et al, 1993).
More recent studies have demonstrated that these MIAs, both A5 and C
fibre nociceptors, respond to chemical irritation. Following sensitisation using
chemical or electrical stimulation, many of these receptors will respond to previously
suprathreshold mechanical and thermal stimuli, though some of them do appear to be
thermo- or chemo-specific (Davis et al, 1993). By means of electrophysiological
recording, either directly from the nerve, dorsal roots or central neurons, MIAs have
been found in the skin of the rat, following continuous electrical stimulation
(Handwerker et al, 1991; Kress et al, 1992), and the monkey after the application of
an inflammatory 'soup' (Meyer et al, 1991; Davis et al, 1993), as well as in the knee
joint of the cat subsequent to an intra-articular injection of kaolin/carrageenan
(Schaible & Schmidt, 1985; 1988). In microneurography experiments, Torebjork
(1993) also identified such mechanically insensitive nociceptors in the human skin
using topical application of mustard oil and/or capsaicin (both of which are known to
irritate C fibres) to induce sensitisation.
Sometimes following such injury to the skin hyperalgesia is produced,
whereby pain is experienced when normally subthreshold stimuli are used and the
response to suprathreshold stimuli is exaggerated (Lewis, 1942; Hardy et al, 1952).
Two forms of hyperalgesia exist: primary hyperalgesia to both mechanical and
thermal stimuli, occurs at (or very close to) the site of injury and is thought to be due
to both local and central mechanisms (Treede et al, 1992). Secondary hyperalgesia,
which manifests itself as sensitisation to mechanical stimuli only, arises in an
undamaged area around the injury, and is thought to come about through changes that
predominantly occur in the spinal cord (see Treede et al, 1992 & Meyer et al, 1992).
From the periphery the nociceptor primary afferent extends to its cell
body, the dorsal root ganglion (DRG) cell, before it enters the spinal cord by means
of the dorsal roots. Anatomical tracing, using retrograde transport of several
horseradish peroxidase (HRP) conjugates, and more recently a plant lectin (phaseolus
vulgaris leuko-agglutinin; PHA-L) which reaches the end of fine fibres, along with
electrophysiological recording experiments have shown that while the large A(3 fibres
enter the spinal cord from the medial portion of the dorsal roots to terminate in the
deeper layers, the fine A5 and C afferents enter through the lateral portion,
terminating predominantly in the superficial laminae (Light & Perl, 1979; McMahon
& Wall, 1985; Sugiura et al, 1989). These axons do not have many collaterals and
terminate in the spinal cord very close to the segment at which they enter
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(Szentagothai, 1964). However, recent single fibre-labelling studies have highlighted
the extensive branching which occurs once these fibres have entered the dorsal horn
(Sugiura et al, 1986; 1989). Histological investigations as well as
electrophysiological recording experiments have revealed that primary somatic
afferent fibres terminate in a strict topographic pattern in the dorsal horn of the spinal
cord (Szentagothai & Kiss, 1949; Brown & Fuchs, 1975; Koerber & Brown, 1980;
Ygge & Grant, 1983; Swett & Woolf, 1985).
1.2. The Dorsal Horn of the Spinal Cord
1.2.1. Classification of Sensory Neurons
This study will refer to several types of dorsal horn neurons which can be
classified according to their responsiveness to evoked sensory stimuli, (Iggo, 1974).
Non-nociceptive (Class I) cells are innervated by sensitive mechanoreceptors and
respond only to innocuous mechanical stimulation of the cutaneous receptive field
(Dubner & Bennett, 1983). Multireceptive (Class II), also known as Wide-dynamic-
range (WDR) neurons, have convergent inputs from peripheral nociceptors and
sensitive mechanoreceptors, therefore respond to both innocuous and noxious
mechanical stimulation of the skin as well as noxious thermal stimuli (Price et al
1976; 1978). Finally, nocispecific (Class III) neurons receive an exclusive input from
cutaneous nociceptors and thus respond only to very high-threshold evoked stimuli
(Cervero et al, 1976), both mechanical (Class Ilia) and mechanical and thermal
(Class Illb, Cervero & Iggo, 1980).
1.2.2. Laminar Organisation and Cutaneous Primary Afferent Input
Anatomical variations throughout regions of the dorsal horn have been
recognised since the last century. However, clear documentation of all areas was not
duly recorded until 1952 when Rexed histologically examined the feline spinal cord
and classified the laminae according to their cytoarchitectonic characteristics. It is
Rexed's nomenclature that is most widely recognised today, and will be referred to
throughout this study. Molander et al (1984) carried out a similar study on the rat
spinal cord (see Figure 1.2) and found few differences between the two species.
Within each species itself however, cytoarchitectonic organisation often differs
slightly depending on the spinal segment (Rexed, 1952; Molander et al, 1984).
4
Where this occurs descriptions are given for lumbar segments, as those are of direct
relevance to this study. Both investigations describe six layers in the dorsal horn:
(a) Lamina I (The Marginal Zone): This, the thinnest and most
superficial layer, partially follows the lateral edge of the dorsal horn. The most
prominent neurons of lamina I, marginal cells (Waldeyer, 1888), have dendritic trees
which run mediolaterally within this layer. As well as these cells, lamina I contains
other cells which merge with the outer layer of lamina II (Lima & Coimbra, 1983)
and many nerve fibres. Innervation includes dorsal root afferents (A8) and axons of
deeper dorsal horn units, including C fibres from lamina II (Cervero & Iggo, 1980;
see Figure 1.2). Using HRP labelling, Gobel et al (1980) claimed that some fine (C)
afferent fibres directly enter lamina I. Electrophysiological recording experiments in
cats first documented nocicspecific cells in this lamina (Christensen & Perl, 1970)
and this was later confirmed by other studies in the monkey and rat (see Cervero &
Iggo, 1980). Wide dynamic range units have also been found in lamina I
(Christensen & Perl, 1970; Handwerker et al, 1975a; Cervero et al, 1976; Menetrey
et al ,1977; Rethelyi et al, 1983).
(b) Lamina II (The Substantia Gelatinosa): As with lamina I, this
layer also curves around the lateral edge of the dorsal horn (see Figure 1.1). Due to
its gelatinous appearance, probably because of the large number of small cells and
unmyelinated afferent fibres contained there (Szentagothai, 1964; Light & Perl,
1979), the term 'substantia gelatinosa' was given to this region by Rolando (1824). It
was further divided into two areas by Rexed (1952), the outer (most dorsal) and inner
layers (see Figure 1.2). Ramon y Cahal (1909) classified two types of neurons in this
region, both of which are among the smallest found in the spinal cord: the limiting
(or stalked, Gobel, 1975; 1978) cells are situated in the outer region (cell bodies 10-
15|im), whereas central (or islet, Gobel, 1975; 1978) cells, which are slightly smaller
(7-14fim) and more compact, are found in the inner portion. Both cells have
dendritic trees and axon collaterals which remain almost completely within the
superficial layers (I-III) of the dorsal horn, though their mediolateral and rostrocaudal
branching is widespread (Cervero & Iggo, 1980). A combination of degeneration
and Golgi experiments have demonstrated that many C afferent fibres terminate in
this lamina (LaMotte, 1977; Rethelyi, 1977; Ralston & Ralston, 1979), with PHA-L
injection of single fibres recently confirming this (Sugiyara et al, 1989). The




Schematic drawings of the cytoarchitectonic subdivisions of segments
LI - L6 of the rat spinal cord
The laminar divisions of Rexed (1952) can be seen re-presented here in the rat
spinal cord. The dorsal horn consists of laminae I - VI.
CC - column of Clarke; IL - intermedio-lateral nucleus; IM - intermedio-medial
nucleus; LSN - lateral spinal nucleus; Liss - Lissauer's tract; LG - lateral group of
large cells in the dorso-lateral part of the ventral horn; LM - latero-medial
nucleus; MG - medial group of large neurons in the intermediate zone.




Schematic diagram of the neuronal organisation of the superficial dorsal
horn and its afferent input
A hypothetical transverse section of the dorsal horn is represented, showing the
types of neurons and afferent fibres which terminate there. The receptors which
are associated with each fibre type are listed on the left of the diagram. Indicated
on the right are the laminar divisions of Rexed (1952), along with the
corresponding anatomical nomenclature. The neurons schematised are typical of
those found in each lamina: {from top to bottom) a marginal cell, an SG limiting
cell, two SG central cells and two neurons of the nucleus proprius, the most
superficial of which has dendrites penetrating lamina II.
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As a consequence of the very small size of lamina II cells there have been
relatively few electrophysiological experiments recording directly from them.
Nevertheless, activity of presumed lamina II cells in monkeys and cats (defined either
by depth/position and/or intracellular HRP staining) has been recorded, both intra-
and extra-cellularly and despite much controversy these studies have revealed several
common features (Kumazawa & Perl, 1976; 1978; Cervero et al, 1977a; 1977b; Wall
1978; Light & Perl, 1979; see also Cervero & Iggo, 1980). Firstly, all investigations
found that substantia gelatinosa cells are highly responsive to activity in cutaneous C
afferent fibres. Secondly, lamina II cells demonstrated habituation to repeated
stimulation of the cutaneous surface. Thirdly, neurons in this lamina, of all classes,
could be inhibited by cutaneous (innocuous, noxious or both) stimuli. Although A(3
fibre-evoked inputs have been reported to excite substantia gelatinosa cells, this is,
on the basis of latency measurements, thought to be polysynaptic in nature (Price et
al, 1979; Wall et al, 1979; Fitzgerald, 1981).
(c) Laminae III - IV (The Nucleus Proprius): Lamina III is sometimes
thought of as a transitional layer between the substantia gelatinosa and the remainder
of the dorsal horn, with the Il/m border sometimes hard to distinguish (Molander et
al, 1984). Lamina III contains many small cells, whereas neuronal size in layer IV is
more heterogeneous, including scattered large neurons (Rexed, 1952; Molander,
1984). Lamina III receives direct inputs from both A5 and A(3 fibres (Brown et al,
1977; Light & Perl, 1979), though many of the A5 fibres are of D type hair follicle
receptor in origin. The input to lamina IV is from larger fibres, however many of
these project their dendrites superficially to laminae I - III, therefore receiving direct
inputs from these layers (Willis & Coggeshall, 1991). Consequently, many of the
neurons in these laminae are multireceptive, with some studies also reporting
nocispecific neurons here (Kumuzawa & Perl, 1977; Menetrey et al, 1977).
(d) Laminae V - VI: This layer contains fewer neurons than those
superficial to it and they are larger still (Rexed, 1952; Molander et al, 1984). Some
nociceptive (A8) afferents do terminate in layer V and both nocispecific and
multireceptive neurons are found in this region (Kumuzawa & Perl, 1977; Menetrey
et al, 1977; Rethelyi et al, 1982). The final lamina of the dorsal horn, layer VI, has a
slightly curved ventral edge. Similar to lamina V, there are large cells, but layer VI
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also contains smaller units in its medial portion (Rexed, 1952; Molander et al, 1984).
Both of these layers receive direct inputs from large A(3 afferent fibres (Molander et
al, (1984).
There are in total ten laminae described by Rexed (1952) and Molander
et al (1984), but the remainder are principally ventral horn structures and are beyond
the scope of this study.
1.2.3. Descending Inputs to the Dorsal Horn
As well as primary afferent inputs from peripheral areas, spinal cord
neurons receive efferent input from descending fibres. These pathways are important
in the maintenance of inhibitory control on dorsal horn neurons. Several areas in the
brainstem, including the periaqueductal grey, the raphe nuclei, reticular nuclei and
the locus coeruleus, provide analgesia when stimulated, (Reynolds, 1969; Oliveras et
al, 1974; Segal & Sandberg, 1977). Moreover, when these supraspinal sites are
stimulated the result is often, though not always, a specific inhibition of activity
evoked by noxious (mechanical, thermal and electrical), and not non-noxious stimuli
applied to the periphery or peripheral nerves (Oliveras et al, 1974; Willis et al, 1977;
Carstens et al, 1979; Duggan & Griersmith, 1979; Hodge et al, 1981; Yezierski et al,
1982; Gebhart et al, 1983; Morton et al 1983; Mokha et al, 1985). Various
transmitters are associated with such inhibitory effects, including the opioid peptides,
serotonin (5-HT), noradrenaline, dopamine and the inhibitory amino acids 7-
aminobutyric acid (GABA) and glycine (see Besson & Chaouch, 1987 for review).
Electrophysiological studies utilising reversible cold blocking of the spinal cord have
demonstrated that there is a tonically active descending inhibitory influence on dorsal
horn cells (Wall, 1967; Brown, 1971; Handwerker et al, 1975b; Duggan et al, 1977).
These and other experiments have shown that neurons in lamina I and IV-VI are
under such influences (Besson et al, 1975; Cervero et al, 1976; Duggan et al, 1981),
though no evidence supports such tonic inhibition on lamina II units (Cervero et al,
1979). Tonic inhibitory effects are not reduced by the administration of naloxone, an
opioid antagonist, and mixed effects of monoamine antagonists have been reported
(see Duggan, 1985) The exact origin of this tonic inhibition is unclear, though
bilateral lesions of the lateral reticular nuclei and the nucleus paragigantocellularis
lateralis in the brainstem appear to result in its elimination (Hall et al, 1982; Morton
et al, 1983; Foong & Duggan, 1986).
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In addition to receiving these inputs, many of the cells throughout the
dorsal horn laminae are projection neurons which relay sensory information to higher
areas in the central nervous system. There are several main tracts through which this
information may travel.
1.2.4. Ascending Somatosensory Pathways
(a) Spinothalamic Tract: Neurons in the spinal dorsal horn project to
thalamic nuclei via the ventrolateral quadrant of the spinal cord, usually contralateral
to the side of sensory input (Willis et al, 1979). Human studies have shown that
lesions in this quadrant may lead to analgesia (Spiller & Martin, 1912), whereas
stimulation can result in sensations that are painful (Mayer et al, 1975). Tracing
experiments based on the retrograde transport of HRP in the rat have demonstrated
that neurons primarily in lamina I, III and IV have axons which terminate in the
ventro-posterolateral nucleus and the intralaminar complex of the thalamus (Giesler
et al, 1979; Granum, 1986; Burnstein et al, 1990). Antidromic activation in
electrophysiological studies has confirmed that neurons of the rat and cat
spinothalamic tract (STT) are found in laminae III-V, with many of them being
nociceptive, both multireceptive and nocispecific (Dilly et al, 1968; Giesler et al,
1976).
(b) Spinoreticular Tract: Also ascending through the ventrolateral
quadrant of the spinal cord, this tract projects to the brainstem reticular formation
which in turn relays information to the thalamus (Kevetter & Willis, 1983). HRP
labelling provides evidence that laminae VII and VIII cells in the rat ventral horn are
the main origin of spinoreticular tract (SRT) units, though some cells in more
superficial layers of the dorsal horn are also apparent (Chaouch et al, 1983).
Menetrey et al (1980) found it possible to activate many neurons in laminae III-IV,
and a few in laminae I, V and VI, when stimulating the reticular formation. In this
study they observed almost half of the cells to be multireceptive and a further fifth
were nocispecific.
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(c) Spinomesencephalic Tract: HRP and fluorescent dye tracing
showing prominent projections from laminae I and some in lamina V neurons to the
mesencephalic reticular formation and the periaqueductal gray matter (Menetrey et
al, 1982; Harmann et al, 1988; Yezierski & Mendez, 1991). Electrophysiological
evidence from rats also demonstrates that many spinomesencephalic tract (SMT)
neurons originate in the marginal zone and respond to noxious cutaneous inputs
(Menetrey et al, 1980)
(d) Postsynaptic Dorsal Column System: Not all axons in the dorsal
columns are primary afferent fibres, with an estimated 15% thought to be second
order neurons; the postsynaptic dorsal column (PSDC) pathway, some of which relay
nociceptive information (Angaut-Petit, 1975). These neurons project to the nucleus
gracilis and nucleus cuneatus, with HRP labelling providing evidence that the
majority of their cell bodies originate from the laminae H/III border in the rat (Giesler
et al, 1984). In electrophysiological recording experiments both multireceptive and
nocispecific neurons are reported to be among the PSDC destination nuclei (Angaut-
Petit, 1975; Brown et al, 1983).
As well as these direct routes beyond the spinal cord there are other
pathways, including the spinocervical tract (Brown et al, 1976; 1977; 1980), which
carry information via other spinal cord segments to the brain. There are many
neurotransmitters and neuromodulators which may
contribute to encoding nociceptive information within the various stages of these
pathways, and among them is the ubiquitous excitatory amino acid glutamate.
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1.3. Glutamate as a Spinal Neurotransmitter
The extensively studied excitatory amino acid (EAA) glufamate has been
shown to be a neurotransmitter eliciting fast excitatory responses throughout the
central nervous system (Watkins & Evans, 1981; Mayer & Westbrook, 1987). The
present study was focused on the role of glutamate (especially by means of
metabotropic receptors) in nociceptive processing in the dorsal horn of the spinal
cord.
Since glutamate is involved in cellular metabolism, its presence in a
neuron cannot immediately indicate neurotransmitter function. However,
immunogold electron microscopy studies have extensively demonstrated that
throughout the central nervous system there are higher levels of glutamate-like
immunoreactivity (Glu-LI) in putative glutamatergic terminals than in any other
cellular compartment (Somogyi et al, 1986; Montero & Wenthold, 1989; Ottersen
1989a; 1989b; Bramham et al, 1990; Broman et al, 1990; Maxwell et al, 1990a;
1990b; Montero 1990; Zhang et al, 1990; Broman & Ottersen, 1992). The presence
of Glu-LI at such terminals is also higher around synaptic vesicle clusters (Ji et al,
1991; Broman et al, 1993). Furthermore, Battaglia & Rustioni (1988) showed with
double-labelling immunocytochemistry in DRG cells how the intensity of staining for
cytochrome oxidase, an enzyme believed to be a metabolic marker (Wong-Riley,
1979; Wong-Riley & Carroll, 1984), does not correlate with that of glutamate. This
would suggest that the cellular complement of this amino acid is not solely for
metabolic purposes. Still, when interpreting challenge-induced alterations in cellular
glutamate levels, it should be considered that changes in the neurotransmitter pool,
since it is much smaller, may be occluded by simultaneous metabolic alterations
(Roberts & Hill, 1978).
An attempt to demonstrate the release of glutamate from primary afferent
fibres in vivo was first made by Roberts (1974). Following electrical stimulation of
dorsal column tracts raised glutamate levels were successfully measured in dorsal
column nuclei in the brainstem. In vitro preparations have since confirmed the
presence of glutamate in primary afferent fibres by either measuring changes in its
high affinity uptake following dorsal column lesions (Roberts & Hill, 1978) or dorsal
root stimulation (Jessel et al, 1986; Kawagoe et al, 1986). Glutamate was initially
inferred to be associated with intrinsic neurons of the dorsal horn by means of
biochemical, histochemical and immunocytochemical assays (Rizzoli, 1968; see
Fagg & Foster, 1983; Storm-Mathisen & Ottersen, 1987). More recent electron
microscopy studies have specifically shown Glu-LI associated with synaptic vesicles
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throughout neurons and primary afferent terminals of the superficial dorsal horn (De
Biasi & Rustioni, 1988; Miller et al, 1988; Maxwell et al, 1990a; Broman et al,
1993).
For several other reasons glutamate is believed to be involved in the
transmission of nociceptive information, in the spinal cord. Glutamate release in the
dorsal horn has been demonstrated following noxious stimulation or peripheral
inflammation (Skilling et al, 1988; Sorkin et al, 1992). Ionophoretic application of
glutamate was initially shown to cause excitation of spinal neurons by Curtis et al in
1959. This and other early studies suggested it played a nonselective excitatory
action in the cord (Curtis et al, 1960; Ziegelgangsberger & Herz, 1971;
Ziegelgangsberger & Puil, 1973). However, more recent evidence indicated that
glutamate could be selective for the transmission of nociceptive information. There
are higher levels of glutamate in dorsal rather than ventral roots (Graham et al, 1967;
Duggan & Johnston, 1970) and, more specifically, in dorsal root axons Glu-LI is
higher in those which are unmyelinated (Westlund et al, 1989). Furthermore,
although glutamate is found in DRG cells of all sizes, it is preferentially located in
the smaller cells associated with nociception (Duce & Keen, 1983; Salt & Hill, 1983;
Cangro et al, 1985; Battaglia & Rustioni, 1988). By means of
immunocytochemistry, it has also been located in primary afferent terminals fitting
the light and electron microscope criteria, in terms of size and morphology, of A8
and C fibres (De Biasi & Rustioni, 1988). Recording extracellularly from a hamster
spinal cord slice preparation, Schneider & Perl (1985; 1988) found that the majority
of units in the dorsal horn responding to extracellular glutamate were in the
superficial laminae and could be activated by C fibre volleys. Furthermore, the
neurons not excited by glutamate were usually only activated by myelinated fibres,
and were distributed throughout the remainder of the dorsal horn. These data support
a more selective role for this excitatory amino acid. Some studies do however
support a further role for glutamate, in mediating low threshold inputs. These will be
presented later with specific reference to the receptor subgroups involved.
Intrathecal administration of glutamate produces behavioural
hyperalgesia and spontaneous nociceptive behaviour (Aanonsen & Wilcox, 1986;
1987) and increases formalin-induced behavioural responses when given as a
pretreatment (Coderre & Melzack, 1992). The subcutaneous injection of formalin
into the hindpaw results in an initial acute stage (typically for 0-10 minutes after
administration) followed by a prolonged, tonic phase (25-60 minutes). This biphasic
effect can be seen both behaviourally as animals lick and bite their paw (Dubuisson
& Dennis, 1977; Alreja et al, 1984; Seguin et al, 1995) and in the
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electrophysiological correlate of increased activity of dorsal horn neurons (Dickenson
& Sullivan, 1987; Shibata et al, 1989). This is therefore used as a model of
prolonged noxious stimulation. Sluka & Westlund (1993b) immunohistochemically
monitored glutamate levels in the dorsal horn following the induction of arthritis due
to an injection of kaolin and carrageenan into the knee joint, and found that its
increase correlated with behavioural hyperalgesia.
There are several receptor subtypes through which glutamate (and
perhaps other EAA transmitters such as aspartate) may mediate cellular effects. The
ionotropic group, receptor linked ion channels, consists of (i) a-amino-3-hydroxy-5-
methyl-4-isoxazolepropionate (AMPA/quisqualate, QA), (ii) kainate (KA) and (iii)
N-methyl-D-aspartate (NMDA), each named after their preferential agonists. The
metabotropic glutamate receptors (mGluRs) are coupled through GTP-binding
proteins to various second messenger systems (Schoepp et al, 1990b).
16
1.3.1. IONOTROPIC GLUTAMATE RECEPTORS
1.3.1.(a) Non-NMDA Receptors
Differential effects of AMPA and KA on C-fibre afferents demonstrated
that two distinct receptor types existed in the spinal cord (Davies et al, 1979).
However, since no other agonist or antagonist clearly distinguishes between these
receptors they are often regarded collectively, as non-NMDA receptors. Reference is
now frequently made to AMPA- and KA-preferring receptors (Partin et al, 1993).
Initial expression cloning studies in the Xenopus oocyte resulted in the
molecular characterisation of two ionotropic glutamate receptor subunits, one each
for NMDA (Moriyoshi et al, 1991) and for AMPA (Hollmann et al, 1989).
Following these experiments, novel but homologous sequences were amplified from
complementary DNA (cDNA) using the polymerase chain reaction (PCR) with
degenerate primers based on the conserved sequence domains. This provided the
sixteen ionotropic receptor subunits now being investigated (see Nakanishi et al,
1992; Wisden & Seeburg, 1993). In vitro, functional AMPA receptors can be
composed of one or any two of the GluRl-4 subunits (Boulter et al, 1990; Nakanishi
et al, 1990). It is the GluR2 subunit which provides the receptor with its low
divalent cation permeability and linear current-voltage relationship (Jonas &
Sakmann, 1992). Kainate-preferring receptors are generated in vitro from the
subunits GluR5, 6 and 7 (Bettler et al, 1990; Egeberg et al, 1991; Sommer et al,
1992; Bettler et al, 1992; Lomeli et al, 1992), orKAl and KA2 (Werner et al, 1991;
Herb et al, 1992; Sakimura et al, 1992). The latter two subunits are not functional if
expressed alone, but can be combined with GluR5 or 6 to provide viable channels
(Herb et al, 1992).
(ai) Location in the Spinal Cord
Ligand binding studies have demonstrated that there are AMPA-
preferring receptors throughout the central nervous system (Monaghan et al, 1984)
and in the spinal cord [^HJAMPA binds preferentially in the substantia gelatinosa of
the dorsal horn (Albin et al, 1993; Henley et al, 1993). Subunits thought to be
primarily involved in the AMPA-preferring receptor complex (GluRl-4) have been
shown by means of in situ hybridisation histochemistry (ISHH) and
immunocytochemistry to be present throughout the dorsal horn with GluR2 showing
strongest expression throughout, and being concentrated in the superficial laminae
(Furuyama et al, 1993; Sato et al, 1993; Tolle et al, 1993). Similarly, [^H] kainic
acid binding shows kainate receptor sites to be widespread throughout the whole of
17
the centra] nervous system, including the substantia gelatinosa (Monaghan &
Cotman, 1982), and messenger RNA (mRNA) for KA2, a kainate receptor subunit, is
abundant in the dorsal horn (Tolle et al, 1993). Also, functional KA receptors have
been characterised in DRG cells (Huettner, 1990).
(aii) Electrophysiological Evidence for a Role in Sensory Processing
Evidence from studies investigating the latency of different synaptic
transmission components suggests that AMPA/QA and KA receptors are involved in
monosynaptic pathways in the spinal cord and they are thus believed to mediate the
fast synaptic transmission brought about by glutamate release (Jahr & Jessell, 1985;
Jahr & Yoshioka, 1986; Gerber & Randic, 1989a), whereas NMDA receptors are
though to contribute towards prolonged changes in excitability and polysynaptic
inputs (Davies & Watkins, 1983; Davies & Lodge, 1983; Peet et al, 1983; Schneider
& Perl, 1985; Schouenborg & Sjolund, 1986; King et al, 1988; Gerber & Randic,
1989a; Morris, 1989).
Electrically-evoked C fibre inputs can be decreased by 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; an antagonist at the non-NMDA type ionotropic
EAA receptors, Blake et al, 1988; Alford & Grillner, 1990), to a greater extent than
A5 fibre inputs (Yoshimura & Jessell, 1990). AMPA has been shown to increase the
response of spinal neurons to noxious mechanical stimulation (Aanonsen et al,
1990), whereas CNQX can decrease dorsal horn neuron responses to both innocuous
and noxious mechanical stimuli (Dougherty et al, 1992, Neugebauer et al, 1993a),
noxious thermal and Ap and A5 fibre strength electrical stimuli (Dougherty et al,
1992). Paleckova et al (1992) demonstrated that C-fibre strength electrical
stimulation of the sciatic nerve evoked the release of glutamate which could be
blocked by CNQX, suggesting this was via AMPA receptors on interneurons.
CNQX can prevent the development of arthritis-induced hyperexcitability
(Neugebauer et al, 1993b) as well as reducing the response of dorsal horn neurons to
innocuous and noxious mechanical stimulation in the inflamed state (Neugebauer et
al, 1994a). Radhakrishnan & Henry (1993) found that CNQX blocked innocuous
hair movement responses only, leaving thermal nociceptive responses completely
unaffected. Haley et al (1990) showed that a non-selective EAA antagonist (y-D-
glutamylglycine, DGG) could decrease both early and late phases of the formalin-
induced firing of dorsal horn neurons, yet an NMDA antagonist inhibited only the
second phase, thus demonstrating a role for non-NMDA receptors, but not NMDA
receptors, in the acute phase of the formalin response.
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(aiii) Behavioural Evidence for a Role in Sensory Processing
The role of non-NMDA receptors in behavioural analgesia is somewhat
controversial. Behavioural testing has demonstrated how intrathecally administered
AMPA or kainate results in caudally-directed biting and scratching (Aanonsen &
Wilcox, 1986; Kitto et al, 1992). Malmberg & Yaksh (1992a) found that
intrathecally administered AMPA resulted in thermal hyperalgesia in the paw,
accompanied by acute agitation of the rats. Both effects were reversed by CNQX. In
contrast Kitto et al (1992) did not observe such decreases in withdrawal latencies to
noxious thermal stimulation. Intrathecal CNQX has been shown to have
antinociceptive effects in the hot plate test, formalin-induced irritation of the
hindlimb (Nasstrom et al, 1992), carrageenan-induced hyperalgesia (Ren et al, 1992)
and, when given as a pre-treatment, can decrease thermal hyperalgesia that was
elicited by chronic constrictive injury (CCI) of the sciatic nerve (Mao et al ,1992).
The release of glutamate due to kaolin/carrageenan-induced arthritis is also decreased
by CNQX (Sluka & Westlund, 1993a). Furthermore, a second AMPA antagonist,
2,3-dihydroxy-6-nitro-sulphamoyl-benzo(f)quinoxaline (NBQX) blocks the
behavioural hypersensitivity produced by laser-induced spinal ischemia (brought
about by an intravascular photochemical reaction, involving the activation of
systemically injected Erythrosin B by an argon laser beam, Xu et al, 1993). In
contrast, Coderre & Melzack (1992) found that AMPA did not increase, and CNQX
did not decrease, the nociceptive behaviour induced by formalin. Non-NMDA
ionotropic receptors clearly appear to play some role in the transmission of
nociceptive information, however the exact physiological significance of these
receptors in sensory inputs to the spinal cord is still unresolved.
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1.3.1.(b) NMDA Receptors
NMDA receptors have been located throughout the brain and central
nervous system (Greenamayre et al, 1984; Monaghan & Cotman, 1985; Moriyoshi et
al, 1991). There is compelling evidence that they play a role in excitability changes
such as long-term potentiation (LTP) in the hippocampus (Collingridge et al, 1983;
Herron et al, 1986; Morris et al, 1986; Bliss & Lynch, 1988). Under normal
physiological conditions the channel which is linked to this receptor is blocked by
magnesium (Mg++, Mayer et al, 1984; Nowak et al, 1984) and the receptor is
unlikely to exert any substantial cellular effects in such an environment. However,
this Mg++ block may be alleviated by partial depolarisation of the membrane (Ben-
Ari et al, 1992), perhaps by another neurotransmitter/modulator. The absence of
glycine in in vitro media led to the discovery that the NMDA receptor has a glycine-
sensitive site which must be occupied for functional activity (Johnson & Ascher,
1987; Kleckner & Dingledine, 1988). Blockade by NMDA receptor antagonist 2-
amino-5-phosphonic acid (APV) of the slow component of neuronal activity, evoked
by electrical stimulation or agonist ionophoresis, has led to the theory that NMDA
receptors mediate the slow synaptic responses brought about by glutamate (Dale &
Roberts, 1985; Dale & Grillner, 1986; Collingridge et al, 1988; King et al, 1988).
As described in section 1.3.2.1. for non-NMDA receptors, the subunits of
the NMDA receptor have been cloned and expressed in vitro. This receptor is a
dimeric structure which can be composed of the NR1 subunit and any one of four
NR2 (A-D) units (Monyer et al, 1992; Kutsuwada et al, 1992; Meguro et al, 1992;
Ikeda et al, 1992; Ishii et al, 1993). The properties of the receptor, including the
strength of Mg++ block and the sensitivity to glycine, are highly dependent on the
NR2 subunit utilised (Monyer et al, 1992; Meguro et al, 1992; Ishii et al, 1993). The
NR1 unit is expressed ubiquitously in the brain and spinal cord (Moriyoshi et al,
1991) and it is the NR2 subunits which show temporal and spatial specifications (e.g.
in the spinal cord see Tolle et al, 1993).
(bi) Location in the Spinal Cord
There are various lines of evidence indicating the presence of NMDA
receptors in the spinal cord. Ligand binding (Greenamayre et al, 1984; Monaghan &
Cotman, 1985; Albin et al, 1993; Henley et al, 1993) indicates that they are present
in the superficial dorsal horn, though Nagy et al (1994) suggest that this may be due
to receptors on the dendrites of deeper cells. The mRNA for NR1, a glutamate-
binding subunit of the NMDA receptor (Kumar et al, 1991), has been located in the
20
dorsal horn. Furuyama et al (1993) observed diffuse and low intensity hybridisation
throughout, but strongest in the deeper layers. Tolle et al (1993) reported an
abundant, widespread and even expression of NR1 mRNA over all of the grey
matter, including the substantia gelatinosa, along with low levels of NR2C and D.
The mRNA for NR1 has also been found in dorsal root ganglia (Shigemoto, 1992).
(bii) Electrophysiological Evidence for a Role in Sensory Processing
Spinal neurons can be excited by NMDA (Anis et al, 1983; King et al,
1988; Sher & Mitchell, 1990a; Dougherty & Willis, 1991b), in some cases those
receiving nociceptive inputs respond preferentially (Aanonsen et al, 1990). Under
normal physiological conditions, i.e. without any deliberate damage or injury,
NMDA receptors do appear to have a role to play, although less clearly than the
AMPA receptor. Responses to noxious mechanical and thermal stimulation of the
skin can be enhanced by NMDA (Aanonsen et al, 1990) and one study found an
increase in the response to innocuous brush (Dougherty & Willis, 1991a). In accord,
under normal conditions NMDA receptor antagonist APV has also been shown to
reduce neuronal responses to noxious mechanical, thermal and electrical stimulation
(Dougherty et al, 1992; Radhakrishnan & Henry, 1993; Raigorodsky & Urea, 1990),
as well as noxious pressure to the knee joint (Neugebauer et al, 1993a). Conversely,
Headley et al (1987) found that ketamine, a dissociative anaesthetic and NMDA
antagonist, failed to alter any sensory responses of dorsal horn neurons under
"normal" conditions. Davies & Lodge (1987) also found that this compound did not
produce any consistent effect until wind-up (a sensitisation phenomenon, see
1.3.1 .(biii)) was induced. These two studies may differ from the others simply
because of the drugs used.
A role for NMDA receptors in the induction and maintenance of a
pathophysiological or sensitised state is strongly indicated. In dorsal horn neurons,
the NMDA receptor-selective antagonists, APV and ketamine can block hindlimb-
ischaemia-evoked firing (Sher & Mitchell, 1990b) and 5-methyl-10,l l-dihydro-5H-
dibenzo[a,d]cyclohepten-5-10-imine maleate (MK-801) reduces background activity
and the response to noxious heating of the skin, following complete Freund's
adjuvant (CFA)-induced inflammation (Ren et al, 1992b). Intravenously or
ionophoretically administered NMDA antagonists can decrease neuronal responses to
innocuous and noxious stimulation of the inflamed knee (Schaible et al, 1991;
Neugebauer et al, 1994a) and prevent the development of neuronal hyperexcitability
induced by acute arthritis (Neugebauer et al, 1993b).
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The second peak of firing evoked in dorsal horn neurons by subcutaneous
formalin (see pi5 for details of the model) can be markedly reduced if NMDA
receptor antagonists are given as a pretreatment or administered during activity,
whereas the first acute phase is largely unaffected (Haley et al, 1990). Similarly,
Woolf & Thompson (1991) found that reflex facilitation induced by either electrical
stimulation or the cutaneous application of mustard oil, a chemical irritant which
selectively activates C-fibres (Heapy et al, 1987; see section 3.2. for details of this
model), could be blocked by NMDA receptor antagonists if they were given before or
after the induction of such sensitisation. Both of these experimental paradigms are
thought to be analogous to the phenomenon of "wind up", an event which may occur
as part of central sensitisation.
(biii) Wind Up and Central Sensitisation
Mendel 1 (1966) initially described "wind up" as the increased firing of a
neuron due to repetitive electrical stimulation of C afferent fibres. The discharge of a
cell could be increased if the stimulus was applied at greater than or equal to one
impulse every two or three seconds (>0.3Hz). Wind up is therefore thought to be
frequency dependent and relies only on the features of the afferent (C-fibre) input,
and not the post-synaptic cell. A central origin for wind up has been proposed, as it
occurs without any rise in the size of the incoming volley (Davies & Lodge, 1987).
This phenomenon typically consists of a transient early phase, thought to be A-fibre
mediated, and a longer-lasting second phase evoked by C-fibre activity (Davies &
Lodge, 1987). However, Headley & Grillner (1990) suggested three components of
wind up. The initial one being NMDA-insensitive, followed by an NMDA sensitive
event and finally a third, longer lasting episode likely to be mediated by some other
neurotransmitter (e.g. tachykinins, see Thompson et al, 1993).
Studies using the electrically-evoked wind up model have consistently
observed the ability of NMDA receptor antagonists to decrease or abolish ongoing C
fibre activity (Davies & Lodge, 1987; Dickenson & Sullivan, 1987; Dickenson &
Sullivan, 1990; Thompson et al, 1990), thus implicating the NMDA receptor in
prolonged nociceptive inputs. The non-selective EAA receptor antagonist
kynurenate can decrease the two phases of wind up suggested by Davies & Lodge
(1987), whereas ketamine, a selective NMDA antagonist, only the second (Davies &
Lodge, 1987). Haley et al (1990) observed a similar outcome in the formalin model
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using DGG and APV. These studies, along with further electrophysiological
experiments in which electrically-evoked synaptic responses have been broken down
into separate components (Gerber & Randic 1989a; 1989b; Dickenson & Sullivan,
1990), have therefore suggested that non-NMDA receptors are involved in both low
and high threshold inputs to the dorsal horn, whereas NMDA receptors play a more
selective role in high threshold, particularly C-fibre, inputs.
The activity-dependent alterations in dorsal horn neuron responsiveness
brought about during wind-up are thought to be part of the phenomenon of central
sensitisation. This process is initiated by prolonged noxious or inflammatory
stimulation of these neurons, with a normally innocuous A(3 fibre input resulting in
an exaggerated, painful response ("allodynia"; Woolf & King, 1990). Further
consequences of central sensitisation can be seen as an elevated level of neuronal
firing in response to mechanical (Kenshalo et al, 1979; 1982; McMahon & Wall,
1984; Hylden et al, 1989; Laird & Cervero, 1989; Simone et al, 1991; Woolf &
King, 1990), thermal (Kenshalo et al, 1979; Simone et al, 1991) and chemical
(Simone et al, 1991; Dougherty & Willis, 1992) stimulation, as well as a facilitation
of nociceptive flexor reflexes (Woolf & Wall, 1986). An expansion of the cutaneous
receptive field is also observed (McMahon & Wall, 1984; Cervero et al, 1990; Woolf
& King, 1990; Treede et al, 1992). An additional manifestation of central
sensitisation is secondary hyperalgesia, whereby an area outwith the site of injury
(often well beyond the region of neurogenic inflammation, perhaps even a
contralateral limb) experiences increased sensitivity to noxious stimulation - changes
which cannot be fully explained by peripheral mechanisms. Evidence for a central
component includes a demonstration by LaMotte et al (1991) that local anaesthetic in
the primary area prevents capsaicin-induced secondary hyperalgesia to mechanical
stimuli only if given before the capsaicin injection, but not after. Also, in
behavioural studies, secondary hyperalgesia, due to noxious thermal injury of the
ipsilateral paw fifteen minutes previously, persists in an uninjured contralateral paw
(Coderre & Melzack, 1991). Pretreatment with intrathecal APV prevented the
development of this hyperalgesia.
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(biv) Behavioural Evidence for a Role in Sensory Processing
The involvement of NMDA receptors in nociception has been
demonstrated in a variety of behavioural tests, including those mentioned above as
reflecting at least in part, secondary hyperalgesia. Intrathecal NMDA itself can
induce biting and scratching behaviour indicative of a painful state (Aanonsen &
Wilcox, 1986; 1987; Raigorodsky & Urea, 1987; Coderre & Melzack, 1991) and this
can been reversed by the NMDA receptor antagonist APV (Aanonsen & Wilcox,
1986 ; Raigorodsky & Urea, 1990). Also, when delivered as a pretreatment NMDA
can potentiate similar nociceptive behaviour observed in response to a subcutaneous
injection of formalin (Coderre & Melzack, 1992). Kolhekar et al (1993) found that a
higher dose of NMDA could give rise to reflex facilitation in the thermal tail flick
test, with a lower dose inducing hypoalgesia. Spinalisation, by local cold blocking of
the cord, resulted in abolition of the NMDA-induced inhibition, but no change in the
facilitation of the reflex. It was therefore suggested that a local mechanism was
employed for NMDA-evoked hyperalgesia but the involvement of supraspinal sites
was required in NMDA-evoked hypoalgesia. Further support for a local mechanism
being responsible for this NMDA facilitation is that it can also be observed in the
hemisected spinal cord in vitro (Thompson et al, 1992; Rusin et al, 1993b) and in
skin-hindlimb (Thompson et al, 1990) preparations, where supraspinal circuitry is
irrelevant.
Antagonists to NMDA receptors have been shown to be antinociceptive
in a number of behavioural studies involving sensitisation (and on some occasions in
models not considered to involve sensitisation). In the acute state, latencies in the
thermal tail flick reflex (Cahusac et al, 1984; Raigorodsky & Urea, 1990) and the hot
plate response (Cahusac et al, 1984; Nasstrom et al, 1992) are both delayed by
NMDA antagonists (APV, 2-amino-7-phosphonoheptanoic acid (AP7) and 3-(2-
carboxypiperazine-4-yl)propylphosphonate (CPP)). The latencies of paw withdrawal
to noxious mechanical stimulation is also prolonged by APV administration
(Cahusac et al, 1984). In more chronic situations NMDA receptor antagonists are
also analgesic: thermal hyperalgesia induced by carrageenan is reduced by MK-801,
APV & CPP, Ren et al, 1992a; 1992b); sciatic nerve ligation hyperalgesia is reduced
by MK-801 (Davar et al, 1991; Yamamoto & Yaksh, 1992a; 1992b); and by 1-
hydroxy-3-aminopyrrolidone-2 (HA 966, Mao et al, 1992) and heat injury
hyperalgesia is reduced by APV (Coderre & Melzack, 1991). Similarly, autotomy
evoked by sciatic nerve ligation is prevented by intrathecally applied MK-801 or
APV (Seltzer et al, 1991). Licking of the paw induced by the subcutaneous
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administration of formalin can likewise be decreased by APV, MK-801, AP7 & CPP;
(Murray et al, 1991; Coderre & Melzack, 1992; Nasstrom et al, 1992; Vaccarino et
al, 1993), as can the mechanical hyperalgesia resulting from intraplantar injection of
complete Freund's adjuvant (Ren et al, 1992b; Ren & Dubner, 1993).
It would therefore appear that NMDA receptors are involved in the
transmission of nociceptive information, particularly after the system has undergone
some form of sensitisation. They mediate high threshold inputs via A5 and C fibres.
Non-NMDA receptors, on the other hand, have a more general function, in that they
do play some role in nociception, but are also involved in low threshold A(3 fibre
inputs. There is a further group of receptors by which glutamate may exert its
effects, that is the metabotropic group, which, rather than acting via ion channels, are
directly coupled to intracellular signalling pathways.
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1.3.2. Metabotropic Glutamate Receptors
A metabotropic type of glutamate receptor was initially implicated
following the enhancement of inositol phosphate hydrolysis by glutamate, in
mammalian brain cells (Sladeczek et al, 1985; Nicoletti et al, 1986). Sugiyama et al
(1987) later demonstrated a quisqualate (QA)-preferring receptor directly activating
inositol phosphate metabolism, via a G protein, which could not be blocked by Joro
spider toxin, a known blocker of ionotropic QA receptors.
(a) Cloning and Expression of Receptor Subtypes
Masu et al (1991) were the first to isolate a metabotropic glutamate
receptor (mGluR) cDNA, now known as mGluRla. Using the mRNA of mGluRla
as a probe for sequences with high homology, cloning and expression of the other
receptors quickly followed, with a total of 8 to date (Tanabe et al, 1992; Abe et al,
1992; Nakajima et al, 1993; Okamoto et al, 1994; Duvoisin et al, 1995). Three
further splice variants of mGluRl have been found: mGluR lb (Tanabe et al, 1992)
and mGluRlc (Pin et al, 1992), both of which are around 300 amino acids shorter
than mGluRla. More recently a truncated (presumably non-functional) sequence
termed mGluRle has also been detected (Pin & Duvoisin, 1995). Similarly, a splice
variant of mGluR4 has been cloned, resulting in an mGluR4b protein which is 127
residues longer than the original (Simoncini et al, 1993). Finally, there is an
mGluR5b variant which is 32 amino acids longer than mGluR5a (Minakami et al,
1993). It is not yet clear whether the splice variants have different functional roles or
not.
Most of the receptor subtypes are expressed throughout the central
nervous system, however, some have specific regions of preference: mGluR 1
mRNA is highly expressed in the hippocampus and cerebellar neurons (Masu et al,
1991) whereas mGluR2 is found primarily in Golgi cells of the cerebellum and the
olfactory bulb (Tanabe et al, 1992; Ohishi et al, 1993). mGluR3 is prominently
expressed in the cerebral cortex and dentate gyrus, but is also very abundant in glial
cells (Tanabe et al, 1992; 1993). Granule cells of the cerebellum appear to be rich in
mRNA for mGluR4 (Tanabe et al, 1992), as are the cerebellum, thalamus and
olfactory bulb (Tanabe et al, 1993), while mGluR5 has been localised in the
pyramidal cells in areas CA1-CA4 of the hippocampus and dentate gyrus granule
cells (Abe et al, 1992). Messenger RNA for mGluR6 was found exclusively in the
retina, with no expression elsewhere in the brain (Nakajima et al, 1993), while a
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Table 1.1.
A summary of the subgroups of metabotropic glutamate receptors
Metabotropic glutamate receptors have been divided into three distinct groups, on
the basis of their signal transduction pathways and agonist specificity.
IP3: Inositol-1-4-5-triphosphate; Ca++: calcium; cAMP: cyclic AMP;
QA: quisqualate; Glu: glutamate; ACPD:(lS,3R)-l-aminocyclopentane-l-3-










SIGNAL TRANSDUCTION IP3/ Ca++ inhibition ofcAMP inhibition ofcAMP
AGONISTSELECTIVITY QA>glu>ibotenate>ACPD glu>ACPD>ibotenate»QA L-AP4>glu»ACPD
widespread distribution of mGluR7 mRNA was observed (Okamoto et al, 1994).
Finally, mGluR8 has been primarily located in the olfactory bulb and weakly in the
retina (Duvoisin et al, 1995). Athough several mGlu receptor mRNAs have been
located in the spinal cord, none of them were found to be prominently expressed.
(b) Intracellular Signalling Pathways & Receptor Subgroups
All metabotropic glutamate receptors are, by definition, coupled to GTP-
binding proteins. They appear to elicit not only inositol phosphate hydrolysis as
originally described (Nicolletti et al, 1986; Challis et al, 1988; Sladeczek et al 1988;
Baird et al, 1991) but many other intracellular changes. These receptors can activate
protein kinase C (PKC), via diacylglycerol (Manzoni et al, 1990; Behnisch &
Reymann, 1993), evoke the release of arachidonic acid (Aramori & Nakanishi,
1992), increase (Aramori & Nakanishi, 1992; Winder & Conn, 1992; 1993), decrease
(Manzoni, et al, 1990; Cartmell et al, 1992; Schoepp & Johnson, 1992) cyclic AMP
(cAMP) formation, elevate intracellular calcium (Murphy & Miller, 1988; 1989) or
activate phospholipase D (Boss & Conn, 1992). Downstream modulation of various
ion channels is also evident (Lester & Jahr, 1990; Fagni et al, 1991; Bleakman et al,
1992; Cerne & Randic, 1992). Due to the complexity of cellular activity, these initial
steps induced by the binding of glutamate to a metabotropic receptor may then go on
to activate, or indeed inhibit, further intracellular pathways.
The eight different mGluRs known at present (Nakanishi, 1992;
Okamoto et al, 1994; Duvoisin et al, 1995) have been divided into three groups
based on their mRNA sequence homology, coupling to intracellular signalling
pathways and their agonist (and more recently antagonist) pharmacology:
(I) mGluRs 1 and 5: These receptors are directly coupled to inositol
phosphate hydrolysis/calcium signal transduction (see Figure 1.3.(a)) and are most
sensitive to quisqualate (Houamed et al, 1991; Masu et al, 1991; Abe et al, 1992). A
relatively new compound, 3,5-dihydroxyphenylglycine (3,5-DHPG), has also been
shown to have preferential agonist properties for these receptors (Schoepp et al,
1994). (S)-4-carboxy-3-hydroxyphenylglycine ((S)-4C3HPG and (S)-CHPG) are
antagonists at Group I mGluRs, but it is possible that their potency may be species-
dependent (Joly et al 1995; Kingston et al, 1995). Cyclothiazide (CTZ), a selective
mGluRl antagonist, can pharmacologically distinguish between these two receptors
(Sharp et al, 1994).
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(II) mGluRs 2 and 3: The receptors in this group are negatively linked to
the formation of cAMP (see Figure 1.3.(b)) and are highly sensitive to (1S,3R)-1-
aminocyclopentane-l-3-dicarboxylic acid ((1S,3R)-ACPD; Nakanishi, 1992; Tanabe
et al, 1992; 1993) as well as (2S,3S,4S)-oc-(carboxycyclopropyl)glycine (CCG-I;
Hayishi et al, 1992) and (2S,l'R,2'R,3'R)-2-(dicarboxycyclopropyl)glycine (DCG-IV;
Hayishi et al, 1993). a-methyl-L-CCG-I (MCCG) has been shown to selectively
antagonise responses induced by CCG-I, and not (1S,3R)-ACPD, in neonatal rat
primary afferent terminals (Jane et al, 1994).
(III) mGluRs 4, 6 and 7 (and 8): Finally, the third group are also
involved in an inhibition of cAMP production (see Figure 1.3.(b)). These receptors
are insensitive to (1S,3R)-ACPD, but are easily activated by L-
aminophosphonobutanoate (L-AP4, Thomsen et al, 1992; Nakajima et al, 1993;
Tanabe et al, 1993; Okamoto et al, 1994; Duvoisin et al, 1995). Specific antagonism
of L-AP4-, and not (1S,3R)-ACPD-, induced excitations in primary afferent
terminals has been demonstrated using a-methyl-L-AP4 (Jane et al, 1994).
(See table 1.1. for summary).
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(c) Electrophysiological Evidence for a Role in Sensory Processing
There have been many studies investigating the pharmacological profiles
of the mGluR subtypes, primarily using phenylglycine derivatives from Watkins and
his colleagues (see Watkins & Collingridge, 1994 for review). These experiments,
mainly in vitro, have demonstrated the existence of functional mGluRs in many areas
of the brain including the somatosensory cortex (Cahusac, 1994), visual cortex (Kato,
1993), olfactory cortex (Collins, 1993), olfactory bulb (Hayashi et al, 1993), nucleus
of the tractus solitarius (Glaum et al, 1993), striatum (Lombardi et al, 1993),
thalamus (Birse et al, 1993; Jane et al, 1993; Eaton et al, 1993a; 1993b; Salt & Eaton
1995a; 1995b) and the hippocampus (Harvey et al, 1991; Otani & Ben-Ari, 1991;
Bortollotto & Collingridge, 1992; 1993; Bashir et al, 1993; Behnisch & Reymann,
1993). However, the number of physiological studies concerning nociception or the
spinal cord have been relatively few. Several in vivo investigations into the role of
mGluRs in somatosensory processing in the thalamus have been made. Excitatory
neuronal responses evoked in thalamic neurons by noxious thermal, but not
innocuous air jet, stimulation can be selectively inhibited by mGluR antagonists (S)-
CHPG, (S)-carboxyphenylglycine ((S)-4CPG) and a-methyl-4-carboxyphenylglycine
(MCPG or a-MeCPG; Eaton et al, 1993a; 1993b). Later, using selective
compounds, Salt & Eaton (1995a; 1995b) showed how Group II and III mGluRs may
be presynaptically located on GABAergic terminals in the ventrobasal (VB)
thalamus, and play a role in the disinhibition of air jet- and electrically-evoked
somatosensory inputs. From their studies they also suggest a postsynaptic mGluR 1,
as VB neurons are excited by both (1S,3R)-ACPD and 3,5-DHPG.
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Regarding the spinal cord, in vitro studies have shown mGluR agonist
(1S,3R)-ACPD can potentiate the responses induced by ionotropic receptor agonists
in both isolated dorsal horn neurons and in a spinal cord slice preparation (Bleakman
et al, 1992; Cerne & Randic, 1992). A recent in vivo study confirming this
potentiation used more specific agonists and suggested the action is through either
Group I or II mGluRs (Bond & Lodge, 1995). Jones & Headley (1995) found a
similar rise in ionotropic agonist-evoked activity, however taking increases in
background activity into account they concluded the 'potentiation' was not a specific
interaction between ionotropic and metabotropic glutamate receptors. Neugebauer et
al, (1994b) found mGluR antagonist L-l-amino-3-phosphonopropionic acid (L-AP3)
reduced the response to pressure applied to the knee following the induction of
inflammation, but not before. In contrast to this, in primate STT neurons Palecek et
al (1994) found (1S,3R)-ACPD, at a low, but not high, dose enhanced brief neuronal
responses to innocuous brushing of the receptive field. They did not observe either
dose to enhance the neuronal response to brief noxious stimulation. Also, Thompson
et al (1992) found no effect of L-AP3 on C-fibre-evoked ventral root potentials in a
neonatal in vitro spinal cord preparation. However, this could have been due to the
age of the animal, as the potency of L-AP3 seems to depend on it (Schoepp &
Johnson, 1989a; 1989b), and the developmental stage of the fibres involved.
It would appear from the data available at present that mGluRs may play a
role in prolonged nociception or sensitisation, but perhaps less so in brief
somatosensory inputs, at least in the spinal sord. Another synaptic event which is
thought to be analogous to sensitisation, long-term potentiation, has been the subject
of much investigation with respect to mGluRs.
(d) Long-Term Potentiation Studies
Until recently long-term potentiation (LTP), the activity-dependent
phenomenon whereby a long lasting efficacy in synaptic transmission is brought about
following a brief period of high frequency axonal stimulation, has been mainly
attributed to NMDA receptors (for review see Collingridge, 1992). However,
mGluRs are also known to play a role in this event - analogous to the sensitisation
observed in dorsal horn neurons during sustained nociceptive inputs. Initial studies
showed that (1S,3R)-ACPD could induce (Bortollotto & Collingridge, 1992; Bashir
et al, 1993), mediate (Otani & Ben-Ari, 1991) or augment (McGuinness et al, 1991;
Anikszten et al, 1992) LTP in the hipppocampus. Later Bortollotto & Collingridge
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(1993) demonstrated that an ionotropic receptor-independent LTP could be evoked
using (1S,3R)-ACPD, without the accompanying short term potentiation component
normally seen with NMDA-induced LTP. No tetanic stimulation was necessary for
this to occur, although pathways from CA1-CA3 had to remain intact. Antagonist
studies using L-AP3 (Behnisch et al, 1991; Izumi et al, 1991; Behnisch & Reymann,
1993) and (RS)-aMeCPG (Bashir et al, 1993; Richter-Levin et al, 1994; Riedel et al,
1995) have illustrated how LTP is sensitive to mGluR inactivation - particulary
during, or immediately after the induction of, tetanization (Behnisch & Reymann,
1993). Behaving rats also show a sensitivity to aMeCPG, as they demonstrate a
disrupted performance in spatial learning (water maze) following intraventricular
administration of this compound (Richter-Levin et al, 1994).
(e) Behavioural Evidence for a Role in Sensory Processing
There have been few behavioural experiments concerning mGluRs with regard to
long-term potentiation or nociception. Coderre & Melzack (1992) found that the
behavioural response to formalin was enhanced if mGluR agonist (1S,3R)-ACPD was
given intrathecally as a pretreatment. A similar augmentation in behaviour brought
about by NMDA administration could be increased even further if the two compounds
were given together. However, they did not observe any analgesic effect of L-AP3 in
the same, or later (Coderre & Empel, 1994) experiments.
Metabotropic glutamate receptors therefore appear to be involved in
synaptic events in a variety of areas in the central nervous system. They undoubtedly
have a role to play in the transmission of nociceptive information, and this role may be
more substantial in a sensitised state However mGluRs are only one of a number of
contributors to this kind of role, since several other receptors have been implicated in
nociception and sensitisation, including those which are activated by the tachykinins.
1.4. Tachykinins
The mammalian tachykinins are a family of neuropeptides characterised by
their common carboxy terminal sequence Phe-X-Gly-Leu-Met. The family includes
substance P (SP), neurokinin A (NKA), neurokinin B (NKB), neuropeptide K (NPK)
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and nr.urope.plide y (NPy) There are Iwo prepioladiykiiiin (PPT) genes responsible
for tachykinin production. Preprotachykinin I (PPT I), consists of three variants, a-,
(3- and y-PPT, the first of which encodes SP only, whereas (3- and y-PPT result in
both SP and NKA mRNA expression, accompanied by NPK and NPy respectively
(Nawa et al, 1984; Krause et al, 1987). The second gene, PPT II is responsible for
NKB production (Bonner et al, 1987). Expression of a-PPT I mRNA in the central
nervous system accounts on average for less than 0.5% of the total level of PPT I ((3-
PPT and y-PPT are 22% and 78% respectively; Carter & Krause, 1990), it therefore
seems likely that SP mRNA is rarely expressed, or SP released, alone. In further
support of this, immunohistochemical analysis shows how nearly all SP-LI-labelled
DRG cells are also positive for NKA-LI (Dalsgaard et al, 1985).
There are three receptors through which the tachykinins exert their
effects: NK], NK2 and NK3, at which SP, NKA and NKB are the respective
preferential endogenous ligands (Regoli et al, 1987; Maggi et al, 1993). There is
evidence that pharmaological subtypes of NK] and NK2 receptors exist (especially
between groups of species, see Maggi et al, 1993, for review). All three receptors are
linked via G-proteins to phosphoinositide metabolism (Watson & Downes, 1983;
Bristow et al, 1987; Guard et al, 1988; Nakajima et al, 1992). The present study
concerns the role of NK] and NK2 receptors in sensory processing.
1.4.1. Location in the Spinal Cord
(a) Substance P and NKy Receptors
Using radioimmunoassay, immunohisto- and immunocyto- chemical
techniques, the presence of SP and SP-LI has been detected in the dorsal horn,
predominantly in the superficial layers, and dorsal root fibres (Hokfelt et al, 1975;
1977; Gibson et al, 1981; Chamay et al, 1983; Ogawa et al, 1985). The SP of
primary afferent origin has been shown to come particularly from small unmyelinated
(C) fibres (Hokfelt et al, 1980). Substance P has also been located in intrinsic
neurons and some descending fibres (Jessell et al, 1979; Ogawa et al, 1985; Yaksh et
al, 1988), as demonstrated by nerve section or dorsal rhizotomy. In situ hybridisation
histochemistry has detected mRNA for SP (probing for a sequence common to a-, (3-
and y-PPT) throughout the central nervous system (Haran et al, 1989), including high
expression in laminae I and II of the dorsal horn (Warden et al, 1988). Although
ligand binding studies have revealed NK] receptors predominantly, but not
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exclusively in laminae I, II and X (Yashpal et al, 1990), mRNA for the receptor is not
highly abundant in these areas (Maeno et al, 1993). Studies utilising newly available
antibodies directed against the NK| receptor have revealed a distribution similar to
that observed in ligand binding studies (Bret-Dibat et al, 1994; Brown et al, 1995).
(b) Neurokinin A and NK2 Receptors
NKA, like SP, is synthesised in primary sensory neurons (Harmar & Keen,
1984) and found in fine afferent fibres (Kimura et al, 1983; Sundler et al, 1983;
Ogawa et al 1985). Indeed, Ogawa et al (1985) showed it has a similar distribution
to SP throughout dorsal roots, DRG cells and the dorsal horn. The preferred
receptors for NKA (NK2) have been shown by radioligand binding to be limited to
the superficial laminae of the dorsal horn, unlike NKj receptors which are present in
both sensory and motor systems (Yashpal et al, 1990). Using antagonists which have
varying activity at putative NK2 receptor subtypes Wiesenfeld-Hallin et al, (1994)
have suggested the existence of at least two subtypes in the rat spinal cord, suggesting
that NK2A is the one likely to mediate NKA-induced excitation. Attempts have been
made to locate the mRNA for NK2 receptors in the nervous system, but levels in
spinal cord have so far proved too low to quantify (Poosch et al, 1991; Takeda &
Krause, 1991; R.M.C. Parker, PhD thesis, 1994).
1.4.2. Evidence for a Role of NKj Receptors in Sensory Processing
(a) Electrophysiological Studies
Upon ionophoretic application, SP can excite dorsal horn neurons (Henry,
1976; Zieglgangsberger & Tulloch, 1979), resulting in a slow postsynaptic
depolarization (Urban & Randic, 1984; Randic et al, 1988), and in laminae I - II it
selectively activates those neurons responsive to noxious stimuli (Randic & Miletic,
1977). The role of SP in the transmission of acute nociceptive information is unclear.
A decrease in the response of dorsal horn neurons to "brief" noxious cutaneous
stimuli was observed by Radhakrishnan & Henry (1991) and De Koninck
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& Henry (1991) using non-peptide NK] receptor antagonist CP,96345. However, the
intensity and duration of the stimuli in those studies do seem substantial, and this
compound exerts calcium channel-blocking effects, which should be considered
when interpreting findings. In contrast, Fleetwood-Walker et al (1987; 1990), using
spantide, saw little change in the responses of dorsal horn neurons to noxious
cutaneous stimulation, but did observe an attenuation in those to innocuous stimuli.
In several experimental paradigms NK] receptor antagonists are seen to
reduce nociceptive responses only after a sustained input or some form of
conditioning stimulus: CP96345 (Xu et al, 1992) and RP67580 (another non-peptide
antagonist, Laird et al, 1993) facilitate a nociceptive reflex following a noxious
electrical conditioning stimulus, but have no effect on the baseline reflex. Also,
while no effect of CP96345 is observed on single C-fibre volleys (De Koninck &
Henry, 1991; Chapman & Dickenson, 1993), it does reduce the activity elicited in
dorsal horn neurons during the second phase of the formalin response (Chapman &
Dickenson, 1993) and high intensity electrical stimulation (De Koninck & Henry,
1991). Furthermore, when applied onto the spinal cord, SP enhanced and NK]
antagonist [D-Pro^, D-Pro^'9]-SP attenuated wind up (Kellstein et al, 1990). In
addition to this, RP67580 and CP96345 do not decrease responses to acute and
sustained C-fibre stimulation in normal amimals however they do following a UV-
induced burn to the cutaneous receptive field (Thompson et al, 1994). Furthermore,
flexion of the knee joint induces SP release in the dorsal horn, (measured with
antibody microprobes), only following the induction of inflammation by an intra¬
articular injection of kaolin/carrageenan (Schaible et al, 1990). Capsaicin-induced
sensitisation of primate STT neurons can be prevented by NK] antagonists CP96345
and GR82334 (Dougherty et al, 1994), though Nagy et al (1993) did not observe this
in when recording from rat dorsal horn neurons in an in vitro spinal cord preparation.
Thompson et al (1993) demonstrated an APV-iesistant component of wind-up which
is sensitive to both of the non-peptide NK] receptor antagonists mentioned above,
but the peptide antagonist GR82334 failed to reduce the comparable sustained
neuronal response elicited by applying mustard oil to the cutaneous receptive field
(Munro et al, 1993). This may be an indicator as to the level of nociceptive input
required before NK] receptors participate directly in nociception, since the collective




Although intrathecally administered SP evokes biting and scratching
behaviours highly indicative of a painful sensation (Hayes & Tyers, 1979; Hylden &
Wilcox, 1981; Yashpal et al, 1982) and it, or an NK] receptor agonist, can facilitate
the tail flick reflex (Cridland & Henry, 1986; Gamse & Saria, 1986; Couture et al,
1993; Picard et al, 1993), non-peptide NK] antagonists fail to alter latencies to this
acute noxious thermal stimulation of the tail, or paw (Garces et al, 1992; Malmberg
&Yaksh, 1992a; Yamamoto & Yaksh, 1992a; Couture et al, 1993; Picard et al, 1993
- all using CP96345; Seguin et al, 1995 - CP99994, RP67580, SRI40333,
WIN51708 & WIN62577). Similarly in the hot plate test, SP does not cause
facilitation (Gamse & Saria, 1986) nor does CP96345 prove antinociceptive (Garces
et al, 1992).
Several antagonists to the NK] receptor do however appear to be
analgesic when the noxious input is more prolonged. In writhing induced by acetic
acid or phenylbenzoquinone, NK] receptor antagonists CP96345, CP99994,
RP67580, SR140333, WIN51708 and WIN62577 are antinociceptive (Garret et al,
1991; Seguin et al, 1995). Similarly, acetylcholine-evoked abdominal constriction is
reduced by CP96345, CP99994, RP67580 and peptide antagonist GR82334 (Birch et
al, 1993). Furthermore, the behaviour induced by a prolonged noxious input due to
the subcutaneous administration of formalin is reduced, particularly in the later
phase, by CP96345, CP99994, RP67580, SRI40333, WIN51708 and WIN62577 and
by peptide antagonists GR82334 and D-Pro-SP (Garret et al, 1991; Murray et al,
1991; Yamamoto & Yaksh, 1991; Birch et al, 1992; 1993; Yashpal et al, 1993;
Seguin et al, 1995). Nagahisha et al (1992) found both CP96345 and its enantiomer
CP96344 (with low NK] affinity) to be antinociceptive in carrageenan- and formalin-
induced behavioural responses, and although this has not been observed in all cases
(see Yamamoto & Yaksh, 1991; Yashpal et al, 1993) data using only CP96345
should be considered with care. Capsaicin-induced licking and biting is also reduced
by intrathecal injection of NK] antagonist D-Phe'-SP (Sakurada et al, 1992), as is
heat injury-evoked hyperalgesia in the contralateral paw, with D-Pro^-SP (Coderre &
Melzack, 1991). However, NK] receptor antagonists CP96345 and GR82334 failed
to increase paw withdrawal latencies to noxious thermal or mechanical stimulation
following chronic constrictive nerve injury- (Yamamoto & Yaksh, 1992a) or
carrageenan- (Young et al, 1995a) induced hyperalgesia. The reason for such
variability is likely to lie in the models, but could reflect distinct C-fibre populations.
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1.4.3. Evidence for a Role of NK2 Receptors in Sensory Processing
(a) Electrophysiological Studies
Unlike NK] receptors, there appears to be a clear role for NK2 receptors
in acute nociceptive transmission, as well as sustained. Selective NK/> receptor
antagonists, both peptide (D-Tyr^-SP and D-Pro4-SP) and non-peptide (SR48968),
reduce neuronal responses to brief noxious thermal, but not mechanical, stimulation
in both the dorsal horn (Fleetwood-Walker et al, 1990) and thalamus (Santucci et al,
in muscle afferents
1993). The baseline flexor reflex^can be facilitated by NKA and blocked by non-
peptide antagonist MEN 10376 (Xu et al, 1991). Similarly, single electrically-evoked
C-fibre potentials can be reduced with MEN 10376 both before (Thompson et al,
1993; 1994) and after a UV-induced burn to the cutaneous receptive field (Thompson
et al, 1994). Also, pre-UV, UV-enhanced (Thompson et al, 1994), capsaicin-evoked
(Nagy et al, 1993) or mustard oil-induced (Munro et al, 1993) sustained C-fibre
inputs can be reduced by NK2 antagonists MEN10376 and L659,874. Detection of
IR-NKA, using by antibody microprobes, can be seen following noxious, but not
innocuous, mechanical or thermal stimulation in the normal cat (Duggan et al, 1990).
Furthermore, normally innocuous joint flexion fails to result in any release of IR-
NKA until inflammation is induced by the injection of kaolin/carrageenan into the
knee (Hope et al, 1990).
(b) Behavioural Studies
Few studies have addressed the antinociceptive role of NK2 receptors by
means of behavioural testing. Intrathecally injected NKA, or an NK2 agonist, will
decrease latencies in tail flick and, in some cases hot plate, test (Cridland & Henry,
1986; Gamse & Saria, 1986; Fleetwood-Walker et al, 1990; Couture et al, 1993;
Picard et al, 1993). Accordingly, in the same tests, antagonists to NK2 receptors, D-
Pro-SP and F659,874 have been shown to increase latencies to such noxious thermal
(though not mechanical) stimulation, both in naive and carrageenan-treated animals
(Fleetwood-Walker et al, 1990; Young et al, 1995a; F.E. Munro, PhD thesis, 1995).
Also, the second phase of formalin-induced behaviours can be inhibited by NK2
antagonist SR48968 (Seguin et al, 1995). In contrast, this drug was not
antinociceptive in the tail flick or acetic acid-induced writhing tests. Birch et al
(1993) failed to see an antinociceptive effect of another NK2 antagonist GR115211
in thermal (hot plate/tail flick) or chemical (acetylcholine-induced abdominal
constriction/formalin-evoked biting and scratching) tests. However, in this study
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GR115211 also failed to antagonise the nociceptive effect induced by intrathecally
administered NK2 agonist GR64349. As with behavioural data using NKj receptor
antagonists the discrepancies may lie in subtleties in the method of testing, or indeed
the drugs chosen.
The tachykinins seem to mediate nociception with temporal and modality
differences through both NK] and NK2 receptors. It would appear SP, via NKj
receptors, is involved in mediating prolonged nociceptive inputs whereas NKA,
through NK2 receptors, mediates both brief and sustained nociceptive transmission,
particularly of a thermal nature.
On some occasions the antinociceptive effects of NK] and NK/? receptor
antagonists can be altered, indeed enhanced, by the co-administration of EAA
receptor compounds. It would appear that these two receptor groups interact in the
dorsal horn to exert an integrated influence on dorsal horn neurons.
1.5. Interactions Between Excitatory Amino Acid &
Tachykinin Receptors
Substance P and glutamate have been shown to co-exist in DRG cells
(Battaglia & Rustioni, 1988) and, more importantly, C-, and some A5-, afferent fibre
terminals (DeBiasi & Rustioni, 1988) - suggesting that they are likely to be co-
released upon stimulation of the presynaptic cell. Furthermore, since the presence of
NKA almost always accompanies SP in DRG cells (Dalsgaard et al, 1985; see
section 1.4.), all three neurotransmitters may be presumed to exist in the same
primary sensory neurons. There is a growing body of evidence which suggests that
glutamatc and tachykinin receptors interact to enhance the transmission of
nociceptive information.
(a) Electrophysiological Studies
Both in vitro and in vivo studies support an interaction between
NK1/NK2 and glutamate receptors, with the general consensus being that agonists to
neurokinin receptors can both enhance and attenuate responses induced by EAA
receptor agonists. The release of EAAs can be induced by SP superfusion in both the
frog (Nagy et al, 1981) and rat spinal cord, in vitro (Kangrga & Randic, 1990) and in
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vivo (Skilling & Larson, 1993). Substance P was originally shown to enhance
glutamate-evoked dorsal horn neuron activity in the 1970s (Zieglgangsberger & Puil,
1973; Zieglgangsberger & Tulloch, 1979). Since then several in vitro studies have
reiterated this, but found also that EAA-evoked activity can be diminished by the co-
application of SP: Randic et al (1990) found in voltage clamped isolated dorsal horn
neurons that NMDA-, but not other EAA-, induced currents could be increased, or
less often (in 35% of cells) decreased, following pretreatment with SP. Later Rusin
et al (1992; 1993a,b) confirmed that the same occurred with NKA, though it caused a
decrease in a higher proportion of cells (75% of those tested). The results due to co¬
administration versus pretreatment with tachykinins differed in that pretreating a
neuron resulted in an initial decrease of NMDA-elicited reponses, followed by an
elevation, whereas a co-administration led to one or the other. In vivo, NMDA-
evoked increases in responses of primate spinothalamic tract neurons to noxious
mechanical stimulation of the receptive field can be augmented or attenuated when
SP is simultaneously ionophoresed (Dougherty & Willis, 1991b; 1993), and in
around half of the dorsal horn neurons in the cat tested by Song & Zhao (1994) the
NK] antagonist spantide enhanced the reductions of C-fibre responses brought about
by APV. Urban et al (1994) found NMDA or QA-induced ventral root potentials
could be increased by both NK] agonist SP-methyl ester and NKA, but they did not
report mixed effects.
Substance P-induced facilitation of the flexor reflex can be reduced with
NMDA receptor antagoinst MK801 (Xu et al, 1992), and in this study low doses of
NK] and NMDA antagonists (MK801 and CP96345), that alone did not decrease this
nociceptive reflex, reduced it markedly when given together. Similarly, the C-fibre-
mediated activity elicited by capsaicin in DRG cells could be partially decreased by
NMDA and NK2 receptor antagonists, APV and MEN10376, but almost completely
abolished when given together (Nagy et al, 1993). These studies are comparable
with the NMDA- and tachykinin-sensitive components of wind-up that Thompson et
al (1993) describe (see section 1.4.2.(a).)
(b) Behavioural Studies
Kainate, AMPA and NMDA all evoke caudally-directed biting and
scratching, but when the same dose is co-administered with SP the resulting
behavioural responses are increased twenty-, thirty- and forty-fold respectively
(Mjellem-Joly et al, 1991). Furthermore, while either NMDA or SP given alone as
an intrathecal injection has no effect on formalin-evoked licking/biting of the
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hindlimb, together they increase the response in both the acute and tonic phase
(Mjellem-Joly et al, 1992). Also, SP- or noxious thermal stimulation-induced
facilitation of the tail flick reflex is attenuated by NMDA receptor antagonist APV
(Yashpal et al, 1991); results corresponding with those observed
electrophysiologically by Xu et al (1992, see above). However, Murray et al (1991)
did not observe any additive antinociceptive effect in the formalin test when
antagonists to NK] and NMDA receptors were administered together.
Clearly there are various possible interactions between these receptors at
the cellular level, and concurrent activation is likely to result in enhanced
nociception.
The prolonged changes occurring due to a sustained noxious input cannot
be fully attributed to the momentary effects induced by synaptic excitatory amino
acid and/or neurokinin receptors. Instead they are likely to be mediated by the
subsequent intracellular events triggered by the activation of such receptors.
1.6. Possible Signal Transduction Mechanisms Involved in
Nociception
When a ligand binds to a cell surface G-protein coupled receptor, such as
the metabotropic glutamate or neurokinin receptors, it triggers another chemical
signal (a second messenger) following the activation of the G-protein to which it is
linked. This in turn leads to the engagement of further systems and is eventually
manifest as a physiological result. Therefore such second messenger pathways
govern the outcome of cellular activity by translating diffuse external information
into limited internal signals.
Several recent studies have aimed to elucidate the intracellular
mechanism(s) by which nociceptive information is transmitted in dorsal horn
neurons. There are undoubtedly multiple second messenger pathways involved in
this process, many of which are beyond the scope of this present study. There are
five signal transduction targets which were investigated in the current experiments:
• Calmodulin/Ca++-Dependent Kinase II (CamKII)
• calcium-phospholipid-dependent protein kinase C (PKC)
• phospholipase A2 (PLA2)
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• cyclic AMP-dependent protein kinase (PKA)
• non-receptor tyrosine kinases
(a) Calmodulin/Ca++-Dependent Kinasell (CamKII)
This is a multifunctional kinase which is activated, as its name suggests,
by calcium and calmodulin, downstrean of inositol-1,4,5-triphosphate (IP3)
metabolism (see Figure 1.3.(a)). CamKII is abundant in neural tissue, and in the rat
hippocampus it accounts for 2% of total protein (Erondu & Kennedy, 1985). It has
been proposed that this kinase could act as a calcium-triggered molecular switch
(Miller & Kennedy, 1986; Lisman & Goldring, 1988), with prolonged
phosphorylated activity beyond the initial calcium-evoked activating signal. Such a
role in prolonged synaptic events has already been investigated: the induction of
LTP in the hippocampus can be prevented by application of CamKII inhibitors into
the postsynaptic cell, though once the phenomenon has been initiated the inhibitor is
no longer effective (Malenka et al, 1989; Malinow et al, 1989). Also, mutant mice
which are deficient of CamKII fail to express LTP in the hippocampus, even though
their behaviour appears otherwise normal (Silva et al, 1992). CamKII has been co-
localised with glutamate receptors in the post synaptic density of forebrain synapses
(Wu et al, 1986) and has been shown to modulate glutamate-induced currents in vitro
in isolated Sf9 cells (McGlade-McCulloch et al, 1993) and in the snail (Watanabe &
Onozuka, 1994) and crayfish (Noronha & Mercier, 1995). McGlade-McCulloch et al
(1993) also reported how this kinase phosphorylated ionotropic glutamate receptors
in cultured Sf9 and hippocampal cells. Together these data would suggest a
regulatory role for CamKII in glutamate transmission.
(b) Calcium/Phospholipid-Dependent Protein Kinase C (PKC)
Phosphoinositide metabolism by phospholipase C results in the
production of diacylglycerol (DAG) as well as IP3 (see Figure 1.3.(a)). DAG
subsequently stimulates the translocation of protein kinase C (PKC) from the cytosol
to the membrane (Manzoni et al, 1990), a recognised feature of its activation (Lutz et
al, 1993). A role for PKC in synaptic plasticity has been stronglt indicated.
Inhibitors of this kinase will block LTP in the hippocampus (Lovinger et al, 1987;
Malinow et al, 1988; 1989; Malenka et al, 1989), with their intracellular application
demonstrating the particular importance of postsynaptic kinase activity for LTP
induction (Malenka et al, 1989; Malinow et al, 1989). The exact role of PKC in LTP
is unclear as some studies investigating the time course have reported that PKC
becomes less crucial with time after initial LTP induction (Lovinger et al, 1987)
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while others claim it is necessary for LTP maintenence (Reymann et al, 1988). A
more recent discussion concluded that PKC activation alone seems insufficient to
induce LTP (Bliss & Collingridge, 1993).
A role for PKC in the modulation of NMDA receptor currents has been
reported in both the hippocampus (Ben-Ari et al, 1992) and the spinal cord in vitro
(Gerber et al, 1989). Also, glutamate and aspartate release in the spinal cord slice
can be increased with PKC activators (Gerber et al, 1989). Background activity and
that evoked by innocuous cutaneous stimulation were both augmented by the
infusion of PKC-activating phorbol esters (Palecek et al, 1994). Ionophoresis of
selective PKC inhibitors markedly reduces the sustained activity in dorsal horn
neurons elicited by the cutaneous application of C-fibre activator mustard oil (Munro
et al, 1994a). This study and others, using a chronic constrictive injury (CCI, Mao et
al, 1992; 1993) and formalin-evoked hyperalgesia (Yashpal et al, 1995), have shown
by means of [3H]-phorboI-12,13-dibutyrate ([^HJPDBu) binding assays how
sustained noxious inputs result in the translocation of PKC to the membrane
compartment, in the spinal cord. Such PKC activation correlates with behavioural
hyperalgesia (Mao et al, 1992; 1993). Furthermore behavioural hyperalgesia brought
about by CCI (Hayes et al, 1992) or subcutaneous formalin, with or without
glutamate-induced enhancement of the nociceptive input, (Coderre, 1992; Coderre &
Yashpal, 1994; Yashpal et al, 1995) is reduced if PKC activation is prevented.
(c) Phospholipase A2 (PLA2)
This enzyme is responsible for the generation of arachidonic acid (AA)
and ultimately its eicosanoid metabolites (see Figure 1.3.(a)) - prostaglandins (PG)
and thromboxanes, via cyclooxygenase (COX - of which there are two forms -
'constitutive' COX1 (see Xie et al, 1992) and 'inducable', by inflammation, (Hla &
Neilson, 1992) COX2), and leukotrienes via lipoxygenase. These metabolites are
known to mediate numerous events in the periphery during inflammatory conditions.
However, recent evidence suggests they may also play a crucial role centrally.
Intrathecal treatment with AA results in the enhancement of behaviours elicited by
the subcutaneous administration of formalin (Yashpal & Coderre, 1993). In addition
to this, intrathecally administered non-steroidal anti-inflammatory drugs (NSAIDs),
which inhibit the action of COX (McCormack, 1994), and AA inhibitors will
markedly reduce the second, but not first phase of this formalin-induced behaviour.
(Malmberg & Yaksh, 1992b; Coderre & Yashpal, 1994). The corresponding
formalin-induced activity in dorsal horn neurons is also attenuated by intrathecal
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NSAIDs (Chapman & Dickenson, 1992). Furthermore, the behavioural hyperalgesia
induced by intrathecally applied NMDA, AMPA and SP can be decreased in a
similar manner by NSAIDs (Malmberg & Yaksh, 1992a), as can SP- or glutamate-
enhanced formalin responses be reduced by dexamethasone, an inhibitor of AA
production (Coderre & Yashpal, 1994). Interestingly, in this study Coderre &
Yashpal did not see any change in baseline paw withdrawal latencies when the
inhibitor of AA was administered. Specific inhibition of COX2, by an antagonist
selective over COX1, results in the reduction of carrageenan-induced hyperalgesia
(Boyce et al, 1994).
(d) Cyclic AMP-Dependent Protein Kinase (PKA)
Following the activation of some receptors, adenylate cyclase mediates
the formation of cyclic AMP (cAMP) from adenosine triphosphate (ATP). As a
result of cAMP formation a cAMP-dependent protein kinase (PKA) is activated (see
Figure 1.3.(b)). PKA is ubiquitous throughout the nervous system and is responsible
for the phosphorylation of many intracellular proteins (Cohen, 1992). An NMDA
receptor-dependent rise in cAMP in LTP has been reported (Chetkovitch et al, 1991),
thus implicating a possible role for PKA in prolonged synaptic events. In isolated
dorsal horn neurons the catalytic unit of PKA can increase NMDA-evoked currents,
as can a cAMP analogue (Cerne et al, 1993), suggesting that this pathway may also
be involved in regulating NMDA receptor sensitivity in the spinal cord.
(e) Non-Receptor Tyrosine kinases
As well as many membrane receptor tyrosine kinases (eg nerve growth
factor (NGF) receptor, Kaplan et al, 1991), a variety of membrane-bound and
cytosolic non-receptor tyrosine kinases are present in many cells (see Figure 1.3.(a)).
These kinases have multiple tyrosine residues and are typically autophosphorylating
(Cohen, 1992). The regulation of non-receptor tyrosine kinase activity with several
IP3-linked G-protein receptors has been reported (Zachary et al, 1991). Extra- and
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Figure 1.3.(a)
Possible signal transduction following the activation of group I (1 and 5)
metabotropic glutamate receptors
Following the stimulation of metabotropic glutamate receptors 1 and 5 inositol
phosphate and diacylglycerol activation can result in the triggering of many signal
transduction pathways.
AA - arachidonic acid; Ca++ - calcium; CamKII - calmodulin/Ca++-dependent
kinase; DAG - diacylglycerol; G - GTP-binding protein IEGs - immediate-early
genes; I?3 - inositol -1,4,5-phosphate; MAPK - microtubule-associated protein
kinase; NO - nitric oxide; NOS - nitric oxide synthase; PGs - prostaglandins;






Signal transduction following the activation of group II (2-4) and group III
(6-8) metabotropic glutamate receptors
Metabotropic glutamate receptors 2,3,4,6 and 7 (and 8) are linked to inhibitory G
proteins (or partial, as shown) resulting in a decrease in the conversion of cAMP
from ATP and subsequent lowering in the levels of active PKA.
ATP - adenosine triphosphate; cAMP - cyclic AMP; Gi - inhibitory GTP-binding
protein; mGluR - metabotropic glutamate receptor; PKA - protein kinase A
47
v v_y \ \ \
mGluR v\ mGluR V ^













postsynaptic intra- cellular application of tyrosine kinase inhibitors have been shown
to block LTP, though they do not affect the phenomenon once it is established
(O'Dell et al, 1991). They may therefore, by analogy,also play a role in sustained
sensory inputs to the spinal cord.
Any or all of these signal transduction mechanisms may be involved in
the transmission of nociception. As well as NK] and NK2 receptors, group I
mGluRs have been shown to operate through phospholipase C and therefore may act
by mechanisms incorporating any of the downstream systems discussed. Beyond the
initial effects of second messenger activation, a number of longer-term consequences
are also initiated. The transcription of a number of genes, including immediate-early
genes (IEGs) such as c-fos and c-jun ("third messengers"), is a further signal
transducing mechanism within cells. Regulation of IEG function (both by increased
expression and phosphorylation) is brought about by a variety of second messenger
pathways, including some of those discussed, and is a critical factor in controlling
expression of many cellular changes. There are many IEG products which may be
involved in nociception, however this project concerns only the role of c-fos and its
protein product Fos.
1.7. Possible Molecular Mechanisms Involved In Nociception
Transcription factors, which are encoded by immediate-early genes
(IEGs) such as proto-oncogenes c-fos and c-jun, are responsible for the initiation of
gene expression in eukaryotic cells (Evan, 1991; Morgan & Curran, 1991). C-fos
encodes a nuclear protein, Fos, suggesting that it could be involved in gene
regulation. Heterodimeric transcription factors can be constructed from members of
the c-fos and c-jun family, as can homodimers from the c-jun family alone, to interact
with the activator-protein-1 (AP-1) DNA consensus sequence on target genes (Curran
& Franza, 1988). The affinity for such consensus sequences depends on the fos-jun
components of the transcription factor and both the relative levels of c-fos and c-jun
(and their congeners) together with their phosphorylation can influence AP-1
activation. In cultured cells the activation of several second messenger pathways
results in c-fos expression - these include calcium-calmodulin (Morgan & Curran,
1986), PKC (Greenberg et al, 1986) and cAMP (Greenberg et al, 1985) systems.
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1.7.1. The Expression of c-fos as a Marker of Neuronal Activity In
Response to Noxious Stimulation
Several studies using immunocytochemistry have demonstrated how Fos-
like-immunoreactivity (c-fos LI; reflecting c-fos expression) can be elevated in
response to a variey of noxious, but not innocuous, stimuli.
Fos-LI increases in the dorsal horn, primarily in the superficial laminae - the
principal termination site for small nociceptive afferent fibres, following noxious
thermal (Hunt et al, 1987; Bullitt, 1990; Tolle et al, 1990a, 1990b; 1994; Williams et
al, 1990; Wisden et al, 1990; Dai et al, 1993; Abbadie et al, 1994), mechanical
(Bullitt, 1989; 1991; Leah et al, 1992; Abbadie & Besson, 1994), chemical (mustard
oil, Hunt et al, 1987; Pretel & Piekut, 1991) and electrical C-fibre strength (Herdegen
et al, 1991; Molander et al, 1992) stimulation of the skin or the fibres innervating it.
Histamine-evoked cutaneous itch also induces Fos-LI (Yao et al, 1992). Various
non-cutaneous noxious stimuli have led to increased levels of c-fos expression in the
dorsal horn: intramuscular mustard oil (Hunt et al, 1987), intra-articular urate
crystals, which induce tissue damage, (Menetrey et al, 1989), intraperitoneal acetic
acid, resulting in writhing, (Menetrey et al, 1989; Hammond et al, 1992; Lanteri-
Minet et al, 1993a), and colorectal distension (Lanteri-Minet et al, 1993a; Traub et
al, 1993) all increase Fos-LI. In contrast, innocuous brushing (Hunt et al, 1987;
Bullitt, 1989), heating (<44°C; Hunt et al, 1987; Wisden et al, 1990; Abbadie et al,
1994), or A(3-fibre strength electrical stimulation (Herdegen et al, 1991; Molander et
al, 1992) of the cutaneous receptive field or nerve does not result in any increases in
Fos-LI above those observed in controls. Molander et al (1994) found that although
A(3-fibre strength electrical stimulation of the sciatic nerve did not result in any
increase in Fos-LI in the dorsal horn of normal animals, it did 3-21 days after nerve
transection - this may correspond with the abnormally painful sensations of Ap-fibre
stimulation observed in allodynia (see section 1.3.1 .(biii)).
Immunocytochemical and northern blot analysis has shown how
sustained chemical stimulation also increases c-fos expression in the dorsal horn,
again primarily the superficial laminae: intraplantar injection of carrageenan (Draisci
& Iadorola, 1989; Ruda et al, 1990), CFA (Menetrey et al, 1989; Abbadie & Besson,
1992; Lanteri-Minet et al, 1993b) or formalin (Presley et al, 1990; Williams et al,
1990; Kehl et al, 1991; Leah et al, 1992; Sugimoto et al, 1994) leads to a rise in Fos-
LI within as little as 15-30 minutes, usually peaking around 3-4 hours later.
Interestingly, in an immunohistochemical study Zhang et al (1994) found that
formalin-evoked c-fos expression could be abolished by capsaicin pretreatment (used
to inactivate nociceptive fibres), suggesting that such expression is mediated, at least
50
partially, by C-fibres. Time-course experiments have shown how Fos-LI correlates
with the behaviour seen in animals with CFA-induced acute inflammation and
chronic arthritis (Abbadie & Besson, 1992; Lanteri-Minet et al, 1993b).
1.7.2. C-fos and Opioids
Pretreatment with morphine, or an opioid agonist, decreases the Fos-LI
which is evoked in the dorsal horn by noxious thermal stimulation (Tolle et al,
1990a, 1990b; 1994; Abbadie et al, 1994), by intraplantar formalin administration
(Presley et al, 1990), intrapertioneal acetic acid (Hammond et al, 1992) and by
histamine-induced itch (Yao et al, 1992). One significant functional role of
increased spinal c-fos expression elicited by nociceptive inputs is likely to be
increasing the expression of genes with opioids which may be involved in
endogenous analgesia. The augmented synthesis of these opioids evoked by noxious
stimuli is preceded by an increase in c-fos expression in the ipsilateral dorsal horn
(Draisci & Iadorola, 1989; Naranjo et al, 1991). Also, proenkephalin and
prodynorphin mRNAs are colocalised with c-fos in some spinal neurons following
inflammation (Noguchi et al, 1991; 1992). Furthermore, prodynorphin mRNA
contains the AP-1 sequence (Naranjo et al, 1991), thus making it possible for Fos to
bind and initiate transcription. These two groups of experiments with opioids
underline the importance of c-fos expression in the control of other genes, and also
exemplify how the measurement of c-fos expression can be used as a tool to assess
the role of particular receptors in the dorsal horn in nociception/analgesia.
1.7.3. C-fos and Glutamate Receptors
Glutamate-, qusiqualate-, kainic acid- and NMDA-induced c-fos
expression has been reported in various central neurons including the hippocampus,
both in vitro and in vivo, (Szekely et al, 1987; 1989; Kaczamarek et al, 1988; Cole et
al, 1989; Sonnenberg et al, 1989; Hisanga et al, 1992; Lerea et al, 1992). Morgan &
Curran (1986) showed that an increase in intracellular calcium ([Ca++]j) was
required for c-fos activation. However voltage-gated Ca++ channel blockers do not
affect NMDA-evoked c-fos expression (Szekely et al, 1989; Lerea et al, 1992),
suggesting that this expression is mediated, at least in part, by NMDA receptor-
linked Ca++channels. However, the effect of NMDA receptor antagonists on c-fos
expression is debatable. Some studies have found that pretreatment with MK-801 or
APV can reduce noxious chemical-evoked c-fos expression in dorsal horn neurons
(Kehl et al, 1991; Birder & de Groat, 1992). Conversely others have failed to see any
such reduction following noxious thermal stimulation with either these compounds
or ketamine (Tolle et al, 1990a, 1990b; Wisden et al ,1990). These contrasting
results may well be due to the nature of the noxious stimulus utilised. The
possibility of metabotropic type glutamate receptors mediating nociception-induced
c-fos expression has not been investigated.
1.8. Aims of Current Study
The present study aimed to elucidate the possible role of metabotropic
glutamate receptors (mGluRs) in sensory processing, and the intracellular
mechanisms by which they may elicit their effects. Also, an interaction between
these receptors and NK] and NK2 tachykinin receptors was investigated. This was
done by means of electrophysiological, behavioural and molecular approaches and
consists of three projects:
(a) Electrophysiological Experiments
(a) In order to assess the role of mGluRs in individual cells, recordings
from single dorsal horn neurons were made whilst they were activated by innocuous
(quantified, motorised brush) or noxious (mustard oil) cutaneous stimuli, or by
ionophoretic application of agonists specific to EAA receptors. Antagonists to
mGluRs were ionophoresed during each of the evoked activities to determine (i) the
role of these receptors in sensory processing and (ii) to verify antagonist specificity at
metabotropic, not NMDA, glutamate receptors.
(b) Subsequent to the characterisation of mGluR involvement in sensory
processing, the effect of specific inhibitors of several intracellular signalling
pathways - (i) calmodulin/Ca++-dependent kinase II (CamKII), (ii) calcium-
phospholipid-dependent protein kinase C (PKC), (iii) phospholipase A2 (PLA2), (iv)
cyclic AMP-dependent protein kinase (PKA) and (v) non-receptor tyrosine kinases -
were investigated on brush-, mustard oil- and mGluR agonist-evoked activity. This
was in order to determine the possible pathways involved not only in sensory
processing, but also the activation of mGlu receptors.
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(b) Behavioural Testing
In order to investigate the role of mGlu and neurokinin receptors in the
whole animal, antagonists to each receptor were tested either alone or as part of a co-
injection. Behavioural responses to noxious mechanical and noxious thermal
stimulation of either (i) a normal paw, or (ii) in separate animals a paw which had
undergone carrageenan-induced inflammation, were measured. The effect of
intrathecal injections of (i) mGluR antagonists, L-AP3 or (S)-CHPG; (ii) NK]
antagonist, GR82334; (iii) NK2 antagonist, L659874; or (iv) a combination of each
mGluR antagonist with either GR82334 or L659874 on paw withdrawal responses
were investigated.
(c) Molecular Biology
A limited study employing a slot blot analysis of c-fos mRNA expression
in the spinal cord was carried out to assess the role of mGluRs on a broad population
of neurons (See Appendix I). Acute inflammation was induced in both paws by an
intraplantar injection of complete Freund's adjuvant (CFA), a stimulus known to
evoke c-fos expression in dorsal horn neurons. Simultaneously mGluR antagonists
L-AP3 or (S)-CHPG were administered through an intrathecal cannula previously
placed at the appropriate spinal segments. The whole spinal cord was examined for
alterations in c-fos expression, in response to CFA with, and without, concurrent





Urethane and a-chloralose were obtained from Sigma Chemical
Company, Poole, UK. Halothane was supplied by ICI Pharmaceuticals,
Macclesfield, UK.
2.2. Drugs
2.2.1. Excitatory Amino Acid Receptor Agonists and Antagonists
(1 S,3R)-1 -aminocyclopentane-1,3-dicarboxylic acid ((1S,3R)-ACPD)),
l-aminocyclobutane-c/s'-l,3-dicarboxylic acid (ACBD), L- and D-l-amino-3-
phosphopropionic acid (L- and D-AP3), (R,S)-, (R)- and (S)-4-carboxy-3-
hydroxyphenylglycine ((R,S)-, (R)- and (S)-CHPG) and (R,S)-a-methyl-4-
carboxyphenylglycine ((R,S)-oc-MeCPG) were all obtained from Tocris Cookson,
Bristol, UK.
2.2.2. Tachykinin Receptor Antagonists
[D-Pro9[spiro-y4actam]LeulO,Trpl l]physalaemin(]_j ])(GR82334) was
a gift from Glaxo Group Research, Ware, UK.
Acetyl-Leu-Met-Gln-Trp-Phe-Gly-NH2 (L659,874) was supplied by
Cambridge Research Biochemicals Ltd., Cambridge, UK.
2.2.3. Second Messenger Inhibitors
3,4,3',5'-tetrahydroxy-trans-stilbene (piceatannol) and 5-{[2,5-
Dihydroxyphenyl)methyl][(2-hydroxyphenyl)methyl]amino}-2-hydroxybenzoic acid
(lavendustin A) were supplied from Boehringer Mannheim, Lewes,UK.
[2-(p-amylcinnamoyl)amino-4-chlorobenzoic acid (ONO-RS-082) was a
gift from Dr Tsuboshima, ONO Pharmaceuticals, Osaka Japan.
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Benzenesulphonamide 4 was a gift from Mike Clark, Schering-Plough Research,
Kenilworth, N.J., USA.
The remaining compounds were from Calbiochem Novabiochem Ltd.,
Nottingham, UK: 2-[ 1 -(3-dimethylaminopropyl)-indol-3-yl]-3-(indol-3-yl)
maleimide (GF109203X), (1,2-dimethoxy-N-methyl-( 1,3)benzodioxolo(5,6-




isoquinolinesulfonamide (H89), (8R,9S,1 lS)-(a)-9-hydroxy-9-(n)hexanoxy,carbonyl-
8-methyl-2,3,9,10-tetrahydro-8,l l-epoxy-lH,8H,l lH-2,7b,l la-
triazadibenzo[a,g]cycloocta[c,d,e]trinden-l-one (KT5720).
2.3. Oligomer Probes and Radiolabel
The oligodeoxyribonucleotides used were synthesised and purified by
high performance liquid chromatography by Oswel Chemicals, Department of
Chemistry, University of Edinburgh, UK. Deoxyadenosine [oc-35s]-triphosphate,
used to label the oligomer probes, was supplied by New England Nuclear Research
Products, Du Pont de Nemours, Dreiech, Germany. The specific activity of the
radiolabel was 1-1.3 x 1C)3 Ci/mmol. It was stored at -70°C until required. Terminal
deoxynucleotidyl transferase and potassium cacodylate tailing buffer, used in
labelling the probes, came from GIBCO BRL Ltd., Paisley, UK. Nu-Clean D25
disposable spun columns were from International Biotechnologies Inc., New Haven,
Connecticut, USA.
2.4. Miscellaneous
Allyl isothiocyanate (mustard oil) was obtained from Aldrich Chemical
Company, Gillingham, England. Liquid paraffin was supplied by Mackay & Lynn,
Edinburgh, UK. Lambda carrageenan and complete Freund's adjuvant were both
from Sigma Chemical Company, Poole, UK.
All reagents were of highest analytical grade and, unless otherwise stated
in the text, were obtained from Sigma Chemical Company, Poole, UK.
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CHAPTER 3
THE EFFECTS OF METABOTROPIC GLUTAMATE RECEPTOR
ANTAGONISTS ON RESPONSES OF DORSAL HORN NEURONS TO
SENSORY STIMULI AND TO GLUTAMATE RECEPTOR AGONISTS
3.1. AIMS
The effects of several antagonists of metabotropic glutamate receptors
(mGluRs) on dorsal horn neurons were investigated comparing activity evoked by (i)
innocuous brushing of the cutaneous receptive field and (ii) noxious chemical
stimulation by topical application of mustard oil to the skin. The pharmacological
specificity of one compound, L-AP3 and its stereoisomer, D-AP3 was also assessed
using agonists to mGlu and NMDA receptors.
3.2. METHODS
3.2.1. Animals
Wistar rats were purchased from Charles River UK Ltd, Margate, Kent,
UK. They were housed in groups of 3 or 4 in standard rat cages on a 12 hour light/12
hour dark cycle, with a room temperature of 19-23°C. Food and water were available
ad libitum.
3.2.2. Surgical Procedures
Experiments were carried out on adult males (240 - 420g). Under an
initial halothane anaesthesia the jugular vein and trachea were cannulated. Animals
were then given intravenous a-chloralose (60mg kg _1) and urethane (1.2g kg-1).
Supplementary doses of 0.2ml (25mg ml _1) a-chloralose were given throughout the
experiment, requirement determined by blink reflex. Core body temperature was
maintained at 37-38°C by means of a thermostatically-controlled heat blanket linked
to a rectal probe. The animal was allowed to breathe freely with a light flow of
oxygen (0.11 / min) passed over the tracheal cannula to enrich the inspired air.
The animal was placed in a stereotaxic frame, with stability provided by
jaw and ear bars. A pool was made by tying back the skin flaps. The thoraco-lumbar
spinal column was supported using 3 pairs of swan-necked clamps, the middle clamp
being assigned to the position of the floating rib (in the region of T12 spinal process
and spinal segment L2). A laminectomy, LI - L4, was performed under xl2.5
magnification. To provide further stability, agar (2% in 0.9% saline, 39°C) was
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injected under the most rostral vertebra and then over the whole pool, including the
spinal cord. Once the agar was set a small area was removed to uncover the region of
interest for recording. Finally the dura was removed, ensuring pressure was relieved
at both ends of the cord. Liquid paraffin, 37°C, was then poured over the exposed
spinal cord to prevent dehydration.
3.2.3. Electrophysiological Recording and Ionophoresis of Drugs
Extracellular recordings were made from single neurons at depths of 0-
lOOOjlm (as stated on the microdrive) via the central barrel of a 7-barrelled glass
microelectrode filled with 4M NaCl (pH 4.0-4.5). The tip diameter ranged from
4-5|im with dc resistances of 5-8MF2. The bandwidth of the recording amplifier was
1 Hz - 7kHz. The microelectrode was secured by means of a steel arc which spanned
the animal transversely, and moved through the spinal cord in 2 or 6p.m steps using a
microdrive system. Extracellular recordings from the central barrel was displayed on
an oscilloscope (Tektronix). Output activity from the oscilloscope was continuously
monitored using a D. 130 Digitimer Spike Processor. Neuronal firing rate, along with
the analogue signal from the heat stimulator, was continuously plotted on-line by a
customised analysis program on an IBM PS/2-70-121 computer (Scap 90, Dr M.
Dutia, Department of Physiology, University of Edinburgh). This program allowed
event markers to be added as data was collected. Occasionally recordings onto FM
tape were also made.
Drugs were ionophoresed from the side barrels of the electrode.
Retention currents of ±10nA were employed to minimize drug leakage between tests.
One of the remaining barrels contained 1M NaCl (pH 4.0 - 4.5) for automatic current
balancing, using a Neurophore BH2 Ionophoresis system (Medical Systems
Corporation), and current controls. A second side barrel contained Pontamine Sky
Blue (PSB; 2% in 0.5M sodium acetate) which was used to mark recording sites by
ejecting for 12-14 minutes at 10pA. The resistance of side barrels was standardly
measured and ranged from 20-30MQ.
3.2.4. Drugs for Ionophoresis
All solutions were lOmM in distilled water, pH adjusted to 8.0-8.5 with
sodium hydroxide.
Agonists- Metabotropic glutamate receptor: (IS,3R)-ACPD (Irving et
al, 1990) and NMDA receptor: ACBD (Lanthorn et al, 1990)
Antagonists - Metabotropic glutamate receptor: L-AP3 (Schoepp et al,
1990a), (R,S)-CHPG (Watkins et al, 1987), (S)-CHPG (Glaum et al, 1993) and
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(R,S)-a-MeCPG (Eaton et al, 1993; Pook et al, 1993). D-AP3, a weak NMDA
antagonist (Schoepp et al, 1990a).
3.2.5. Controls
1M NaCl was ionophoresed upto 80nA for simultaneous current and
vehicle controls. These controls were carried out on agonist-, brush- and mustard oil-
evoked activity.
3.2.6. Quantification of Neuronal Responses to Cutaneous Sensory Stimuli
Neurons were located by simultaneously lowering the electrode into the
spinal cord, using a microdrive, and manually brushing the hindlimb. All neurons
were multireceptive and had cutaneous receptive fields located on the ipsilateral
hindlimb. Care was always taken to ensure clear discrimination of spikes from any
other activity (see Figures 3.2 and 4.7). Once the most appropriate position for the
electrode was found, some background firing was recorded, then neuronal
characterization was carried out by manual innocuous brushing and noxious pinching
and by quantified noxious heating. The heat stimulus was supplied by a thermistor-
controlled radiant heat lamp which was placed on the skin and raised from 30°C to
46-48°C in 5 seconds, and was maintained for a total of 10 seconds. Test innocuous
brush stimulation was provided by positioning a rotating motorised brush onto the
centre of the receptive field for the duration of drug ionophoresis, as well as one
minute prior to and one minute after the application of drugs.
3.2.7. Quantification of Neuronal Responses to Cutaneous Application of
Mustard Oil
Neurons were located as described above. Mustard oil is a chemical
irritant which can be administered topically, intramuscularly or intra-articularly in
order to selectively activate C-afferent fibres (Woolf & Wall, 1986; Heapy et al,
1987). Although it does activate some A8 fibres, the reponse they exhibit is transient
compared to that of C-fibres (Heapy et al, 1987; Harris & Ryall, 1988). Similarly, C
afferents innervating hairy, rather than glabrous, skin are preferentially activated by
this chemical (Harris & Ryall, 1988), this may purely be due to skin penetration, but
could also reflect a group of mustard oil-insensitive C-fibres. Mustard oil induces
skin temperature increases of 2-3°C, an increase in plasma extravasation and
oedema, all of which are thought to be a result of an increased release of vasoactive
mediators from capsaicin sensitive fibres (Lippe et al, 1993). When applied to
abraded skin in man it causes an intense burning sensation (Woolf, 1984) and it
results in a prolonged flexion reflex in the rat (Woolf & Wall, 1986). Mustard oil
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induces central sensitisation (Woolf & Wall, 1986), one of the manifestations of
which is an increase in the cutaneous receptive field (Woolf & King, 1990). The
cutaneous application of mustard oil in this study was used to evoke a sustained level
of C-fibre activation, analogous to that seen in "wind-up" (see section 1.3.1 .(biii))
Since the vigorous response of a neuron to noxious heating of the receptive field is a
good indication of C-fibre innervation, a cell responding to noxious heat stimulation,
which was not on the glabrous skin, was considered acceptable for mustard oil
application. Occasionally, cells in which noxious pinching, but not heating, evoked a
reponse were tested for a response to mustard oil; this rarely resulted in elevated
firing.
Following the standard background recording, mustard oil (7.5% in
liquid paraffin) was topically administered to the receptive field using a small paint
brush. Sometimes one application was sufficient to evoke a maintained level of
neuronal activity. Flowever, if it was not, applications were repeated at 5 minute
intervals until a sustained level of elevated neuronal firing was observed. No tests
were executed until the response was stable for 1-2 minutes. Therefore drugs were
tested at anything between 5 and 35 minutes after the first administration of mustard
oil.
Initially compounds were ionophoresed for 1-2 minutes. This time was
adjusted depending on their effect on the neuron, some drugs were ejected for up to 6
minutes in later tests.
3.2.8. Quantification of Neuronal Responses to Ionophoretic Application of
Agonists
Cells were found in one of two ways: either in the usual manner,
whereby they would be located due to manual brushing of the hindlimb, or by
searching with the agonist on an ejection current of 5-10nA. If they were found by
brushing the hindlimb, the agonist would be ionophoresed following at least 1 minute
of recorded basal firing. Once a stable response to the agonist was obtained, an
antagonist was co-ejected. If a cell was located using the other method, ionophoresis
of the agonist was terminated to ensure neuronal firing stopped as a result. Basal
firing would be recorded in the usual way and tests resumed as above.
3.2.9. Histological identification of recording sites
At the end of the majority of experiments the spinal cord was removed in
order to determine the position of the recording electrode. The cord was rostro-
caudally marked then fixed in 10% formal saline. It was then mounted on a freezing
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microtome in 0.25% agar and 52|im sections were cut until a blue spot, formed in the
experiment by ejecting PSB at 10|lA for 12-14 minutes, could be observed. The
sections containing this blue dye were then placed onto gelatin-subbed slides and
stained with 1% neutral red. Observation under a light microscope allowed the
laminar position of the electrode to be defined.
3.2.10. Analysis of Results
Analysis was carried out off-line using the Scap 90 program. The
inhibitory effects of antagonists on evoked activity (agonists, mustard oil and
motorised brush) were calculated by comparing mean firing levels immediately prior
to their administration (10-60seconds) with mean activities during their ionophoresis.
The period of greatest inhibition (10-60seconds) was chosen for such comparisons,
and expressed as a percentage of the control value taken before antagonist
administration. All values are given as the mean ± standard error of the mean
(SEM). The statistical significance of drug-induced changes from control responses
was evaluated using the Wilcoxon test.
Changes brought about in neuronal firing which were within 15-20% of
pre-drug controls were not considered to be significant, as they were within (or close
to) the range of natural variability brought about by vehicle or currrent controls.
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Figure 3.1.
Schematic representation of the protocol utilised in electrophysiological
recording experiments
A: Schematic representation of the spinal cord in the region of LI - L4, revealed
by a laminectomy performed on vertebrae stabilised using 3 pairs of swan-necked
clamps. Following this exposure, the spinal cord and surrounding area was
covered with 2% agar, to provide stability during recording. Upon removal of an
agar core immediately above the exposed cord, 37°C paraffin was applied and
extracellular recordings were made via a 7-barrelled glass microelectrode.
B: During extracellular recordings activity was evoked in dorsal horn neurons by
various peripheral stimuli. Activity was elicited with (a) a motorised rotating
brush, (b) calibrated pincher and/or (c) a radiant heat lamp. Noxious chemical
stimulation was attained by topically applying 7.5% mustard oil onto the receptive
field. Finally, activity in dorsal horn neurons could be induced by ionophoresing
the metabotropic glutamate receptor (1S,3R)-ACPD from a side barrel of the glass
microelectrode. Various antagonists were applied in a similar manner.
I
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3.3.1.1. Characteristics of Neurons
In all, 90 neurons were investigated, from 47 rats, with microdrive
electrode depth readings of 150- 1000pm from the spinal cord surface. Neurons
consistently had receptive fields on the cutaneous surface of the ipsilateral hindlimb.
The 'receptive field' was defined as the area in which a response to innocuous
brushing was observed, this always incorporated the receptive field to noxious pinch
or heat, which tended to be smaller. Basal firing rates were low (0-1 Hz).
Of the 22 neurons investigated for the effect of antagonists on innocuous
brush-evoked activity, not all neurons were characterised, but in the total population,
examples of multireceptive and low threshold non-nociceptive cells were observed.
No nocispecific cells were examined; most likely due to the search strategy, in which
cells were initially found by manual brushing of the hindlimb. All of the cells
assessed here responded readily to innocuous stimuli, and a number of them also
displayed nociceptive responses. One out of four cells tested responded to noxious
heat (46- 48°C, 10 seconds), 10 of 11 tested responded to noxious pinching
(manual), 3 units were activated by brush only and 7 were not characterised in terms
of their sensory inputs.
A total of 28 neurons were used in the mustard oil experiments, all of
which were multireceptive and responded vigorously to noxious heating of the
cutaneous receptive field. Experience indicated a greater likelihood of the cell
responding with a sustained increase in activity to mustard oil application, if it had
responded to the noxious heat stimulus. In later experiments, when changes in the
receptive field were monitored, it was noted that the application of mustard oil most
frequently caused an increase in its size. Such alterations have been seen before with
this chemical and are suggestive of central neuronal sensitisation (Woolf & Wall,
1986)
For the agonist study a total of 40 neurons were assessed. Of the units
responding to (1S,3R)-ACPD or ACBD, 9 out of 12 and 7 out of 12 tested
respectively also fired when their receptive field was stimulated with noxious heat.
In 20 cells tested with both agonists, 6 gave clear responses to both, 3 responded
selectively to (1S,3R)-ACPD, 9 to ACBD only and 2 were unaffected. In each
category there were examples of cells which did or did not respond to heat. The
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approximate dorsoventral positions of these cells, with their responses to agonists and
heat can be seen in Fig 3.7. No correlation was found between depth and the
presence/absence of a thermal nociceptive input or responsiveness to agonists.
3.3.1.2. Current Controls
Although the equipment employed had an automatic current balancing
system, therefore minimising the likelihood of current effects on cell membranes,
some additional controls were performed. The ejection of 1M Na+ did not depress
the firing of the cells studied. In the absence of current balancing extracellular cation
ejection would be expected to hyperpolarise adjacent cell membranes.
3.3.2. EFFECTS OF MGLU RECEPTOR ANTAGONISTS ON NEURONAL
RESPONSES TO INNOCUOUS BRUSH STIMULATION
Firing was evoked by placing a motoriscd rotating brush applied to the
central area of the cutaneous receptive field. One minute of this evoked activity (8-
45 Hz) was recorded before applying any compounds. Three mGluR antagonists were
assessed (see Fig 3.3): L-AP3, (R,S)-CHPG and (S)-CHPG , the isomer selective for
mGluRs, as opposed to the NMDA-type glutamate receptor (Birse et al, 1993; Glaum
et al, 1993). No significant change (p>0.05, Wilcoxon test) was brought about in
neuronal firing for either L-AP3 (9 out of 9 cases), (R,S)-CHPG (5 out of 5) or for
(S) CHPG (12 out of 12). Occasionally during the ionophoresis of these compounds
a slight increase in activity was observed, but this was never greater than 15% of the
brush-evoked response, was not consistent and was always transient. All three drugs
were ionophoresed from -15 to -55nA.
3.3.3. EFFECTS OF MGLU RECEPTOR ANTAGONISTS ON NEURONAL
RESPONSES TO NOXIOUS CHEMICAL STIMULATION BY MUSTARD OIL
Mustard oil-evoked activity (5-13Hz) was markedly inhibited by L-AP3
(-15 to -50nA), by 68±7% (mean±SEM; p<0.05, Wilcoxon test on raw data), in 11
out of 16 cells. In contrast, its stereoisomer D-AP3, in the same current range, failed
to affect such firing. (R,S)-CHPG (-15 to -55nA) also caused clear reductions in
firing in 7 out of 8 units, by 56±9% (p<0.05) Typical examples
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Figure 3.2.
Example of an action potential recorded from a single dorsal horn neuron









The effect of ionophoretically applied metabotropic glutamate receptor
antagonists on brush-evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action potentials
per second (R/s), integrated over 700 millisecond bins, plotted against time. The
hatched areas on the inserts show the receptive field of the cells.
Each neuron was activated by motorised brushing of the cutaneous receptive field.
All three metabotropic glutamate receptor antagonists failed to significantly inhibit
such brush-evoked firing, at the currents shown. In the cases of (R,S)-CHPG and L-
AP3, these currents used for antagonists were greater than or equal to those known to
























The effect of ionophoretically applied metabotropic glutamate receptor
antagonists on mustard oil-evoked activity in dorsal horn neurons
The records show ongoing firing of an individual neuron, displayed as action
potentials per second (R/s), integrated over 700 millisecond bins, plotted against
time. The receptive field of the cell is represented by the hatched areas in the insert.
The traces show activity induced by the application of mustard oil to the cutaneous
receptive field. Metabotropic glutamate receptor antagonists (R,S)-CHPG and L-
AP3 both significantly inhibited this firing (p<0.05, Wilcoxon test). However, D-
AP3, the stereoisomer of L-AP3, did not alter mustard oil-evoked firing when













The effect of ionophoretically applied metabotropic glutamate receptor
antagonists on (lS,3R)-ACPD-evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action potentials
per second (R/s), integrated over 700 millisecond bins, plotted against time. The
hatched areas on the inserts show the receptive field of the cells.
Record A shows how L-AP3, but not D-AP3, reduced firing evoked by metabotropic
glutamate receptor (mGluR) agonist (1S,3R)-ACPD (applied at -l-2nA prior to and
during the test). In B a second mGluR antagonist, (R,S)-CHPG, can also be seen
reducing agonist-evoked activity. The currents at which both antagonists were
applied are equivalent to those which reduced firing induced by the cutaneous


















The effect of ionophoretically applied L- and D-AP3 on ACBD-evoked activity
in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action potentials
per second (R/s), integrated over 700 millisecond bins, plotted against time. The
hatche areas on the insert shows the receptive field of the cell.
Firing was evoked by ionophoresis of the NMDA receptor agonist ACBD (-InA),
prior to and during the test. The selectivity of the AP3 isomers is demonstrated with
D-AP3 showing an inhibitory effect, whereas the ejection of L-AP3, at an equivalent
current, did not result in any change.
N.B. Due to the experimental set-up (manual operation of equipment) "off' was




Schematic representation of the relationship between neuronal responses to
excitatory amino acid agonists, noxious heating of the cutaneous receptive field
and microdrive depth readings
The diagram represents neurons that did or did not respond to the ionophoretic
application of either (A) metabotropic glutamate receptor agonist (1S,3R)-ACPD or
(B) NMDA receptor agonist ACBD, and their response to noxious heating of their
receptive field.
No correlation was found between the depth recorded by microdrive readings and the
response to agonist ionophoresis. Similarly, there seemed to be no relationship
between the response of a cell to agonist and heat.
O V agonist, * heat

















can be seen in Figure 3.4. Recovery was observed in 15 of the 18 cells markedly
inhibited by the antagonists. This occurred in under five minutes for all but 3 units,
which required upto 15 minutes. As with the experiments on brush-evoked activity,
neither of these compounds induced increased levels of firing. When the effect of
(R,S)-aMeCPG was examined it had mixed effects. Four neurons in total were
tested, 1 showed a clear inhibition whereas 2 showed a modest excitation (< 20%).
Although this compound is a selective mGluR antagonist (Pook et al, 1993; Eaton et
al, 1993) other such mixed effects on spinal motorneurons have recently been
reported by Cao et al (1995).
3.3.4. EFFECTS OF MGLU RECEPTOR ANTAGONISTS ON NEURONAL
RESPONSES TO EXCITATORY AMINO ACID AGONIST IONOPHORESIS
In order to strengthen the evidence for the involvement of a genuine
mGluR it was necessary to verify the selectivity of L-AP3 for mGluRs and D-AP3
for NMDA receptors under the present conditions. This was accomplished by testing
both drugs on responses to agonists selective for each of these sites. (1S,3R)-ACPD
was used to activate mGluRs. This compound acts best at mGluR subtypes 2 and 3,
but also activates 1 and 5 (Tanabe et al, 1992; Tanabe et al, 1993; Watkins &
Collingridge, 1994). ACBD is a highly selective NMDA receptor agonist (Lanthorn
et al, 1990).
From background firing levels of 0-1 Hz, 14 out of 37 cells tested with
(1S,3R)-ACPD (up to -80nA) responded with firing rates of 4-32 Hz. Sixteen out of
23 units responded to ACBD, to 4-40Hz. Agonists were ionophoresed at up to -80
and -90nA respectively, in order to see if a cell was responsive. However, cells that
responded did so at much lower currents (-7 to -25nA for (1S,3R)-ACPD and -1 to -
6nA for ACBD).
Agonist responses were tested comparatively with L- and D-AP3. In 4
out of 6 neurons activated by (1S,3R)-ACPD (-7 to -25nA) L-AP3 (-15 to -30nA)
caused distinct inhibition of activity by 67±12% (p<0.05, Wilcoxon test), whereas in
all six cases D-AP3 had either no effect or caused a negligble excitation (see Fig 3.5).
In contrast, D-AP3 (-15 to -30nA) reduced the firing elicited by ACBD (-1 to -6nA)
in 4 out of 6 neurons by 58±17% (p<0.05), with L-AP3 failing to affect any (see Fig
3.6). In one cell both isomers were tested on each agonist and the expected
selectivity was observed.
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In a later study, (R,S)-CHPG (-15 to -40nA) was tested on (1S,3R)-
ACPD-evoked activity in 5 neurons (see Fig 3.4). It caused a marked inhibition in all
of them, by a mean of 64±6% (p<0.05, Wilcoxon test). When the percentage
inhibition values of brush-, mustard oil- and (lS,3R)-ACPD-evoked activity caused
by (R,S)-CHPG were compared by the non-parametric Mann-Whitney U-test, effects
on each of the other responses were greater than those on brush (p<0.05). (R,S)-a
MeCPG was not assessed and (S)-CHPG was not available at the time of this study.
As a consequence of the lasting nature of activation caused by mustard
oil, it was not possible to test drug effects in a side-by-side comparison if brush-,
mustard oil- and (lS,3R)-ACPD-evoked responses on individual cells. Comparisons
of a drug effect on brush/mustard oil, brush/(lS,3R)-ACPD or (1S,3R)-
ACPD/mustard oil were however made in a number of cases. In individual examples
of each combination both (R,S)-CHPG and L-AP3 caused a similar inhibition (by
>50%) of mustard oil/(lS,3R)-ACPD response, but in examples of sequential
brush/mustard oil and brush/(lS,3R)-ACPD tests the antagonists inhibited brush
responses by <15%, despite causing >50% reduction in mustard oil and (1S,3R)-
ACPD responses.
3.4. DISCUSSION
The population of neurons investigated in this study comprised of both
multireceptive and non-nociceptive units, though all of the neurons used in the
mustard oil study were multireceptive. The outcome of the pharmacological tests did
not appear to bear any relation to the type of cell. On the basis of depth
measurements made during the experiments along with histological examination of
Pontamine Sky Blue ejection sites post-experimentally, the majority of cells were in
laminae III-V of the dorsal horn of the spinal cord, as defined by Molander et al
(1984). These neurons all exhibited very low basal firing rates of 0-1 Hz. The
routine ejection of NaCl vehicle at currents higher than those utilised for drug
ejection caused no marked effects on any evoked activity throughout this study and
failed to reproduce any of the drug-induced effects which were observed.
The mGluR agonist employed in this study, (1S,3R)-ACPD, was the only
selective one widely available at the time. This compound, which caused excitation
in under half of the cells tested (a higher proportion than those of Chapter 4, though
the population was greater in that study) is a potent activator of group II mGluRs
(Nakanishi, 1992; Tanabe et al, 1992; 1993), and is also an agonist at the group I
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receptors (see Pin & Duvoisin, 1995). This data therefore suggests initially that the
mGluRs involved here may be group II, or possibly group I. However, since this
agonist-evoked activity was inhibited by L-(but not D-) AP3 and (R,S)-CHPG, both
of which are antagonists at group I mGluRs, but not group II (Schoepp et al, 1990a;
Watkins & Collingridge, 1994; Pin & Duvoisin, 1995), it would appear that the
receptors in this instance are more likely to be group I. The data from the present
study would suggest that the dorsal horn is not abundant in such (1S,3R)-ACPD-
activated receptors. Comparing the data obtained in these experiments with that from
the results from the NMDA receptor agonist, ACBD, which demonstrates that more
than two-thirds of the population tested could be activated with this compound, there
would appear to be a relatively sparse, though widespread (see Figure 3.7),
distribution of (lS,3R)-ACPD-activated mGluRs in the spinal cord. The present
study also demonstrates that neurons of the dorsal horn may contain both NMDA and
mGlu receptors, as just over one quarter of the units tested could be activated by both
agonists. However, neurons that could be excited by each compound individually
were also observed, therefore there appear to be cells which display each receptor
type exclusively (assuming that the ionophoresed drug was acting on the unit which
was being recorded from). The ability of a neuron to respond to noxious heating of
the receptive field did not reflect the presence or absence of any receptor type, mGlu
or NMDA (see Figure 3.7). This would suggest that mGluRs are not exclusively
involved in thermal nociception, but further studies are required to determine the
possibility of their role in nociception of a mechanical nature, as no such monitoring
of noxious pinch inputs was carried out in this instance.
The chemical irritant mustard oil (allyl isothiocyanate) is an activator of
C-afferent nociceptive fibres (Woolf & Wall, 1986; Heapy et al, 1987) and its
administration results in central sensitisation (Woolf & Wall, 1986). In this study the
cutaneous application of mustard oil to the ipsilateral receptive field was used as an
in vivo model of short-term but sustained activation of C-afferent fibres, in order to
assess the role of mGluRs in nociception. Cleland et al (1994) demonstrated that
mustard oil administered in this manner to spinalised, unanaesthetised rats resulted in
a reproducible model of behavioural hyperalgesia. In this study such application of
mustard oil (7.5% in paraffin oil) to the hairy (dorsal) surface of the skin led to an
elevated firing rate (5-13Hz) of the neurons investigated, with these rises in
background firing being maintained before any pharmacological testing was
executed. Some neurons responded more readily to mustard oil, for unknown
reasons, but the number of applications bore no apparent relevance on the outcome of
pharmacological tests. An increase in the receptive field size often accompanied
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such raised firing levels, a phenomenon which has been previously recorded with the
use of this compound and is indicative of central sensitisation (Woolf & King, 1990;
Woolf & Thompson, 1991). Other studies using mustard oil have found that it does
not penetrate the skin well when applied to the glabrous surface (Harris & Ryall,
1988; F.E. Munro, PhD thesis, 1995), therefore the population of neurons
investigated here were chosen according to their innervation of hairy skin. In a very
small number of units (<5%) with thermal nociceptive inputs the topical
administration of mustard oil failed to induce a sustained elevated firing rate, even
following numerous applications (up to 7, over 35 minutes). This would suggest that
there may be a sub-population of C-afferent fibres which, although they mediate
noxious heat inputs, do not respond to this chemical. Thermo-specific receptors have
been reported elsewhere (Davis et al, 1993) and may well exist in rat cutaneous
structures. Alternatively it may be a simple case of the occasional inability of the
chemical to reach the pertinent sites.
The experiments here provide evidence for a selective role of mGluRs in the
processing of noxious chemical-, but not innocuous brush-evoked inputs. The firing
induced by topical mustard oil could be markedly reduced when mGluR antagonists
L-AP3 and (R,S)-CHPG were ionophoresed. Since D-AP3 brought about no change
in any evoked firing, other than that elicited by ionophoresis of the NMDA agonist
ACBD, it is highly likely that the effects of L-AP3 are indeed via an mGluR. At the
time of these initial experiments (S)-CHPG was not available for testing, though it is
likely that it too, as the isomer with greater activity as an mGluR antagonist (Glaum
et al, 1993), would have resulted in a consistent decrease in this evoked activity. The
mGluR antagonist (R,S)-CHPG used in these mustard oil experiments is a potent
antagonist at the mGluR 1, though shows little activity at the other subgroups of
mGluRs (Watkins & Collingridge, 1994; Pin & Duvoisin, 1995). Although in
general the properties of mGluR5 correspond broadly to those of mGluRl, some of
the phenylglycine derivatives show some selectivity, as (S)-CHPG and (S)-4CPG
have little affinity for mGluR5 (Joly et al, 1995). Although the (R)-enantiomer of
CHPG displays some NMDA receptor antagonism (Watkins & Collingridge, 1994) it
can be inferred that the inhibitory effects of (R,S)-CHPG are due to mGluR blockade
since they are mimicked by L-AP3, and not its isomer D-AP3 (also a weak NMDA
antagonist; Schoepp et al, 1990a). L-AP3 and (R,S)-CHPG along with the mGluR
selective isomer, (S)-CHPG failed to alter the firing elicited by light innocuous
brushing of the receptive field. Statistical comparisons revealed that the inhibitory
effect of these antagonists on agonist/mustard oil-evoked activity was significantly
greater than the effect on brush-elicited activity. It would therefore seem apparent
80
that mGluRs, probably subtypes 1 and/or 5 are involved in the mediation of
nociceptive information via C-, and perhaps A8-, afferent fibres though not low
threshold (Ap) inputs. The mixed effects observed with a-MeCPG in the initial
mustard oil study are not unique. Cao et al (1995) recently observed similar dual
effects with this compound, a reported weak antagonist at several mGluRs (Eaton et
al, 1993; Pook et al, 1993; Pin & Duvoisin, 1995), in a study on spinal
motoneurons. Nevertheless, because of its apparently inconsistent effecLs at the time
of these pilot experiments it was decided that a-MeCPG would not be used in further
investigations.
The evidence presented here for a discrete role for mGluRs is in
agreement with several other studies which have also demonstrated such selectivity
in sensory processing. In thalamic nuclei, Eaton et al (1993a; 1993b) found that
locally administered (S)-CHPG reduced firing elicited by noxious thermal, but not
innocuous air-jet stimulation. Using newly available selective compounds this group
have recently provided evidence that pre- and post-synaptic (group II/III and group I
respectively) mGluRs exist in the ventrobasal thalamus and may play a role in the
disinhibition of various sensory (and electrically-evoked) inputs (Salt & Eaton,
1995a; 1995b). In addition to these studies, Neugebauer et al (1994b) showed how
L-AP3 could only reduce the responses of spinal neurons to pressure applied to the
knee after the induction of inflammation, and not before. Taken together with the
present study, these results indicate that mGluRs are effective only in the
transmission of high threshold sensory inputs, with particular relevance in a
sensitised state. There are however studies which failed to find evidence for such a
role of these receptors. Thompson et al (1992) found that L-AP3 did not affect
ventral root potentials evoked by high intensity (C-fibre) stimulation in vitro, this
could of course have been due to the fact that the preparation was a neonatal rat
spinal cord, and the potency of L-AP3 at mGluRs is lower in neonatal tissue than in
adult (Schoepp & Johnson, 1989a; 1989b). Also, the difference in stimulus type and
population of neurons tested are likely to contribute to a variance in outcome. An in
vivo investigation by Palecek et al (1994) found mixed effects using (1S,3R)-ACPD.
They observed an increase in the response of primate STT cells to innocuous
brushing of the receptive field when a low dose of the agonist was applied by
microdialysis, yet no change in responsiveness with a higher dose. Neither dosage
affected responses to noxious mechanical or thermal stimulation. This anomaly with
the present results is not easily explicable. However, there are several
considerations: firstly it must be remembered that data from experiments using
agonists should not necessarily be directly compared to that obtained with
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antagonists, as the physiological consequences need not necessarily be opposites.
Secondly (1S,3R)-ACPD does not activate solely the exact complement of mGluRs
which are antagonised by the compounds used in the present study. Finally, the
distance from the recorded neurons and the ability of the compound to reach that
neuron adequately may well vary in different studies.
The mechanism by which mGluRs mediate their effects is unknown,
though changes in excitability brought about by channel regulation may be one of the
mechanisms involved. The modulation of Ca++ and K+ channels, both inhibition
and activation, by group I mGluRs (and to a much lesser extent group II/III) has been
observed, and there is evidence that this may be mediated by second messengers such
as PKC (Baskys, 1992; Swartz & Bean, 1992; Swartz et al, 1993; Chavis et al, 1994;
see also Pin & Duvoisin, 1995). Additionally, there is interesting evidence that
mGluRs may act through a more specific functional interaction with NMDA, and
perhaps other, receptors. Potential facilitation of NMDA receptor function is of
special interest for 3 reasons:
(i) it is strongly implicated in the sensitisation of dorsal horn neurons
during repetitive stimulation (Davies & Lodge, 1987; Dickenson & Sullivan, 1987;
Dickenson & Sullivan, 1990; Thompson et al, 1990),
(ii) mGluR (group I) facilitation of NMDA receptor function is likely to
be an important component of at least some forms of LTP in the hippocampus (a
phenomenon with many functional analogies to dorsal horn neuron sensitisation) and
(iii) molecular mechanisms (PKC phosphorylation of the NMDA
receptor) have been described (Chen & Huang, 1992; Tingley et al, 1993) which
could explain how a phospholipase C-coupled receptor (such as a group I mGluR)
could enhance NMDA receptor function.
Early in vitro studies showed how (1S,3R)-ACPD could potentiate
ionotropic glutamate receptor agonist-induced responses in isolated dorsal horn
neurons and a spinal cord slice preparation (Bleakman et al, 1992; Cerne & Randic,
1992). The use of more specific agonists by Bond & Lodge (1995) recently
confirmed this in vivo, with the suggestion of Group I or II mGluRs playing the
crucial role. Interestingly, Jones & Headley (1995) concluded from a similar study
that such elevated NMDA-evoked activity was not due to a potentiation by the
mGluR agonist, but instead a simple additive rise in background activity.
Conceivably mGluRs may be involved in a gating mechanism whereby their initial
activation allows the triggering of other receptor activity, in this case the NMDA
receptor (but perhaps also other receptors), which would otherwise require a synaptic
input differing in intensity, modality or perhaps temporal requirements. Other more
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general changes in excitability may well occur, perhaps with more intense or
prolonged activation of mGluRs or perhaps concurrently with a more specific
regulation of NMDA receptor function. In CA1 hippocampal neurons mGluR
antagonists can block an initial LTP without affecting later trials, and on this basis it
has been suggested that prolonged molecular events are induced - thus the persistent
activation of mGluRs is not necessary beyond the primary 'switch' event (Bortolotto
et al, 1994). The delivery of a low-frequency electrical stimulus in this LTP study
reversed the mGluR 'switch', so the changes do not appear to be irreversible and the
state of responsiveness seems to be dependant on input frequency. This may also be
the case in the transmission of analogous sustained nociceptive inputs, but obviously
further experiments are required to ascertain the exact nature of mGlu activation and
the consequences of this. Since the present study did observe an inhibition of
mustard oil-evoked activity with mGluR antagonists it is unlikely that the
mechanisms are identical. However, it would be prudent to now test the effect of
mGluR antagonists on a brief noxious input to dorsal horn neurons both before and
after mustard oil application, in order to assess the role of the antagonists pre- and
post-sensitisation, and to test the specificity of mGluR subtypes in both instances.
As well as the possible physiological mechanisms by which mGluRs may
act, their pharmacology is becoming increasingly complex. Certain compounds,
including some of the available phenylglycine derivatives, appear to act preferentially
with receptor subgroups, but there is often a degree of overlap thus making it difficult
as yet to fully characterise the receptors studied in vivo. L-AP3 is a weak group I
mGluR antagonist while (R,S)- and (S)-CHPG are potent antagonists at these
receptors, particularly mGluR 1 (Watkins & Collingridge, 1994; Pin & Duvoisin,
1995). It would therefore seem appropriate to deem the receptors involved in this
model of sustained nociception as either mGluR 1 and/or mGluR5. However, the
lack of entirely specific antagonists available at the time of these experiments makes
further judgement unfounded. Recent studies in our laboratory using 3,5-DHPG, a
selective group I agonist and cyclothiazide (CTZ) an mGluR 1 selective antagonist
ineffective at mGluR5 (Sharp et al, 1994), have provided some evidence
demonstrating the specific presence of the mGluR 1 receptor in the dorsal horn and its
involvement in mustard oil-evoked activity (S. Fleetwood-Walker & H. Sparrow,
unpublished observations). Ideally the experiments in this study could be repeated
using such newly available selective mGluR agonists which allow distinction
between the subtypes in question. Selective group II and group III agonists e.g.
CCG-I and L-AP4 respectively (Hayashi et al, 1992; Thomsen et al, 1992; Nakajima
et al, 1993; Tanabe et al, 1993; Okamoto et al, 1994; Duvoisin et al, 1995), would
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also be of interest since, although the mGluRs involved in the present experiments
appear to be of group I, it seems likely that other mGluRs will exert relevant
influences in sensory processing in the dorsal horn. The ongoing development of
increasingly selective antagonists will be crucial in providing unequivocal evidence
as to the nature of the receptors which mediate the C fibre inputs and central
sensitisation generated by the cutaneous application of mustard oil, as well as other
potential mGluR-mediated modulation of dorsal horn neuron function.
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CHAPTER 4:
STUDIES ON THE ROLE OF DIFFERENT INTRACELLULAR
SIGNALLING PATHWAYS IN RESPONSES OF DORSAL HORN
NEURONS TO SENSORY STIMULI AND TO A METABOTROPIC
GLUTAMATE RECEPTOR AGONIST
4.1 AIMS
The effect of inhibitors of several second messenger systems on
innocuous brush- and noxious chemical (mustard oil)-evoked activity was examined,
to elucidate any specific pathways involved in nociception.
Secondly, in order to investigate possible intracellular signalling
pathways linked to metabotropic glutamate receptors (mGluRs), these inhibitors were
ionophoresed, whilst the cell was activated with an mGlu agonist.
4.2. METHODS
4.2.1. General Methods
Regarding animals, surgical procedures and electrophysiological
recording techniques, quantification of neuronal responses to evoked activity,
histological identification of recording sites and analysis of results please refer to
section 3.2.
4.2.2. Drugs for Ionophoresis
All solutions were pH 4.0-4.5. Drugs were dissolved at the greatest
concentration compatible with an acceptable concentration of vehicle, <0.5%
dimethylformamide (DMF) in the final electrode solution.
Calmodulin/Ca++-Dependent Kinase II: calmidazolium (Silver et al,
1986) and KN62 (Tokumitsu et al, 1990) were both 50pM in 0.5% DMF.
Protein Kinase C: GF109203X (Toullec et al, 1991) was lOOpM in
0.5% DMF and chelerythrine (Herbert et al, 1990) was ImM aqueous.
Phospholipase A2: ONO-RS-082 (Banga et al, 1986) was 100|lM in
0.5% DMF and benzenesulphonamide 4 (Oinuma et al, 1991) 50(lM in 0.5% DMF.
Protein Kinase A: KT5720 (Kase et al, 1987) was 50pM in 0.5% DMF
and H89 (Chijiwa et al, 1990) 100|iM in 0.5% DMF.
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Tyrosine Kinase: lavendustin A (Hsu et al, 1991) was 200|iM in 0.2%
DMF and piceatannol (Geahlen et al, 1989) 300|lM in 0.3% DMF.
4.2.3. Controls
As well as 1M NaCl, 0.5% DMF was ionophoresed up to 80nA for
simultaneous current and vehicle controls. Both controls were carried out on
agonist-, brush- and mustard oil-evoked activity.
4.2.4. Analysis of Results
For details on analysis please refer to section 3.2.10. Note that changes
brought about in neuronal firing which were within 15-20% of pre-drug controls
were not considered to be marked, as they were within natural variability brought
about by vehicle or currrent controls (although these were normally <10%).
4.3 RESULTS
4.3.1.1. Characteristics of Neurons
A total of 43 rats were used for this study, with the, investigation of 169
neurons. Microelectrode depths ranged from 150-900p,m, from the surface of the
spinal cord. Resting disharge was between 0 and 1Hz. Most neurons in this study
were found to have receptive fields on the cutaneous surface of the ipsilateral
hindlimb. The size of the receptive field was variable, ranging from a single digit to
the majority of the upper leg, although field size did not appear to result in any
differences observed with the drugs used.
In the overall population the characteristics of neurons which were or
were not inhibited by antagonist ionophoresis did not differ. Seventeen cells were
tested sequentially with several drugs, on either responses to brush (6 cells), mustard
oil (6 cells) or agonist (5 cells). No differences in results were seen due to the order
of application of drugs. Time for full recovery was allowed between these sequential
tests (up to 15 minutes) and the results from such multiple trials were always typical
of the overall population. All evoked activity was always maintained at steady levels
throughout testing, from 10 to 40 minutes.
In a total of 76 neurons, innocuous brushing of the receptive field
resulted in a rise from basal disharges of 0-1 Hz to steady firing rates between 10 and
40Hz. In the mustard oil study 38 multireceptive cells were used. All of these
neurons were required to give a vigorous response to noxious heating of the
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cutaneous receptive field. Repeated topical applications of mustard oil to the
receptive field of these neurons produced elevated levels of firing from 4-37Hz.
Metabotropic glutamate receptor agonist, (1S,3R)-ACPD, was ejected between 0 and
-lOnA, and produced steady firing rates from 7-50Hz. Approximately one fifth (47
out of 244) of neurons were excited by such ionophoresis of the agonist. On only 2
occasions in the 61 tests carried out did an inhibitor fail to reduce agonist-evoked
activity, so it is possible that all five of the intracellular signalling pathways
investigated here are linked to at least one of the four metabotropic glutamate
receptors (mGluRs 1, 2, 3 and 5) activated by this compound. Alternatively, a
number of the compounds may have seondary effects additional to their main
influence on signalling pathways. The degree of inhibition on (1S,3R)-ACPD-
evoked activity was similar for all compounds.
Recovery was observed in approximately three quarters of the tests,
ranging from a few seconds after the termination of drug ionophoresis to 10-15
minutes later. No particular compounds allowed recovery on more occasions than
the others.
4.3.1.2. Ionophoretic and Vehicle Controls
As well as the control data presented in section 3.3.1.2., it was necessary
to test the effect of ionophoresed vehicle containing dimethylformamide (DMF), as
some of the compounds were prepared in that vehicle. 0.5% DMF was ejected at up
to +80nA for 2-5 minutes during brush-, mustard oil- and agonist-evoked firing. It
failed to markedly alter activity (never beyond 15% of pre-drug controls; p>0.05,
Wilcoxon test) in 6 out of 6, 4 out of 4 and 4 out 5 cases respectively (see Fig 4.1).
On the one occasion where it did reduce (lS,3R)-ACPD-induced activity, it did so at
+80nA. This high level of ejection current was only ever employed for the
ionophoresis of the protein kinase C inhibitor chelerythrine, and the effects of this
compound could not be due to DMF as it was dissolved in water.
4.3.2. EFFECTS OF INHIBITORS OF INTRACELLULAR SIGNALLING PATHWAYS
ON NEURONAL RESPONSES TO INNOCUOUS BRUSH STIMULI
4.3.2 (a) Calmodulin/Ca++-dependent kinase II Inhibitors (Calmidazolium
and KN62)
Twenty neurons which had a response to innocuous brush were studied.
Of the 8 units in which an antagonist caused an inhibition beyond control margins
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(15-20% of pre-drug levels), all responded to noxious pinch and 1 of them to noxious
heating of the cutaneous receptive field. These compounds were predominantly
ineffective in altering brush-evoked activity (see Figs 4.2a and 4.2b). Calmidazolium
(30-60nA) caused an overall mean decrease of 16±10% from pre-drug controls (n=8),
this effect was not statistically significant (p>0.05, Wilcoxon test). Two of the 8
units were inhibited beyond the margin of variability (by 69% and 49%). Of the 6
cells which were not inhibited more than 15-20%, 3 showed negligable alterations in
firing during drug ionophoresis, 2 showed small inhibitions (16 and 18%) and 1 had
its firing slightly facilitated (+11% from control levels). KN62 (30-70nA) did cause
a significant inhibition in the overall population of neurons (p<0.05, Wilcoxon test),
with a mean decrease in activity of 42±13%. However, KN62 only markedly
reduced firing (>15-20%) in 6 out of 12 tested neurons. Of the remaining 6 cells, 2
showed no measurable change, 3 were inhibited less than 15-20% and 1 showed a
small facilitatory effect of the compound (+26%).
4.3.2 (b) Protein Kinase C (PKC) Inhibitor (GF109203X)
The effect of GF109203X on firing induced by brushing of the receptive
field was investigated by Munro et al (1994a). This study showed that only 1 of 5
tested units was inhibited beyond 15-20% by this compound, with a mean inhibition
of 3±3% for the whole group; not significantly different from pre-drug control values
(p>0.05, Wilcoxon test).
4.3.2 (c) Phospholipase A2 (PLA2)Inhibitors (ONO-RS-082 and BS4)
A total of 18 neurons were investigated, 9 of which had their brush-
evoked activity significantly inhibited by the PLA2 antagonists. Seven of these
neurons were tested to noxious pinch, 6 responded. One cell was non-nociceptive, 2
were not characterised. These compounds were slightly more effective in reducing
activity evoked by brushing of the receptive field than the PKC inhibitors, but
nevertheless they only considerably inhibited half of the total number of cells tested
(see Figs 4.4a and 4.4b for typical examples of non-inhibition). ONO-RS-082 (30-
65nA) caused a mean inhibition of 28±13% (n=9), a statistically insignificant effect
(p>0.05, Wilcoxon test). Of the 9 units which were investigated, 4 had their activity
reduced beyond 15-20% and the remaining 5 showed decreases in activity from 3-
6%. In the population of cells tested with BS4 (30-60nA) a significant lowering of
evoked activity occurred overall (-37±12% from control values; p<0.05, Wilcoxon
test). However, only 5 of 9 cases tested were reduced beyond the 15-20% margin of
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variability. Of the 4 which did not have markedly reduced firing, 2 showed a slight
decrease in firing (by 13 and 19%), 1 showed no detectable change, and the
remaining cell was excited by 8%.
4.3.2 (d) Protein Kinase A (PKA) Inhibitors (KT5720 and H89)
Twenty neurons were examined. Of the 12 which were showed a
reduction in brush-evoked activity due to these compounds all but 1 was tested , and
fired in response, to noxious pinching. One cell was also activated by noxious heat.
Ionophoretic application of these compounds resulted in a lowered firing rate in just
over half of the neurons tested (see Figs 4.5a and 4.5b for examples of inhibition).
Both drug-induced effects were statistically significant (p<0.05, Wilcoxon test).
KT5720 (20-60nA) reduced neuronal firing by a mean of 59±15% across the
population of cells tested (n=10), although 3 units showed less than 15-20% change
from pre-drug control values. Two of these 3 cells showed no measurable change
and 1 had its firing decreased by 8%. Ionophoresis of H89 (30-70nA) resulted in a
mean decrease across the population of 45± 15% (n=10), although only 5 cells were
inhibited beyond the error margin of 15-20%. The remaining 5 neurons did not have
their activity altered by more than 10% from pre-drug control values.
4.3.2 (e) Tyrosine Kinase Inhibitors (Lavendustin A and Piceatannol)
A total of 24 neurons were studied. Of the 16 in which the inhibitors
were effective on brush-evoked activity, 9 responded to noxious pinching and 1 also
responded to noxious heating of the cutaneous receptive field. Four cells were non-
nociceptive and 3 were uncharacterised. Two thirds of the units tested here were
markedly inhibited by these compounds. Lavendustin A (30-70nA) caused a mean
decrease of 60±12% across the population (n=l 1; p<0.05, Wilcoxon test), reducing
brush-evoked activity beyond the 15-20% error margin in 9 out of 11 cases, with the
other 2 neurons showing no detectable change. Piceatannol (7-50nA) inhibited
activity by a mean of 48±15% (n=13; p<0.05, Wilcoxon test). This reduction was
greater than the margin of variability in 7 of the 13 units. Three of the remaining 6
cells showed no noticable change in activity from pre-drug levels, and in the other 3




Lack of effect of 0.5 % dimethylformamide on evoked activity in dorsal horn
neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second (R/s), integrated over 700 millisecond bins, plotted against
time.
As many of the second messenger inhibitors were dissolved in up to 0.5%
dimethylformamide (DMF), ionophoresis of this vehicle during evoked responses
was investigated.
The records show how ejecting 0.5% DMF at up to 60nA (up to 70nA in other
cases) failed to alter firing evoked by (A) innocuous brush, (B) mustard oil and
(C) (IS, 3R)-ACPD.
The inhibitory effect of ionophoresis of calmodulin/Ca++-dependent kinase II
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Figure 4.2a
The effect of ionophoretically applied Calmidazolium, a
calmodulin/Ca++-dependent kinase II inhibitor, on evoked activity in dorsal
horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second (R/s), integrated over 700 millisecond bins, plotted against
time. The inserts show receptive fields of cells, with hatched areas representing
both sides of the leg/foot.
These are typical examples of how calmidazolium affected evoked responses, and
the similar effects of KN62 are shown in Figure 4.2b. In most cases
calmidazolium did not alter the firing evoked by innocuous brushing of the
cutaneous receptive field, as in (A). However, it did decrease activity induced by






















The effect of ionophoretically applied KN62, a calmodulin/Ca++-dependent
kinase inhibitor, on evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second (R/s), integrated over 700 millisecond bins, plotted against
time.
These are typical examples of how KN62 affected evoked responses. In most
cases KN62 did not alter the firing evoked by innocuous brushing of the cutaneous
receptive field, as in (A). However, it did decrease activity induced by both




















The effect of ionophoretically applied chelerythrine and GF109203X, protein
kinase C inhibitors, on (1S,3R)-ACPD evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second, integrated over 700 millisecond bins (R/s), plotted against
time. Receptive fields are shown by diagonal lines on the inserts.
Firing was evoked by ionophoresis of metabotropic glutamate receptor agonist
(1S,3R)-ACPD (InA in (A) and 3nA in (B)) prior to and during the test. The


















The effect of ionophoretically applied ONO-RS-082, a phospholipase A2
inhibitor, on evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second (R/s), integrated over 700 millisecond bins, plotted against
time. Diagonal lines on the inserts show the receptive field of the cells, with
hatched areas representing both sides of the leg/foot.
The lack of effect of ONO-RS-082 on brush-evoked activity (A) can be contrasted
with its inhibitory effects on both (B) mustard oil- and (C) (1S,3R)-ACPD (-7nA)
-evoked firing. At equivalent currents, this compound can be clearly seen to




The effect of ionophoretically applied Benzenesulphonamide (BS4), a
phospholipase A2 inhibitor, on evoked activity in dorsal horn neurons
Ionophoresis of a second phospholipase A2 inhibitor, BS4, resulted in the same
overall effect. The records show ongoing firing of individual neurons, displayed
as action potentials per second (R/s), integrated over 700 millisecond bins, plotted
against time.
The lack of effect of BS4 on brush-evoked activity (A) can be contrasted with its
inhibitory effects on both (B) mustard oil- and (C) (1S,3R)-ACPD (-5nA) -evoked
firing. At equivalent currents, this compound can be clearly seen to reduce a
noxious input to a greater extent than an innocuous input.
Traces A and C are from the same neuron (common receptive field alongside C),
demonstrating how the compound selectively reduced agonist-evoked activity, but

















The effect of ionophoretically applied KT5720, a protein kinase A inhibitor,
on evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second, integrated over 700 millisecond bins (R/s), plotted against
time. The receptive field is shown on the inserts by diagonal lines, or hatched
areas where it occurred on both sides of the leg.
Record (A) is an example of how ionophoresis of KT5720 led to a reduction in
brush-evoked firing. This was typical in over half of the neurons tested. Traces
(B) and (C) demonstrate how, at much lower currents, KT5720 also reduced the
firing evoked by the cutaneous application of mustard oil and ionophoretic
application of metabotropic glutamate receptor agonist (1S,3R)-ACPD (-InA).















The effect of ionophoretically applied H89, a protein kinase A inhibitor, on
evoked activity in dorsal horn neurons
Ionophoresis of another protein kinase A inhibitor, H89, resulted in similar
changes. The records show ongoing firing of individual neurons, displayed as
action potentials per second, integrated over 700 millisecond bins (R/s), plotted
against time. The receptive field is shown on the inserts by diagonal lines, or
hatched areas where it occurred on both sides of the leg.
Record (A) is an example of how ionophoresis of H89 led to a reduction in brush-
evoked firing. This was typical in half of the neurons tested. Trace (B)
demonstrates how, at a lower current, H89 also reduced the firing evoked by the
ionophoretic application of metabotropic glutamate receptor agonist (1S,3R)-





The effect of ionophoretically applied Lavendustin A, a tyrosine kinase
inhibitor, on evoked activity in dorsal horn neurons
The records show ongoing firing of individual neurons, displayed as action
potentials per second, integrated over 700 millisecond bins (R/s), plotted against
time. Diagonal lines on the inserts show the receptive field of the cells, with
hatched areas representing both sides of the leg/foot.
These are typical examples of how lavendustin A reduced firing evoked by (A)



















The effect of ionophoretically applied Piceatannol, a tyrosine kinase
inhibitor, on evoked activity in dorsal horn neurons
A second tyrosine kinase inhibitor, piceatannol, resulted in similar alterations in
evoked responses. The records show ongoing firing of individual neurons,
displayed as action potentials per second, integrated over 700 millisecond bins
(R/s), plotted against time. Diagonal lines on the inserts show the receptive field
of the cells, with hatched areas representing both sides of the leg/foot.
These are typical examples of how piceatannol reduced firing evoked by (A)












Oscilloscope records of the effect of intracellular signalling pathway
inhibitors lavendustin A and KT5720 on individual dorsal horn neurons
firing in response to the cutaneous application of mustard oil
The records show a sudden cessation of mustard oil-evoked firing during the
ionophoresis of (A) tyrosine kinase inhibitor lavendustin A (35nA) and (B)
protein kinase A inhibitor KT5720 (20nA). In the upper trace a brief period of
excitation can be seen preceding the inhibition of firing. The lower trace however,








A summary of the effects of ionophoretically-applied inhibitors of
intracellular signalling pathways on the activity of dorsal horn neurons
evoked by brush, mustard oil or (1S,3R)-ACPD
The ranges of ionophoretic currents required for the effects reported are indicated
in parentheses below each drug. In the case of (1S,3R)-ACPD, higher currents
(<60nA) were sometimes briefly used to initiate firing, but after the first few
seconds, the elevated activity could always be maintained by <10nA.
The effects of the drugs on evoked responses are indicated as the mean±SEM
percentage inhibition compared to pre-drug control activity. In each case, the
number of neurons contributing to the data is shown below and in parentheses, the
proportion (percentage) of those neurons which individually gave a clear response
of >20% inhibition. The statistical significance of drug-induced changes in firing
rate was assessed using the Wilcoxon test on mean raw firing data in action
potentials per second; comparing the 20 or 30 second period immediately prior to
drug administration with the 20 or 30 second period centred on the greatest
inhibitory effect of the drug (U1 represents p<0.05; ns indicates not significantly
different, p<0.05).
The data from GF109203X and chelerythrine on brush- and mustard oil-evoked
activity is taken from Munro et al, 1994.
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Inhibition of evoked activity
(% inhibition compared to pre-drug controls)
Principal
Target























































































4.3.3. EFFECTS OF INHIBITORS OF INTRACELLULAR SIGNALLING PATHWAYS
ON NEURONAL RESPONSES TO NOXIOUS CHEMICAL STIMULATION BY
MUSTARD OIL
4.3.3 (a) Calmodulin/Ca++-dependent kinase II Inhibitors (Calmidazolium
and KN62)
Both of these compounds significantly reduced activity evoked by the
cutaneous application of mustard oil (see Figs 4.2a and 4.2b). Calmidazolium (30-
60nA) depressed neuronal activity in 5 out of 7 cells, by a mean inhibition on the
population of 42±14% from control levels (p<0.05, Wilcoxon test). Four of the 5
units recovered to between 75 and 100% of pre-drug levels, all within 5 minutes.
The 2 cells which were not markedly inhibited showed very small increases in firing
(+3 and +17% from control). KN62 (30-70nA) produced similar results, in that 4 of
5 tested units showed a marked decrease in firing, with a mean and significant
reduction of 51 ±19% for the whole group (p<0.05, Wilcoxon test). Of these 4
neurons, 1 failed to return to control firing rates (given upto 15 minutes). The
remaining 3 cells did recover, within 2-5 mins. The final tested neuron was excited
by 16%.
4.3.3 (b) Protein Kinase C (PKC) Inhibitors (Chelerythrine and GF109203X)
Munro et al (1994a) investigated the effect of GF109203X and
chelerythrine on mustard oil-induced firing. They showed that both antagonists had a
significant and reproducible effect on such neuronal activity. GF109203X (20-60nA)
reduced fring in all but 1 of the 9 cells tested (mean inhibition of 53±10%) and
chelerythrine (10-80nA) reduced the response of all 8 units examined (a mean
inhibition of 70±10%; p<0.05, Wilcoxon test).
4.3.3 (c) Phospholipase A2 (PLA2)Inhibitors (ONO-RS-082 and BS4)
A total of 10 cells were tested on mustard oil-evoked activity, 5 with each
of the inhibitors. All neurons showed a profound reduction in firing when the
antagonists were ionophoresed (see Figs 4.4a and 4.4b). ONO-RS-082 (30-65nA)
significantly decreased activity by a mean of 70±11% (p<0.05, Wilcoxon test) from
control responses and BS4 (30-60nA) had very similar effects, in that it significantly
reduced firing by 74±11% (p<0.05, Wilcoxon test). Only 1 cell, in the ONO-RS-082
group, failed to recover from antagonist ionophoresis. Two of the units in the BS4
group only returned to within 50% of control firing levels.
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4.3.3 (d) Protein Kinase A (PKA) Inhibitors (KT5720 and H89)
Twelve neurons were investigated. In 6 out of 7 cells KT5720 (20-60nA)
profoundly inhibited mustard oil-evoked activity by 73±13% (p<0.05, Wilcoxon
test). Three of these 6 units recovered (see Fig 4.5a), whereas 3 showed no activity
during the next 10-15 minutes of the experiment. Activity in the seventh cell was not
changed from pre-drug levels by the ionophoresis of KT5720. H89 (30-70nA)
brought about a considerable reduction in neuronal firing from control values in all 5
which were tested (see Fig 4.5b), by a mean of 66+10% (p<0.05, Wilcoxon test).
Recovery (75-100%) was observed in all examples.
4.3.3 (e) Tyrosine Kinase Inhibitors (Lavendustin A and Piceatannol)
Similar to the effect on brush-evoked firing, lavendustin A (30-70nA)
significantly reduced mustard oil-evoked activity from control levels across the
population of cells (markedly in 7 of 8 units; see Fig 4.6a), by a mean of 58+10%
(p<0.05, Wilcoxon test). The cell which was not notably inhibited showed a 7%
decrease in firing. Four of the 7 inhibited cells showed recovery close to pre-drug
levels, whereas the remaining 3 did not show a rise in firing within 10-15 minutes.
Piceatannol (7-50nA) produced comparable effects by clearly inhibiting 5 out of 6
cells, all of which recovered to within 75% of pre-drug activity (see Fig 4.6b), with a
mean decrease of 87±7% (p<0.05, Wilcoxon test). The sixth cell showed no
discernable change in activity during application of the compound.
4.3.4. effects of inhibitors of intracellular signalling pathways
on neuronal responses to ionophoresis of mglu receptor
Agonist (1s,3R)-ACPD
4.3.4 (a) Calmodulin/Ca++-dependent kinase Inhibitors (Calmidazolium
and KN62)
All 10 cells in this group responded to innocuous brushing and noxious
pinching of the receptive field. In 4 of 5 cells calmidazolium (30-60nA) markedly
reduced the firing evoked by ionophoresis of (1S,3R)-ACPD (see Fig 4.2a), by a
population mean of 68+16% (p<0.05, Wilcoxon test). In the fifth cell there was a
slight elevation in firing (+10% from pre-drug activity). In all of a further 5 units
KN62 significantly inhibited the response by a mean of 83+9% (p<0.05, Wilcoxon
test). See Fig 4.2b.
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4.3.4 (b) Protein Kinase C (PKC) Inhibitors (Chelerythrine and GF109203X)
Of the 12 units tested, 4 responded only to brushing of the receptive field.
As well as responding to brush, 5 showed increased activity to noxious pinching and
1 to noxious heating. Three did not have their sensory inputs characacterised.
Ionophoresis of chelerythrine (10-80nA, n=7) and GF109203X (20-60nA, n=5)
significantly reduced (lS,3R)-ACPD-evoked activity in all cases (see Fig 4.3), with
mean inhibitions of 84+11% and 86+12% respectively (both p<0.05, Wilcoxon test).
4.3.4 (c) Phospholipase A2 (PLA2)Inhibitors (ONO-RS-082 and BS4)
Two of these 15 units responded only to brushing of the receptive field, 8
were not characterised further and the remaining 5 responded to noxious pinch. In 8
out of 8 cases ONO-RS-082 (30-65nA) profoundly decreased (lS,3R)-ACPD-evoked
firing levels (see Fig 4.4a), with a mean reduction of 75+9%. Similarly, BS4 (30-
60nA) caused all 7 tested units to be inhibited (see Fig 4.4b), the mean fall being 86+
6% (both p<0.05, Wilcoxon test).
4.3.4 (d) Protein Kinase A (PKA) Inhibitors (KT5720 and H89)
Eight of the 11 units in this group responded to noxious pinch as well as
innocuous brushing of the reeptive field. The other 3 cells were not characterised
beyond their response to brush. Ejection of KT5720 (20-60nA) and H89 (30-70nA)
resulted in a marked inhibitory effect on (lS,3R)-ACPD-evoked activity in all but 1
cell. KT5720 (n=5) decreased firing across the population by a mean of 87+11%
(p<0.05, Wilcoxon test). In one neuron this compound had a dual effect in that it
caused a facilitation (>200%) in firing at 20nA and a reduction of 85% at 40nA. H89
clearly reduced the firing of all 6 tested cells, by a mean of 79+13% (p<0.05,
Wilcoxon test). See Figs 4.5a and 4.5b.
4.3.4 (e) Tyrosine Kinase Inhibitors (Lavendustin A and Piceatannol)
Four of the cells tested with (1S,3R)-ACPD responded positively to
noxious pinching of the skin, 1 to noxious heating and the remainder of the group
were not tested beyond their response to brushing of the receptive field. Of the 7
units in which lavendustin A (30-70nA) was tested, activity was decreased by a mean
of 69+12% from pre-drug controls (see Fig 4.6a). Likewise, piceatannol (7-50nA)
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inhibited 6 out of 6 tested neurons (see Fig 4.6b), with a mean reduction of 84±9%
(both p<0.05, Wilcoxon test).
As with the results in Chapter 3, side-by-side comparisons of the effect of
each compound on all three types of evoked activity could not be carried out as a
consequence of the lasting effects induced by mustard oil. However, several
comparisons were made on the population of neurons tested. In the case of CamKII,
PKC and PLA2 inhibitors, but not the other agents, there appeared to be a lesser
effect on brush-evoked activity than on the other responses. The mean percentage
inhibition of mustard oil- and (lS,3R)-ACPD-evoked responses by CamKII inhibitor
calmidazolium, and the PLA2 inhibitors ONO-RS-082 and BS4 were consistently
two-fold greater than their effect on brush-evoked responses, and in the case of the
PKC inhibitor GF109203X, it was many fold more. Furthermore, comparisons
between two types of evoked activity were possible in some cases. For example, in
the case of a single neuron tested with BS4, direct comparison on brush and (1S,3R)-
ACPD responses revealed a selective inhibition of the latter (see Figure 4.4b), in
accordance with the overall population of neurons investigated. Similarly,
piceatannol caused inhibition of responses to both brush and mustard oil when
directly compared on a single cell, again typical of the overall population.
A summary of these results can be found in Table 4.1, where data are
given as the mean±SEM percentage inhibition in the total population of cells tested.
The results are presented in a manner which shows how each sensory input was
affected by the range of inhibitors. However, the effect of individual compounds on
all three inputs can be compared in figures 4.2 - 4.6.
One phenomenon which occurred occasionally during evoked activity
was a very abrupt end in the firing of the neuron. This was sometimes preceded by a
slight excitation and/or reduction in spike height, showing characteristics similar to a
depolarisation block (see Fig 4.7). Recovery was not seen in these instances. This
occurred throughout the range of compounds tested, although KT5720 showed more
cases than any other drug, and was not specific to the type of activity evoked. The
following shows which drugs induced this type of response and, in parentheses, the
frequency with which it occurred:
Brush: KN62 (1/13); BS4 (1/10); KT5720 (3/13); H89 (1/11);




calmidazolium (1/8); KT5720 (3/10)
calmidazolium (1/6); KN62 (1/6); chlerythrine (1/8); KT5720
(2/7); piceatannol (1/7)
4.4. DISCUSSION
Extracellular recordings were made from neurons in laminae III-V of the
dorsal horn, data based on depth readings from the microdrive attached to the
electrode, along with subsequent blue spot histology carried out on the spinal cord.
The majority of units in this study were multireceptive, with a number of non-
nociceptive neurons in the brush and agonist experiments. The type of cell did not
appear to have any effect on the outcome of pharmacological tests. All cells
displayed very low basal firing rates of less than 1Hz prior to activity evoked by
brush, mustard oil or (1S,3R)-ACPD. Frequent vehicle and current controls revealed
no reproducible effects of the ionophoresis of either 1M NaCl or 0.5% DMF on the
evoked activities discussed. Following the characterisation of the role of mGluRs in
sensory processing, utilising innocuous brush- and noxious mustard oil-evoked
activity in dorsal horn neurons (see Chapter 3) the same model was subsequently
used to investigate the mechanism(s) by which they may act.
Of the five signal transduction targets which were investigated, protein
kinases A and C (PKA; PKC), phospholipase A2 (PFA2), non-receptor tyrosine
kinases and the Ca++/calmodulin-dependent kinase II (CamKII), all showed an
apparent link with whichever of the group I/n mGluRs involved here, as their
inhibitors caused distinct reductions in the activity evoked by the ionophoresis of
mGluR agonist (1S,3R)-ACPD. These decreases appear not to be non-selective
effects for several reasons: not all evoked activity could be reduced by the
ionophoresis of these second messenger inhibitors (eg brush-evoked activty in a
number of instances, notably in the cases of PKC, PFA2 and CamKII)) Furthermore,
(lS,3R)-ACPD-elicited neuronal activity cannot be reduced by the co-ionophoresis
of any drug, as Chapter 3 demonstrated how D-AP3 could not alter firing evoked by
this agonist. However, as some of the compounds used were equally effective in
reducing all evoked responses the possibility of a non-selective action, or one
secondary to the inhibition of the specific signal transduction targets, cannot be
excluded. Therefore the link between mGluRs and PKA or non-receptor tyrosine
kinases in particular is not conclusive. The present study still however provides
evidence that mGluR activation is likely to involve the mobilisation of several
118
second messengers and their subsequent pathways. This evidence is consistent with
previous experiments which have shown the ability of mGluR agonists to induce
various signal transduction pathways (see section 1.3.3.(b)).
Some of the signal transduction antagonists tested in this study
demonstrated a preferential inhibition of mustard oil-, rather than brush-evoked
responses of dorsal horn neurons. Calmidazolium, an inhibitor of the Ca++-binding
protein calmodulin (thence Ca++/calmodulin-dependent kinase II; CamKII), ONO-
RS-082, a PLA2 inhibitor and the PKC antagonist GF109203X had no significant
effect on the brush-evoked responses observed in the population of neurons tested.
Also, the inhibitory effect of an additional PLA2 inhibitor, BS4, was consistently
two-fold greater on agonist and mustard oil responses than on activity induced by
innocuous brushing of the hindlimb. Along with the data from the agonist
experiments, these results are in agreement with the hypothesis of a
phosphoinositide-hydrolysing-linked Group I mGluR participating in the mediation
of sustained C-fibre responses evoked by the application of mustard oil.
The consequences of mGluR activation are likely to be widespread, as
these targets which demonstrate a modality-selective role represent stages in merely
three of many possible different pathways which can be activated by a single initial
step which generates IP3 (see Figure 1.3.(a)). Activation of Group I mGluRs can
result in phosphoinositide hydrolysis (Nicolletti et al, 1986; Challis et al, 1988;
Sladeczek et al 1988; Baird et al, 1991) to produce IP3, with subsequent rises in
intracellular calcium (Murphy & Miller, 1988; 1989). On the other arm of the
phospholipase C (PLC) cascade (see Figure 1.3.(a)) there will be mGluR-linked
activation of diacylglycerol with the subsequent mobilisation of PKC (Manzoni et al,
1990; Behnisch & Reymann, 1993), thereby potentially leading to PLA2 activation
and a release of arachidonic acid (Aramori & Nakanishi, 1992). Downstream
modulation of various ion channel activity by mGluR agonists has also been reported
(Lester & Jahr, 1990; Fagni et al, 1991), including in spinal cord neurons (Bleakman
et al, 1992; Cerne & Randic, 1992). Longer-term alterations, for example due to
immediate-early gene activation, may be initiated as a result of these pathways being
implemented. The data from the present experiments highlights the roles of PKC,
PLA2 and CamKII in the mediation of nociceptive inputs, via one or more mGluRs
which can be activated by (1S,3R)-ACPD. Since all three of these second
messengers are generally downstream of IP3 or diacylglycerol production, it is likely
that the mGluR involved is of Group I in origin, i.e. mGluRl and/or 5, which are
coupled to the activation of PLC.
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The activity evoked by the ionophoresis of mGluR agonist (1S,3R)-
ACPD was markedly reduced, without exception, by the co-ionophoretic application
of both PKC inhibitors, GF109203X and chelerythrine. This decrease in activity
matched that observed on mustard oil-, but not innocuous brush-evoked responses by
Munro et al (1994a). This data is highly indicative of an mGluR-associated role for
PKC in the selective transmission of C-afferent fibre inputs. The prominent
blockade of mustard oil-evoked activity by PKC inhibitors is congruent with the
translocation/activation of dorsal horn PKC observed by measuring PDBu-binding,
following mustard oil- and formalin-induced inflammation, as well as after a chronic
constrictive nerve injury (CCI) (Mao et al, 1992; 1993; Munro et al, 1994a; Tolle et
al, 1994; Yashpal et al, 1995). In further support of a role for PKC in mediating
nociception, behavioural testing has demonstrated how persistent nociceptive
responses elicited by the subcutaneous administration of formalin can be attenuated
by PKC inhibitors (Coderre, 1992; Coderre & Yashpal, 1994; Yashpal et al, 1995),
as can the prolonged nociceptive behaviour induced by CCI (Hayes et al, 1992).
Interestingly, Yashpal et al (1995) observed a matched GF109203X- and
chelerythrine-induced reduction in the contralateral mechanical hyperalgesia resulting
with the formalin-evoked ipsilateral hyperalgesia. In addition to the evidence from
nociception and pain studies, the sensitivity of LTP in hippocampal cells to inhibition
of PKC (Lovinger et al, 1987; Malinow et al, 1988; 1989; Malenka et al, 1989; Bliss
& Collingridge, 1993) and the requirement of PKC activation in memory processing
(Olds et al, 1989) are further common features between this phenomenon and the
analogous sensitisation which occurs in dorsal horn neurons following a sustained
noxious input. Therefore the data from previous experiments which implicate PKC
in the mediation of nociceptive, but not non-nociceptive inputs (Munro et al, 1994a)
can now be integrated with the results from the present study to suggest that this
mediation can occur, at least in part, via a Group I mGluR. There is of course the
possibility of other receptors having a link with PKC, among them being the
neurokinin receptors. Urban et al (1994) found that an NK2, though not NK]
agonist-induced VRPs could be blocked by staurosporine, a PKC and PKA inhibitor,
thus indicating the possibility of PKC involvement in NK2 receptor-mediated
depolarisation. In addition to this, the intravenous administration of non-peptide
NK2 receptor antagonist SR48968 prevented the in vivo translocation of PKC
normally observed following the cutaneous application of mustard oil (F.E. Munro
PhD thesis, 1995). As mentioned previously, ion channel receptors can be modulated
downstream of second messengers. PKC is a good example of this phenomenon, as
phorbol ester activators of this kinase can facilitate responses elicited by NMDA in
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dorsal horn neurons in vitro (Gerber et al, 1989). Rusin et al (1992) observed a
reversal of SP-induced facilitation of NMDA responses when staurosporine was
administered, this may have been due to PKC, or perhaps PKA inactivation. Thus
there is the possibilty of a cellular interaction at the second messenger level, as a
consequence of the simultanous activation of EAA and other receptors.
As well as a selective role for PKC in nociception being established
(Munro et al, 1994a), the current investigation has provided substantial evidence for
a specific role of PLA2. The activity evoked in dorsal horn neurons by either the
cutaneous administration of mustard oil, or by ionophoretic application of (1S,3R)-
ACPD could be markedly reduced when PLA2 inhibitors ONO-RS-082 and BS4
were ionophoresed. However, in the case of the responses elicited by light innocuous
brushing of the hindlimb, the effect on the population of neurons tested with
ONO-RS-082 was not significant. Furthermore, the inhibitory effect on brush
responses by BS4, which was significant in the overall population was only
considerable in just over half of the neurons on which it was tested. The data here
would therefore suggest that PLA2, like PKC, plays a distinct role in the mediation of
sensory inputs, and that this can be, at least in this intance via mGluRs. This enzyme
can be activated downstream of PKC and is responsible for the generation of
arachidonic acid (AA) and its subsequent metabolites, including the prostaglandins
(PGs). Until recent years the role of these agents was thought to lie primarily in the
periphery, with some of the most common analgesics and anti-pyretics used today
targeting this pathway (non-steroidal anti-inflammatory drugs (NSAIDs), which
inhibit cyclooxygenase (COX), the enzyme responsible for the conversion of AA to
PGs). However some recent experiments have highlighted a capacity for these signal
transduction mechanisms to operate in central structures. When administered
intrathecally, NSAIDs can diminish the activity evoked in dorsal horn neurons by the
subcutaneous injection of formalin (Chapman & Dickenson, 1992). In accordance
with this, the behaviour which results from such formalin administration can be
markedly increased or decreased in animals which receive intrathecal AA or NSAIDs
respectively (Malmberg & Yaksh, 1992b; Yashpal & Coderre, 1993; Coderre &
Yashpal, 1994). Additionally, baseline paw withdrawal latencies were not affected
by an inhibitor of AA (Coderre & Yashpal, 1994), thus indicating a specific role for
this signal transducer in a sensitised state. The behavioural hyperalgesia which is
elicited when NMDA, AMPA and SP are intrathecally administered can also be
decreased when NSAIDs are applied (Malmberg & Yaksh, 1992a). Similarly
formalin-evoked responses which have been facilitated by SP or glutamate are
reduced by an inhibitor of AA (Coderre & Yashpal, 1994). It therefore seems
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apparent that nociceptive inputs to the spinal cord are at least partially mediated by
PLA2 and the pathways in which it is involved. The current study re-iterates this fact
and moreover provides evidence that this can be brought about by an mGluR, which
is activated by (1S,3R)-ACPD. With the use of newly selective antagonists Boyce et
al (1994) demonstrated that carrageenan-induced hyperalgesia can be reduced when
the action of COX2 is inhibited, without producing gastric ulceration, a common
side-effect of general COX inactivation. This may provide an even more discrete
downstream target in this cascade at which to target novel analgesics.
One of the most selective compounds observed in this investigation was
the CamKII inhibitor calmidazolium. This drug prevents calmodulin from binding to
Ca++, and thus the activation of the kinase in question, an event which would
normally result in the further phosphorylation of many other proteins, including
autophosphorylation of CamKII subunits in the rat brain (McGuinness et al, 1985;
Miller & Kennedy 1985; 1986). Inhibition of this step appears to have specifically
interrupted the transmission of sustained C-, but not A^-afferent fibre inputs to
dorsal horn neurons. A switch-like role for this CamKII has been suggested, and its
kinetics have led to the hypothesis that it has the ability to encode long-term
alterations in cellular activity (Lisman & Goldring, 1988). The present data are
consistent with this hypothetical role. Furthermore the results here give an insight
into the likely nature of this sustained input, i.e. it would appear that activity of a
high intensity is necessary. A role for CamKII in sustained high threshold synaptic
inputs is substantiated by evidence from LTP studies. Inhibition of this kinase results
in the inability of hippocampal cells to induce LTP, though once it is established
CamKII inhibitors are no longer effective (Malenka et al, 1989; Malinow et al,
1989). In addition to this, Silva et al (1992) examined genetically-engineered mice
which did not express CamKII, to reveal that LTP could not be evoked in the
hippocampus. Behavioural testing showed these mice were otherwise normal, thus
indicating a specific role in this prolonged synaptic sensitisation phenomenon.
Unfortunately no nociceptive testing was carried out, as it would be very interesting
to know the effect of this knock-out on pain thresholds, and the ability of known
analgesics to affect the responses.
In the present study the PKA inhibitors KT5720 and H89 were equally
effective in inhibiting all types of evoked activity in dorsal horn neurons. This could
imply that either the compounds were acting in a non-selective manner, or that PKA
phosphorylation is indeed involved in the transmission of both innocuous and
noxious information. Group II and III mGluRs are negatively linked to cAMP
formation (Manzoni, et al, 1990; Cartmell et al, 1992; Schoepp & Johnson, 1992; see
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Figure 1.3.(b)). No evidence from the present investigation supports the hypothesis
that one of these cAMP inhibiting mGluRs is found in the spinal cord, otherwise the
ionophoresis of PKA inhibitors might have been expected to mimic, rather than
inhibit the agonist-evoked responses. However, the inhibition of (1S,3R)-ACPD-
induced activity by both KT5720 and H89 is actually consistent with the hypothesis
that there are also (lS,3R)-ACPD-activated mGluRs which are positively linked to
cAMP production (Aramori & Nakanishi, 1992; Winder & Conn, 1992; 1993). In
further support of a possible role of PKA here, this enzyme has been implicated in
prolonged synaptic events such as LTP (Chetkovitch et al, 1991). Furthermore, the
adenylate cyclase activator forskolin can facilitate the neuronal responsiveness of
dorsal horn neurons to NMDA (Cerne et al, 1993). Although this cumulative
evidence may suggest the involvement of this kinase in sustained synaptic inputs, the
possibility of non-selective actions of these drugs makes it difficult to derive any
further conclusions as to a role for PKA in the transmission of sensory information at
the level of the spinal cord. The data obtained using these compounds may in fact be
representative of effects secondary to the inhibition of PKA, although both KT5720
and H89 are highly selective inhibitors of PKA activity (Kase et al, 1987; Chijiwa et
al, 1990). This may also the case for the non-receptor tyrosine kinase inhibitors
which were investigated. Activity evoked by all three inputs, brush, mustard oil and
agonist, could be equally reduced by the application of piceatannol and lavendustin
A. These compounds have demonstrated high selectivity for non-receptor tyrosine
kinases (Geahlen et al, 1989; Hsu et al, 1991) and it is therefore possible that the
interruption of all evoked activity was due to a genuine inhibition of these kinases,
particularly as they both behaved in a similar manner. A previous intracellular
recording study investigating LTP in the hippocampus, demonstrated how bath-
applied and post synaptically-injected lavendustin A (lOpM), and a further tyrosine
kinase inhibitor, genistein, could block LTP initially, though not once it was
established and neither compound affected normal synaptic transmission (O'Dell et
al, 1991). From this LTP study it may be expected that mustard oil-evoked activity
could likewise remain unaffected once established. Since this was not the case, it
must be assumed the role of tyrosine kinases in prolonged synaptic events in the
hippocampus and spinal cord are somewhat different (though the two events have
many other similarities) or that the drug effects here are non-specific. This data
nonetheless indicates, at least in the case of lavendustin A, that tyrosine kinase
inhibitors are capable of selective inhibition of some cellular events. Furthermore,
since both compounds in the present study yielded similar results (and they are
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structurally quite different) the data should not necessarily be discounted on the basis
of the likelihood of non-specific effects.
Interestingly, the three pathways investigated in this study which appear
to be specifically linked to mustard oil-evoked activity in dorsal horn neurons are all
downstream of the activation of Group I mGluRs. This substantiates further the
hypothesis in Chapter 3, that is it is mGluRl and/or 5 which selectively mediate
noxious inputs. It would be most interesting to now observe the effect of
intrathecally applied second messenger inhibitors on behavioural responses. In the
case of those yielding general inhibitory effects in the present study, there may be the
possibilty of testing them on other reflexes, in order to re-assess their role in sensory
inputs. Also, different models of sustained nociception, such as carrageenan- or
CFA-induced inflammation may provide further information as to the specific roles
of these inhibitors. In light of the numerous studies on the role of second messengers
in LTP, and since many inhibitors affect the induction but not maintenance of this
phenomenon, it may be very advantageous to assess the role of the signal transducers
in the induction of the sensitisation process which occurs in dorsal horn neurons
following a sustained noxious input.
In summary, the present data suggest that PKC, PLA2 and CamKII are
highly likely to play a role in the mediation of mustard oil-evoked activity in dorsal
horn neurons. However, due to the inability to rule out non-specific events, the same
cannot be concluded about non-receptor tyrosine kinases and PKA. These two
signalling pathways may however play a genuine role in mediating a broad range of
sensory inputs to the spinal cord. Furthermore, in this model of sustained
nociception the signal transduction events discussed are likely to be linked at least in
part to the activation of an mGluR (with the results from Chapter 3 indicating this to
be mGluRl and/or mGluR5).
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CHAPTER 5:
THE EFFECT OF INTRATHECALLY APPLIED METABOTROPIC
GLUTAMATE AND TACHYKININ RECEPTOR ANTAGONISTS ON
BEHAVIOURAL NOCICEPTIVE REFLEXES
5.1. AIMS
Electrophysiological experiments, including the present study, have
demonstrated a role for metabotropic glutamate (mGlu) and neurokinin (NK)
receptors in various nociceptive inputs. In order to evaluate the possible
corresponding role of mGlu, NK] and NK2 receptors as analgesics in the behaving
animal, the effect of intrathecally applied antagonists on behavioural responses to
noxious mechanical and noxious thermal stimuli was assessed. These effects were
investigated in the normal paw, and in separate groups of animals with a paw which
had been inflamed by an intraplantar injection of carrageenan. Each antagonist was
tested individually, as well as part of a co-injection regime in order to determine any
interaction between mGlu and NK receptors.
5.2. METHODS
5.2.1. Animals
Animals were Glaxo-bred male and female Lister-hooded rats (30 - 70g).
They were housed in steel bar based cages in a similar manner to that described in
3.2.
5.2.2. Drugs
All drugs were administered as a 10pl injection. L- and D-AP3 (30 and
60nmol), (S)-CHPG (24 and 48nmol) and GR82334 (0.1, 0.3 and 3nmol) were all
made up in sterile saline. L659,874 (0.1, 0.3 and 3nmol) was dissolved in 0.3%
dimethylsulphoxide (DMSO) in saline. The pH of each solution was adjusted to 7.2 -
7.4. All drug solutions were made by diluting frozen aliquots of stock, either in
sterile saline or DMSO, immediately prior to the behavioural testing. Once thawed,
they were not refrozen.
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5.2.3. Intrathecal injections
Animals received a single 1 Ojj.1 intrathecal (i.t.) injection by means of a
10|J.l Hamilton microsyringe fitted with a disposable 30G needle. The correct
positioning of the needle, around L5 - L6, was determined by a tail flick response.
Immediately after the injection the animals were placed in a perspex box with a layer
of sawdust on its base. They were allowed to move freely between tests.
5.2.4. Behavioural Assessment
Baseline measurements of paw withdrawal threshold/latency to noxious
mechanical/thermal stimulation were taken at least 15 minutes prior to drug
administration. Two thresholds/latencies for the right hindlimb were measured, if
these differed by more than 1.0 units/seconds then a third was also taken, and the
mean value used as baseline.
Following the intrathecal injection of drug or vehicle paw withdrawal
reactions were tested at 1, 3 and 5 minutes. At the end of the test the animal was
humanely destroyed.
5.2.4.(a) Behavioural Reflex to Noxious Mechanical Stimulation
Paw withdrawal threshold to a noxious mechanical stimulus was
measured using an Analgesy-Meter from Ugo Basile, 21025 Comerio - Varese, Italy.
The animal's paw was placed under a plastic cone which provided increasing
pressure, controlled by means of a foot switch, until the paw was withdrawn. The
rise in pressure was brought about by a lOg weight moving along a rotating bar,
which was located above a numerical scale (see figure 5.1.). The reading taken from
the Analgesy-Meter (called "units" in the results section) was representative of grams
x 10, i.e. 8 = 80g, the maximum being 250g. Since the animals used were very small,
the withdrawal was often observed as a pulling action, and was gauged by the
experience of the handler.
5.2.4.(b) Behavioural Reflex to Noxious Thermal Stimulation
The apparatus used for the measurement of paw withdrawal latency to
noxious heat was a Ugo Basile Tail Flick Unit. The dorsal, hairy suface of the paw
was loosely held over a 50W infra-red bulb (see figure 5.2.) with a foot switch to turn
it on, simultaneously activating a digital seconds display. When the rat retracted its
paw the timer, and thus the heat source, automatically stopped due to an electronic
circuit being interrupted because of lack of energy reflected by the foot. Latencies
were recorded to the nearest 0.1 second, with a cut-off of 23.0 seconds.
126
5.2.5. Induction of Inflammation
Separate groups of animals were used to assess the effects of drugs in the
inflamed state, i.e. not the contralateral paw in the normal groups. In these animals,
inflammation was induced in one hindpaw by the administration of lambda
carrageenan. Prior to the induction of this inflammation, baseline responses were
recorded for each animal. A 2% lambda carrageenan (Sigma Chemical Company,
Poole, UK) solution was made up the previous day in sterile saline and left overnight
at 4°C. A lOOpl unilateral injection of this carrageenan was administered
subcutaneously into the dorsal surface of the right (ipsilateral) hindpaw, using a
disposable 21G needle and 1ml syringe, under a brief (one minute) halothane
anaesthesia (one third O2, two thirds N2O, 2% halothane). Previous studies
(Iadorola et al, 1988a; 1988b) have demonstrated how thermal hyperalgesia and
oedema are at their maximum 4 hours after the carrageenan injection, even though
they can persist for up to 4 days. The animals were therefore returned to their cages,
where they could move around freely, and left for 3 (to 4) hours before withdrawal
latencies were remeasured. Any reduction in paw withdrawal latencies at this time
was taken as an indication of hyperalgesia. Paws were seen to be swollen and local
oedema was apparent.
5.2.6. Controls
Rats which received a lOpl injection of either sterile saline or 0.3%
DMSO were tested in both the non-inflamed and the inflamed state.
5.2.7. Analysis of Data
All paw withdrawal latencies were calculated as a percentage of those
determined before the administration of vehicle or drug (represented by 'time 0' on
graphs). The data shown are mean±SEM values for the group of subjects, however
each rat had its own percentage change calculated, for all time points.
In separate groups of animls in which inflammation was induced, 'time -
1' represents basal paw withdrawal latencies preceding the injection of lambda
carrageenan, and is used to determine a shift indicative of hyperalgesia, 3 hours after
such an injection. Readings from 'time 0' in this group are therefore 3 hours after the
induction of inflammation and immediately prior to intrathecal injections.
Drug effects were compared to vehicle controls and statistical




Schematic representation of the procedure for testing paw withdrawal
threshold to noxious mechanical stimulation
The animal had its paw placed under a plastic cone which provided an increasing
pressure controlled by a foot switch.
A lOg weight rested in the groove of a rotating rod. When the foot switch was
activated the motor-controlled rotating bar moved the lOg weight (attached to a
second bar) along the groove by means of a screw-gear, with the pressure
increasing at a constant rate.
When the animal attempted to withdraw its paw the foot switch was released and









Schematic representation of testing paw withdrawal latency to noxious
thermal stimulation
The dorsal hairy surface of the foot was placed over a 50W infra-red bulb.
Depression of a foot switch turned on the heat source (and the timer
simultaneously), which was terminated when a circuit, relying on reflection of the
foot, was broken. Withdrawal latencies were recorded to the nearest 0.1 second.
The control panel allowed resetting of the display and manual operation of the





Nociceptive reflex responses of groups or rats (6<n<16) were assessed by
their withdrawal reaction to a noxious (mechanical or thermal) stimulus applied to
one hindpaw prior to and following intrathecal drug administration. The effects of
drugs were compared in normal rats and those where an intraplantar injection of
carrageenan had been given several (3 to 4) hours earlier, to cause inflammation to
develop in one hindpaw. Withdrawal thresholds/latencies were calculated for each
individual animal, and subsequently converted to a percentage of the reaction
immediately prior to drug administration. The mean changes in paw withdrawal
responses per group of rats are given (mean percentage change ± SEM) with
statistical significance as determined using the Mann-Whitney U-test.
Results are presented according to the stimulus given (noxious
mechanical or thermal) and the state of the tested paw (non-inflamed or inflamed)
and summarised in tables 5.1. - 5.4.
No non-nociceptive or motor testing, eg Rotarod, was carried out. On
only one or two occasions did animals exhibit motor effects, ie paralysis or leg
splaying, and were subsequently withdrawn from further testing. The data obtained
from these animals was not used. The effects of habituation to noxious stimuli could
not be monitored due to the very short time of the whole protocol (3 tests in a total of
5 minutes following the intrathecal injection).
5.3.1. Metabotropic Glutamate Receptor Antagonists
The effect of intrathecally administered metabotropic glutamate receptor
antagonists, L-AP3 and (S)-CHPG, was assessed in animals with non-inflamed paws
and with a unilateral carrageenan-induced inflammation. Paw withdrawal
thresholds/latencies to noxious mechanical and thermal stimuli were measured before
and after drugs were given. The effects on the two models were compared. D-AP3,
the stereoisomer of L-AP3 with much reduced activity at mGlu receptors, was also
investigated.
Comparisons of the effects of individual drugs on responses originating
from non-inflamed and inflamed paws can be viewed graphically in figures 5.3.(a
and b) and 5.5. The differential effects induced by the AP3 isomers on responses
originating from carrageenan-treated paw can be seen in figure 5.4.
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5.3.1.1. vehicle Controls
All drug-induced effects were compared to those of vehicle for analysis
of statistical significance. In the case of mGlu receptor antagonists the vehicle was
0.9% saline.
(a) Non-Inflamed Paw
When lOpl of saline was injected intrathecally (n= 12) there was a slight
elevation in both mechanical and thermal responsiveness at 1 minute (132±27% and
110±5% respectively, of 3.9±0.5 units and 10.4+0.4 seconds immediately prior to
drug injection). This transient tendency to an increase in threahold/latency quickly
subsided and by the third test, at 5minutes, responses had returned very close to
baseline (102+11% and 102+8%).
(b) Inflamed Paw
In a separate group of animals with carrageenan-induced inflammation of
the ipsilateral hindpaw, saline caused a rise in thermal and mechanical thesholds
(n=14) similar to those results obtained in the above group. However, in this case
not all reponses had returned to pre-drug controls (2.5+0.3 units and 7.0+0.5
seconds) by the end of the tests. Although the response to noxious thermal
stimulation was 118+7% after 1 minute and 112+7% at 5 minutes, withdrawal
thresholds to noxious mechanical stimulation were 141+21% and 154+40%
respectively.
5.3.1.2. THE EFFECT OF l- AND d-AP3 ON BEHAVIOURAL NOCICEPTIVE
reflexes
In summary, L-AP3 did not alter responses originating from the normal
paw. However, following the induction of inflammation, due to carrageenan, this
compound significantly increased paw withdrawal threshold/latency to both noxious
mechanical and thermal stimulation (see figures 5.3.(a) and (b)). D-AP3 was without
effect in all tests and produced responses significantly different from L-AP3 when
assessing responses originating from the inflamed paw (see figure 5.4.).
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Two doses of these compounds were tested, based on a previous study
using them in such behavioural testing (Coderre & Melzack, 1992). However, when
the tests were carried out both doses (30 and 60nmol actually injected; 2.5 and
5mg/ml stock) gave very similar results. As time did not permit the further
construction of an adequate dose response curve, only the results from the higher
dose will be discussed.
L-AP3
(a) Non-inflamed Paw
Mechanical Nociceptive Reflex: The intrathecal administration of L-AP3
failed to significantly alter paw withdrawal thresholds to noxious mechanical
stimulation (with respect to saline controls, p>0.05, Mann-Whitney U-test). One
minute after the injection paw withdrawal thresholds were 137±11% of pre-drug 3.7±
0.2 units, at 3 minutes they were 132±11% and by 5 minutes they had lowered to 119
±9% (n=14).
Thermal Nociceptive Reflex: Changes in the latencies for withdrawals to
a noxious thermal stimulus matched those for mechanical stimulation. The shift in
paw withdrawal latency was again insignificant (p>0.05, Mann-Whitney U-test),
rising to 127±6%, 117±8% and 105±4% at 1, 3 and 5 minutes respectively of the pre-
drug 10.5±0.4 seconds (n=14).
(b) Inflamed Paw
Mechanical Nociceptive Reflex: In contrast to its lack of effect on
responses from the untreated paw, L-AP3 produced a significant rise, compared to
saline, in paw withdrawal threshold following the induction of inflammation (n=14).
It increased the threshold by greater than two-fold (256±58% of control (2.5±0.3
units); p<0.05, Mann Whitney U-test) at 3 minutes (see figure 5.3.(a)). This was the
largest elevation in paw withdrawal threshold throughout the whole study. When the
responses between the two groups (normal and carrageenan-treated) were compared,
the results at 3 minutes post-drug showed a significant difference (p<0.05, Mann
Whitney U-test).
Thermal Nociceptive Reflex: Similar to the results with noxious
mechanical stimuli, the resultant effect of L-AP3 was a significant shift in the latency
(n=14). This occurred at 1 minute, when the paw withdrawal latency was 197±6% of
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the pre-drug 6.9±0.4 second control (p<0.01, Mann Whitney U-test). The rise was
still evident at 3 minutes (159±10%), but no longer significantly different from saline
(see figure 5.3.(a)). The difference between latencies in normal and inflamed paws
was significant at both 1 and 3 minutes (p<0.01, Mann Whitney U-test).
Figure 5.3.(b) shows the significant difference in effect of L-AP3 on the




Mechanical Nociceptive Reflex: An intrathecal injection of D-AP3 (n=8)
did not significantly alter the paw withdrawal thresholds. After 1 minute the
threshold had risen slightly to 134±25% of the pre-drug level of 3.4±0.3 units, and by
5 minutes was 96±7%; similar to the observations following a saline injection.
Thermal Nociceptive Reflex: As with the responses to noxious
mechanical stimulation, D-AP3 falied to change withdrawal latencies to thermal
stimulation (n=8). At 1 minute the latency was 117±8% of pre-drug control (which
wasl0.9±0.5 seconds) and by 5 minutes it was 103±4%.
(b) Inflamed Paw
Mechanical Nociceptive Reflex: The response in the inflamed paw to
intrathecal D-AP3 was no different from that of saline. Although the paw
withdrawal thresholds were slightly higher at 1 and 3 minutes (160±27% and 171 ±
24% of pre-drug 1.3+0.1 units) this was not statistically significant from saline
(p>0.05, Mann Whitney U-test). However, at 3 minutes these values were
significantly lower than the thresholds induced by intrathecal L-AP3 (p<0.05, Mann
Whitney U-test; see figure 5.4.).
Thermal Nociceptive Reflex: D-AP3 did not alter latencies to values
significantly different from those in the presence of saline. At 1 minute the paw
withdrawal latency was 102+8% of the pre-drug latency of 7.0+0.4 seconds and by 5
minutes it was 94+5% of this control. The latency at 1 minute was significantly
lower than that seen when L-AP3 was injected (p<0.05, Mann Whitney U-test; see
figure 5.4.).
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5.3.1.3. THE EFFECT OF (S)-CHPG ON BEHAVIOURAL REFLEXES
To summarise the results, (S)-CHPG significantly raised paw withdrawal
thresholds/latencies to noxious mechanical and thermal stimuli. This occurred with
responses originating from the normal paw and, in a separate group of animals, the
paw with carrageenan-induced inflammation. See figure 5.5.
Two doses of this compound were tested, based on previous studies using
L-AP3 in such behavioural testing. However, when the tests were carried out both
doses (24 and 48nmol actually injected; 2.5 and 5mg/ml stock) gave very similar
results, as with L-AP3. As time did not permit the further construction of an
adequate dose response curve, only the results from the higher dose will be
discussed.
(a) Non-inflamed Paw
Mechanical Nociceptive Reflex: The only significant change brought
about in responses to a mechanical stimulus in the non-inflamed paw was by
injection of (S)-CHPG (n=14). This occurred at 3 minutes, when paw withdrawal
threshold rose to 149+10% of the pre-drug control level of 3.8+0.2 units (p<0.05).
Thermal Nociceptive Reflex: Again (S)-CHPG caused a significant shift
in latencies at 3 minutes (p<0.05, Mann Whitney U-test; n=14), with respect to saline
controls. The mean withdrawal latency at 3 minutes was 140+8% of the pre-drug 9.4
±0.3 seconds, and by 5 minutes was 126+6%.
(b) Inflamed Paw
Mechanical Nociceptive Reflex: Similar to the results observed when L-
AP3 was injected, intrathecal (S)-CHPG brought about a significant rise in thresholds
(n=13). After 1 minute paw withdrawal threshold had risen to 230+31% of the pre-
drug control of 2.9+0.3 units (p<0.05, with respect to saline). When the test was
carried out at 3 minutes the mean threshold was 193+32%, but this did not reach
significance. The increase observed at 1 minute was also significantly different from
the same test in the non-inflamed foot (p<0.01).
Thermal Nociceptive Reflex: This reflex was significantly depressed by
intrathecal (S)-CHPG at 1 minute (compared to saline controls, p<0.01, Mann
Whitney U-test; n=13), when the mean latency was 174+10% of pre-drug levels (8.0
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±0.4 seconds). As with the response to a mechanical stimulus, the withdrawal
latency was still very high at 3 minutes, 171 + 12%, but no longer significantly
different from reponses observed with a saline injection (p>0.05, Mann Whitney Li¬
test).
5.3.2. Tachykinin Receptor Antagonists
The effects of intrathecally administered tachykinin NK] and NK2
receptor antagonists, GR82334 and L659,874 respectively, were assessed in separate
groups of animals with non-inflamed paws and with a unilateral carrageenan-induced
inflammation. Paw withdrawal responses to noxious mechanical and thermal stimuli
were measured before and after drugs were given. The effects on the two models
were compared.
Paw withdrawal thresholds/latencies were calculated for each individual
animal, and subsequently converted to a percentage of the response immediately prior
to drug administration. It is the mean changes in paw withdrawal
thresholds/latencies per group which are given (mean percentage change ± SEM).
Statistical significance of differences from the effect of vehicle injection were
determined using the Mann-Whitney U-test.
The results are divided according to the stimulus given (noxious
mechanical or thermal) and the state of the paw (non-inflamed or inflamed) and are
provided in summary form in tables 5.1. - 5.4. Comparisons of the effects of
individual drugs on non-inflamed and inflamed paws is illustrated graphically in
figures 5.6. and 5.7.
5.3.2.1. vehicle Controls
Controls for the NK] receptor antagonist GR82334 were saline, as
described previously (section 5.3.1.1.). The NK2 receptor antagonist, L659,874 was
administered in 0.3% dimethylsulphoxide (DMSO) in saline.
(a) Non-Inflamed Paw
When lOpl of DMSO in saline was injected intrathecally (n=6) there was
a slight elevation in both mechanical and thermal paw withdrawal response at 1
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minute (111±12% and 112±12% respectively), compared to pre-drug controls (4.8±
0.1 units and 9.9±0.7 seconds, defined as 100%). This small rise was seen until 5
minutes, when responses were 108±12% and 115±11% respectively. These changes
in withdrawal threshold/latency are slightly less than those observed with
intrathecally administered saline.
(b) Inflamed Paw
Similar to the results obtained in the above group, DMSO caused a
nominal rise in thermal and mechanical paw withdrawal responses (n=14). However,
in this case some thresholds to noxious mechanical stimulation fell below pre-drug
controls by the end of the tests (not markedly): at 1 minute the response to DMSO
was 120±11% and at 5 minutes it was 89±7% of the pre-drug levels of 2.9±0.2 units.
When the reflex to noxious thermal stimulation was tested the results were similar to
those evoked by saline, 107+5% at 1 minute and 115+8% at 5 minutes of a pre-drug
mean of 6.8+0.5 seconds.
5.3.2.2. THE EFFECT OF NKl RECEPTOR ANTAGONIST GR82334 ON
BEHAVIOURAL REFLEXES
In summary, GR82334 failed to alter significantly any responses in the
tests that were carried out in this investigation (see figure 5.6.).
Based on other behavioural analgesia studies carried out by the group, a
dose of 3nmol (actual injection) was selected as a dose expected to be effective. This
dose is above that previously shown to antagonise caudally-directed biting and
scratching evoked by NKj receptor agonist substance P methyl ester (0.7 - lnmol,
Birch et al, 1991).
(a) Non-inflamed Paw
Mechanical Nociceptive Reflex: When GR82334 was administered,
responses were not significantly altered during the ensuing 5 minutes (p>0.05, Mann
Whitney U-test). After 1 minute paw withdrawal threshold was 98+10% of the pre-
drug 4.8+0.4 units, and by 5 minutes was 87+12%.
Thermal Nociceptive Reflex: Latencies remained close to baseline
measurements throughout the tests. At 1 minute mean latency was 109+9% and at 5
minutes 113+9%, compared to pre-drug values of 9.9+0.7 seconds.
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(b) Inflamed Paw
Mechanical Nociceptive Reflex: As with the normal paw, the intrathecal
injection of GR82334 failed to significantly change paw withdrawal thresholds
(p>0.05, Mann Whitney U-test). Tests at 1 minute showed a mean response of 126±
17% (with respect to pre-drug 2.8±0.3 units) and at 5 minutes it was very similar -
127±16%.
Thermal Nociceptive Reflex: This test showed a similar trend to the
others. No discernible changes in paw withdrawal latencies were brought about by
GR82334. The mean latency at 1 minute was 109±6% of the pre-drug 7.9±0.5
seconds, and at 5 minutes was 105±6% (p>0.05, Mann Whitney U-test).
5.3.2.3. THE EFFECT OF NK2 RECEPTOR ANTAGONIST 1,659,874 ON
BEHAVIOURAL REFLEXES
In summary, L659,874 selectively and significantly increased paw
withdrawal responses to noxious thermal, but not mechanical, stimulation. This was
the case in both the non-inflamed and the inflamed paw (see figure 5.7.).
As with GR82334, the choice of dose of L659,874 used in this study
(3nmol) was based on data from other studies carried out by the group, in which this
represented a maximally effective dose.
(a) Non-inflamed Paw
Mechanical Nociceptive Reflex: L659,874 did not significanlty alter paw
withdrawal thresholds to a mechanical stimulus (p>0.05, Mann Whitney U-test).
One minute after the injection the mean threshold was 107±16% compared to the
mean pre-drug level of 3.5±0.5 units, and by 5 minutes it was much the same, 108±
13%.
Thermal Nociceptive Reflex: This reflex was significantly depressed by
the NK2 receptor antagonist, for the duration of the test. At 1 minute paw
withdrawal latency was 183±26% of pre-drug 7.7±0.6 seconds, at 3 minutes it was




Mechanical Nociceptive Reflex: There was no difference in the effect
L659,874 had here, compared to the normal paw: it was still unsuccessful in
changing paw withdrawal responses (p>0.05, Mann Whitney U-test). The mean
threshold after 1 minute was 126±16% and at 5 minutes wasll5±18% of pre-drug
3.5±0.5 units.
Thermal Nociceptive Reflex: The effect of L659,874 in the normal paw
was mirrored in this test. Once again it induced significant rises in paw withdrawal
latencies, although this time only in the first two tests. After 1 minute the mean
latency was 191±21% and at 3 minutes was 170±17% (both p<0.01, with respect to
pre-drug levels of 6.7±0.6 , Mann Whitney U-test). The withdrawal latency at 5
minutes (150±15%) was still elevated, but no longer statistically significant (p>0.05,
Mann Whitney U-test).
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5.3.3. The Effect of Co-injection of Metabotropic Glutamate and
Tachykinin Receptor Antagonists on Behavioural
Nociceptive Reflexes
Following the study on the effect of each individual compound on
nociceptive reflexes, the effect of intrathecally co-administered metabotropic
glutamate receptor antagonists, L-AP3 and (S)-CHPG, with either (1) NKj receptor
antagonist GR82334 or (2) NK2 receptor antagonist L659,874 was assessed in
animals with non-inflamed paws and in a separate group with a unilateral
carrageenan-induced inflammation. Paw withdrawal thresholds/latencies to noxious
mechanical and thermal stimuli were measured before and after drugs were given.
The effects on the two models were compared.
Paw withdrawal thresholds/latencies were calculated for each individual
animal, and subsequently converted to a percentage of the response immediately prior
to drug administration. Results for each group were then expressed as mean
percentage change ± SEM. Statistical significance was determined using the Mann-
Whitney U-test.
The results are divided according to the stimulus given (noxious
mechanical or noxious thermal) and the state of the paw (non-inflamed or inflamed)
and are provided in summary form in tables 5.1. to 5.4. The effect of co¬
administering drugs can be compared to the individual components of the injection in
figures 5.8-5.11.
5.3.3.1. the effect of MGLU receptor antagonists, co-injected with
nk4 receptor antagonist GR82334, on behavioural reflexes
In summary, all significant reductions in paw withdrawal responses
brought about by the sole injection of a metabotropic glutamate receptor (mGluR)
antagonist were attenuated when GR82334 was simultaneously administered.
GR82334 had no significant effect when injected alone (Figure 5.6). However,
GR82334 reduced the mGluR antagonist-induced increases on paw withdrawal
responses, although none of these decreases led to values significantly lower than




(i) L-AP3: L-AP3 did not alter this reflex when given alone, and co-
injection with GR82334 resulted in no change. Mean threshold was 112±14%
compared to pre-drug values of 3.6±0.2 units at 1 minute, and 115±11% by 5
minutes.
(ii) (S)-CHPG: When given on its own this compound significantly
raised the threshold of response. However, following a co-injection with GR82334,
at 1 minute the paw withdrawal threshold was 107±13% of a pre-drug level of 4.1±
0.3 units, significantly lower than the effect of the mGluR antagonist alone (147+9%;
p<0.05, see figure 5.10.).
Thermal Nociceptive Reflex
(i) L-AP3: No significant changes in paw withdrawal latencies were seen
either with L-AP3 alone or in combination with GR82334. There was little alteration
from pre-drug controls (8.2±0.6 seconds): one minute after the co-injection the mean
latency wasl 10±9% and at 5 minutes was 104±10%
(ii) (S)-CHPG Although withdrawal latencies were decreased due to the
co-injection (120±12% and 131 + 12% at 1 and 3 minutes respectively, of a pre-drug
latency of 9.6±0.7 seconds), compared to that of (S)-CHPG alone (138±7% and 140±
8%), the change was not statistically significant (p>0.05, Mann Whitney U-test).
(b) Inflamed Paw
Mechanical Nociceptive Reflex
(i) L-AP3: Administration of L-AP3 alone produced significantly
increased responses at 3 minutes post-injection. When L-AP3 was injected together
with GR82334, thresholds at both 1 minute (119±8% (of pre-drug 3.4±0.2 units)
compared to 223±47%; p<0.05, Mann-Whitney U-test) and 3 minutes (111 ±8%
compared to 256±58%; p<0.01) were significantly lower than with the mGluR
antagonist alone (see figure 5.8.).
(ii) (S)-CHPG: Similar to the results with L-AP3, this compound
increased paw withdrawal thresholds at 1 minute when given alone. However the co-
injection with GR82334 prevented this facilitation - after 1 minute the co-injection
resulted in a significantly lower mean threshold of 154±19% (of pre-drug 2.5+0.3
units), with (S)-CHPG alone 230+31% (p<0.01, Mann-Whitney U-test). Also, at 3
minutes the difference between the two treatments was significant, (S)-CHPG
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administration resulted in a rise to 193+32% of pre-drug controls, whereas the co-
injection only increased to 132±15% (p<0.05, Mann-Whitney U-test). This is
presented in figure 5.10.
Thermal Nociceptive Reflex
(i) L-AP3: At both 1 and 3 minutes post-injection the difference between
the effect of L-AP3 alone and its co-administration with GR82334 was significant
(p<0.01). The 1 minute paw withdrawal latencies were 197±6% and 109±9%, of a
pre-drug level of 7.6±0.5 seconds, respectively, and at 3 minutes they were 159±10%
and 115+9%. (see figure 5.8.)
(ii) (S)-CHPG: All three time points showed significantly lowered
latencies when (S)-CHPG was co-administered with GR82334, compared to when
given alone (p<0.01, Mann-Whitney U-test). Latencies after co-administration were
111±7%, 117±8% and 109+6% or pre-drug controls of 6.2±0.4 seconds at 1, 3 and 5
minutes post-injection respectively, whereas the corresponding values for (S)-CHPG
alone were 174±10%, 171 ±12% and 143+8% (see figure 5.10).
5.3.3.2. the effect of MGLU receptor antagonists, co-injected with
nk2 receptor antagonist l659,874, on behavioural reflexes
In summary, latencies to noxious thermal stimulation in the normal paw,
which were previously increased by L659,874, were decreased when co-administered
with either metabotropic glutamate receptor (mGluR) antagonist, even when (as in the
case of (S)-CHPG) the mGluR antagonist alone also elevated withdrawal latency.
Similar effects were seen in response to stimulation of inflamed paws (where both L-
AP3 and (S)-CHPG, and also L659,874 were effective alone) although the inhibition
of elevated latencies did not reach statistical significance. L659,874 alone did not
increase noxious mechanical response thresholds in normal or inflamed paws, but did
significantly reduce the increase in response due to (S)-CHPG in both cases and
L-AP3 in the inflamed paw.
(a) Non-inflamed Paw
Mechanical Nociceptive Reflex
(i) L-AP3: Co-injection of L-AP3 with L659,874 produced paw
withdrawal responses which were no different from saline or from either drug alone.
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At 1 minute the mean threshold was 117±11% of a mean pre-drug control of 3.8±0.2
units, and at 5 minutes it was 125±8%.
(ii) (S)-CHPG: Although (S)-CHPG alone significantly increased paw
withdrawal thresholds at 3 minutes post-injection (149±10%), the lowering of this
with L659,874 co-administered (121±12% of pre-drug 3.6±0.3 units) was not
statistically different.
Thermal Nociceptive Reflex
(i) L-AP3: Alone L659,874 significantly depressed this reflex at all three
time points (with latencies of 183±26%, 181 ±20% and 164+13% of pre-drug controls
at 1, 3 and 5 minutes respectively; p<0.01, Mann-Whitney U-test). However, when
given simultaneously with L-AP3 this was no longer the case. Latencies at 3 and 5
minutes were significantly lowered to 135±5% and 108±6% of a mean pre-drug level
of 9.5±0.4 seconds (compared to L659,874 alone, p<0.01, Mann-Whitney U-test).
These values were not statistically different from those obtained with L-AP3 given
on its own.
(ii) (S)-CHPG: The co-injection of (S)-CHPG with L659,874 produced
shorter paw withdrawal latencies than the elevated levels seen with L659,874 alone.
This reduction was significant only at 5 minutes post-injection (132±8% compared to
164±13% of pre-drug control of 8.6±0.7 seconds; p<0.05, Mann Whitney U-test)
(b) Inflamed Paw
Mechanical Nociceptive Reflex
(i) L-AP3: The previously high threshold seen after 3 minutes with
L-AP3 alone (256±58% of pre-drug levels) was no longer evident when L659,874
was given at the same time (148±39% of a pre-drug mean of 2.9±0.3 units; p<0.05,
Mann Whitney U-test), even though L659,874 had no effect alone.
(ii) (S)-CHPG: As with the L-AP3, the increase in threshold normally
observed with this compound was reversed when the NK2 antagonist was co-
injected. Instead of a paw withdrawal threshold of 230±31% of pre-drug control at 1
minute ((S)-CHPG alone), the response was reduced to 155±21% of pre-drug levels
(which were 2.9±0.2 units) with (S)-CHPG/L659,874 combination (p<0.05, Mann
Whitney U-test).
Thermal Nociceptive Reflex
(i) L-AP3: Both compounds alone and the co-injection significantly
increased latencies. There was no statistically significant difference between the
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effect of the co-injection (194±20%, 186±14% and 129±11% of pre-drug values of
5.9+0.3 seconds at 1, 3 and 5 minutes post-injection, respectively) and either of its
components..
(ii) (S)-CHPG: All three tests following the co-injection showed lower
latencies than with the individual components, although the differences were not
statistically significant (p>0.05, Mann Whitney U-test).
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Table 5.1.
A summary of the changes brought about in paw withdrawal responses by
intrathecal drug administration
A brief summary of statistically significant increases and decreases in withdrawal
responses induced by intrathecally administered metabotropic glutamate (mGlu)
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A summary of the changes brought about in paw withdrawal thresholds to
noxious mechanical stimulation in the non-inflamed foot, by metabotropic
glutamate and tachykinin receptor antagonists.
These results are also presented in figures 5.3. -5.11.
The effect of the following antagonists on paw withdrawal thresholds was
investigated: L-AP3 (along with its isomer D-AP3) and (S)-CHPG (metabotropic
glutamate receptors {mGluRs}), GR82334 (NK] receptor) and L659, 874 (NK2
receptor).
The third column is the mean±SEM of raw data for thresholds immediately
preceding the intrathecal injection. This was considered as 100%. From raw data
for each animal individual changes in threshold were calculated as a percentage,
then the mean for each group was determined.
Statistical significance of changes relative to vehicle controls and co-injection of
compounds were determined using the Mann-Whitney U-test.
The mean paw withdrawal threshold prior to drug administration was 4.0±0.9
units# (n=97) though percentage changes were calculated, and are shown, per
group.
All compounds, singularly or as a co-injection, with the sole exception of (S)-
CHPG, failed to significantly alter withdrawal thresholds to a greater extent than
vehicle. When (S)-CHPG was co-administered with GR82334 the resultant effect
was a significantly lower withdrawal latency compared to that of the metabotropic
glutamate receptor antagonist alone.
# units are described in section 5.2.4.1.
** = p<0.01, * = p<0.05, with respect to saline












































































A summary of the changes brought about in paw withdrawal latencies to
noxious thermal stimulation in the non-inflamed foot, by metabotropic
glutamate and tachykinin receptor antagonists.
These results are also presented in figures 5.3. -5.11.
The effect of the following antagonists on paw withdrawal latencies was
investigated: L-AP3 (along with its isomer D-AP3) and (S)-CHPG (metabotropic
glutamate receptors {mGluRs}), GR82334 (NK] receptor) and L659, 874 (NK2
receptor).
The third column is the mean±SEM of raw data for latencies immediately
preceding the intrathecal injection. This was considered as 100%. From raw data
for each animal individual changes in latency were calculated as a percentage,
then the mean for each group was determined.
Statistical significance of changes relative to vehicle controls and co-injection of
compounds were determined using the Mann-Whitney U-test.
Mean pre-drug paw withdrawal latency was 9.4±0.3 sees, n=97.
As with the response to noxious mechanical stimulation, (S)-CHPG produced a
significant change in paw withdrawal latency, both from saline and a co-injection
with GR82334. However, the most striking result in this study was the selective
elevation in withdrawal latency to a noxious thermal induced by NK2 receptor
antagonist L659,874. This compound produced an increase in latencies at all three
time points, all p<0.01.
** = p<0.01, * = p<0.05, with respect to saline













































































A summary of the changes brought about in paw withdrawal thresholds to
noxious mechanical stimulation in the inflamed foot, by metabotropic
glutamate and tachykinin receptor antagonists.
These results are also presented in figures 5.3. - 5.11.
As in Tables 5.1. and 5.2., the effect of the following antagonists on paw
withdrawal thresholds was investigated: L-AP3 (along with its isomer D-AP3) and
(S)-CHPG (metabotropic glutamate receptors {mGluRs}), GR82334 (NKj
receptor) and L659, 874 (NK2 receptor). These tables however show the drug-
induced changes 3 hours after a unilateral injection of lambda carrageenan into the
ipsilateral hindpaw.
The third column is the mean±SEM of raw data for thresholds immediately
preceding the intrathecal injection. This was considered as 100%. From raw data
for each animal individual changes in threshold were calculated as a percentage,
then the mean for each group was determined.
Statistical significance of changes relative to vehicle controls and co-injection of
compounds were determined using the Mann-Whitney U-test.
Mean pre-drug thresholds were 2.7+0.2 units# (n=155). This represents the
carrageenan-induced reduction, of which the average was 65+26% (n= 155).
Both metabotropic glutamate receptor (mGluR) antagonists produced a significant
shift in latencies from saline (p<0.05), whereas in the non-inflamed state only (S)-
CHPG did so. Also, the effect observed due to their co-administration with
GR82334 was significantly reduced from the effect each mGluR antagonist had
alone (p<0.01).
#units are described in section 5.2.4.1.
** = p<0.01, * = p<0.05, with respect to saline
• •
= p<0.01, * = p<0.05, with respect to L-AP3













































































A summary of the changes brought about in paw withdrawal latencies to
noxious thermal stimulation in the inflamed foot, by metabotropic glutamate
and tachykinin receptor antagonists.
These results are also presented in figures 5.3. -5.11.
As in Tables 5.1. and 5.2., the effect of the following antagonists on paw
withdrawal latencies was investigated: L-AP3 (along with its isomer D-AP3) and
(S)-CHPG (metabotropic glutamate receptors {mGluRs}), GR82334 (NK)
receptor) and L659, 874 (NK/) receptor). These tables however show the drug-
induced changes 3 hours after a unilateral injection of lambda carrageenan into the
ipsilateral hindpaw.
The third column is the mean±SEM of raw data for latencies immediately
preceding the intrathecal injection. This was considered as 100%. From raw data
for each animal individual changes in latency were calculated as a percentage,
then the mean for each group was determined.
Statistical significance of changes relative to vehicle controls and co-injection of
compounds were determined using the Mann-Whitney U-test.
The mean latency immediately prior to drug administration was 7.0±0.2 sees.
This represents the carrageenan-induced reduction, of which the average was 38±
12% (n= 155). Similar to the mechanical results, the mGluR antagonists caused a
significant rise in withdrawal latencies from both saline and the co-injection with
GR82334. Once again L659,874 induced the most significant rise in latency.
** = p<0.01, * = p<0.05, with respect to saline
* *
= p<0.01, * = p<0.05, with respect to L-AP3












































































The effect of intrathecal injection of L-AP3 on paw withdrawal responses in
the non-inflamed and inflamed paws
The mean response to noxious mechanical and thermal stimulation at time 0 in the
non-inflamed group were 3.8±0.1 units# and 10.5±0.5 seconds respectively
(n=28).
Metabotropic glutamate receptor antagonist L-AP3 failed to alter these
thresholds/latencies (n=14). However, when tests were repeated in a second group
of animals 3 hours after a unilateral injection of carrageenan into the ipsilateral
hindpaw (mean pre-drug responses in this group = 2.5±0.3 units and 7.0±0.1secs;
mean reductions by carrageenan were 109+9% and 44+6%, n=28), L-AP3 caused
statistically significant increases in response threshold in both tests.
Statistical significance was evaluated using the Mann-Whitney U-test.
** indicates p<0.01, and * is p<0.05, with respect to saline controls.
# units are described in section 5.2.4.1.
-A- saline MECHANICAL threshold
—saline THERMAL latency
-A- L-AP3, 60nmol MECHANICAL threshold





























Comparison of the effect of intrathecal injection of L-AP3 on paw
withdrawal responses in the non-inflamed and inflamed paws
The histograms show the effect of L-AP3 on responses originating from non-
inflamed and inflamed paws, as a percentage of pre-drug controls. This
compound was significantly more effective in raising withdrawal responses to
noxious mechanical and noxious thermal stimulation in the carrageenan-inflamed
paw, with respect to the untreated paw.
Statistical significance was evaluated using the Mann-Whitney U-test.














Comparison of the effects of intrathecal injection of L-AP3 and its isomer D-
AP3 on paw withdrawal responses in the inflamed paw
The histograms show a comparison of the effects each of the AP3 isomers had on
paw withdrawal responses, when intrathecally injected (60nmol). L-AP3, the
isomer believed to block metabotropic glutamate receptors, induced a significant
rise in responses to both noxious mechanical and thermal stimulation. D-AP3
produced results similar to those of a saline injection. Responses in the presence
of L-AP3 were significantly greater than those with D-AP3.
Statistical significance was evaluated using the Mann-Whitney U-test.
























The effect of intrathecal injection of (S)-CHPG on paw withdrawal responses
in the non-inflamed and inflamed paws
The mean thresholds from noxious mechanical and latencies from noxious
thermal stimulation at time 0 in the non-inflamed group were 3.9±0.1 units^ and
9.5±0.5 seconds respectively (n=26). In a separate group of animals with
inflamed paws the pre-drug responses were 2.7±0.2 units and 7.5±0.5 seconds
(carrageenan-induced reductions of 79±21% and 39±1%; n=27).
Metabotropic glutamate receptor antagonist (S)-CHPG brought about a significant
elevation in withdrawal responses, with respect to saline effects, when the paw
received a noxious mechanical or thermal stimulation. This rise in
threshold/latency was observed in both the non-inflamed state and following
carrageenan-induced inflammation.
Significance was calculated using the Mann-Whitney U-test. **=p<0.01 and
*=p<0.05 with respect to saline
#units are described in section 5.2.4.1.
-A- saline MECHANICAL threshold
—saline THERMAL latency










The effect of intrathecal injection of GR82334 on paw withdrawal responses
in the non-inflamed and inflamed paws
Mean thresholds from noxious mechanical and latencies from noxious thermal
stimulation at time 0 in the non-inflamed group were 9.5±0.9 units# and 4.4±0.5
seconds respectively (n=18). In a separate group of animals with inflamed paws
the pre-drug responses were 2.7±0.2 units and 7.5±0.4 seconds (carrageenan-
induced reductions of 82±18% and 37±2%; n=28).
GR82334, an NKj receptor antagonist, was without effect on paw withdrawal
responses to both noxious mechanical and thermal stimulation of the paw. It
failed to produce significantly different values from those of saline controls, in
both the non-inflamed paw and the paw with a carrageenan-induced inflammation.
Statistical significance was evaluated by the Mann-Whitney U-test.
#units are described in section 5.2.4.1.
-A- saline MECHANICAL threshold
—saline THERMAL latency













The effect of intrathecal injection of L659,874 on paw withdrawal responses
in the non-inflamed and inflamed paws
Mean thresholds from noxious mechanical and latencies from noxious thermal
stimulation at time 0 in the non-inflamed group were 4.2±0.7 units# and 8.8±0.5
seconds respectively (n=12). In a separate group of animals with inflamed paws
the pre-drug responses were 2.8±0.1 units and 6.8±0.1 seconds (carrageenan-
induced reductions of 38±14% and 52±9%; n=28).
The NK2 receptor antagonist L659,874 selectively increased withdrawal
responses when the paw received a noxious thermal stimulus, but not noxious
mechanical. The effect was significant, with respect to saline, in both the non-
inflamed paw and the paw which received an injection of carrageenan 3 hours
previously.
Statistical significance was determined using the Mann-Whitney U-test, and
p<0.01, with respect to saline, is denoted by **.
#units are described in section 5.2.4.1.
-A- saline MECHANICAL threshold
—saline THERMAL latency
-A- L659,874, 3nmol MECHANICAL threshold





The effect of intrathecal co-injection of GR82334 and L-AP3 on paw
withdrawal responses in the non-inflamed and inflamed paws
In the non-inflamed state the mean paw withdrawal thresholds to mechanical and
latencies to noxious thermal stimulation were 4.0±0.3 units# and 9.3±0.5 seconds
respectively (n=39). Whereas in a separate group of animals, carrageenan induced
average decreases of 73±34% and 48±9% (mean pre-drug responses for this group
being 2.9±0.2 and 7.4±0.2; n=58).
In the non-inflamed state the results of co-injection of GR82334 and L-AP3 were
no different from the effect of either compound alone. However, when the
metabotropic glutamate receptor and NK] receptor antagonists were co¬
administered in the inflamed state, the results were significantly different from the
single injection of L-AP3: they were markedly reduced.
Significance was calculated using the Mann-Whitney U-test. **=p<0.01 and
*=p<0.05, with respect to L-AP3 injected alone. Significance with respect to
saline is not shown, see Figures 5.3.(a) and 5.6.















































The effect of intrathecal co-injection of L659,874 and L-AP3 on paw
withdrawal responses in the non-inflamed and inflamed paws
In the non-inflamed state the mean paw withdrawal thresholds to mechanical and
latencies to noxious thermal stimulation were 4.0±0.3 units* and 9.4±0.6 seconds
respectively (n=32). Whereas in a separate group of animals, 3 hours of
carrageenan-induced inflammation resulted in average decreases of 56±26% and
56±12% of withdrawal responses (mean pre-drug thresholds for this group being
2.8±0.1 units and 6.6±0.2 seconds; n=58).
Co-injection of the metabotropic glutamate and NK2 receptor antagonists made no
difference in the response to noxious mechanical or thermal stimulation, with
respect to the administration of single compounds.
Statistical analysis was carried out using the Mann-Whitney U-test. **=p<0.01
and *=p<0.05, with respect to L-659,874 or L-AP3 alone. Significance with
respect to saline is not shown, see Figures 5.3.(a) and 5.7.




































The effect of intrathecal co-injection of GR82334 and (S)-CHPG on paw
withdrawal responses in the non-inflamed and inflamed paws
In the non-inflamed state the mean paw withdrawal thresholds to mechanical and
latencies to noxious thermal stimulation were 4.2±0.2 units# and 9.5±0.4 seconds
respectively (n=40). Whereas in a separate group of animals, carrageenan-induced
inflammation resulted in average decreases of 64±34% and 48±10% of responses
(mean pre-drug thresholds for this group being 2.7±0.1 units and 7.3±0.4 seconds;
n=57).
Similar to the results obtained when GR82334 was co-administered with the other
metabotropic glutamate receptor antagonist L-AP3, the co-injection with (S)-
CHPG led to a significant reduction in the effect seen with this compound alone -
but in this case in the non-inflamed and inflamed paw.
Significance was calculated using the Mann-Whitney U-test. **=p<0.01 and
*=p<0.05 with respect to (S)-CHPG injected alone. Significance with respect to
saline is not shown, see Figures 5.5. and 5.6.

































The effect of intrathecal co-injection of L659,874 and (S)-CHPG on paw
withdrawal responses in the non-inflamed and inflamed paws
In the non-inflamed state the mean paw withdrawal thresholds to mechanical and
latencies to noxious thermal stimulation were 4.0±0.3 units# and 8.9±0.5 seconds
respectively (n=32). Whereas in a separate group of animals, carrageenan induced
average decreases of 46±16% and 42±10% of withdrawal responses (mean pre-
drug latencies being 2.9±0.1 units and 7.2±0.4 seconds; n=57).
Similar to the results obtained when L659, 874 was co-administered with the other
metabotropic glutamate receptor antagonist, the co-injection with (S)-CHPG
failed to alter the effects of each compound alone.
Statistical analysis was carried out using the Mann-Whitney U-test. **=p<0.01
and *=p<0.05 with respect to (S)-CHPG injected alone. Significance with respect
to saline is not shown, see Figures 5.5. and 5.7.




































The methods of behavioural testing employed in this study were based in
the paw flick test originally described by Woolfe & MacDonald (1944), and the paw
pressure test (Randall & Sellito, 1957). The method employed by Woolfe &
MacDonald (1944) observed the glabrous surface of the foot, and was modified in
the current study to test the hairy skin of the foot. This was easily accomplished by
holding the animal in place with one hand (see Figure 5.2.). The dorsal hairy side of
the foot was assessed because previous experiments (Chapter 3; Harris & Ryall,
1988; F.E. Munro PhD thesis, 1995) have highlighted the possibility that there may
be a difference in sensitivity of the two skin types to certain noxious stimuli, e.g to
mustard oil. This may relate to a sub-population of C afferent fibres in each skin
type. Such testing was therefore used as a reliable method of monitoring drug-
induced analgesia in the present investigation. Previous studies have shown, with the
use of agonists, such as SP and glutamate, how the intrathecal method of drug
delivery (Hylden & Wilcox, 1980) results in a dependable access of compounds to
the spinal cord. Intrathecally administered NK and EAA receptor agonists give rise
to compulsive biting and scratching of the caudal areas (Hayes & Tyers, 1979;
Aanonsen & Wilcox 1986; 1987), i.e. those innervated by the spinal segments at
which the injection is placed. These methods of behavioural testing and intrathecal
drug administration were used in combination in the present experiments to assess
the effect of mGlu, NK] and NK2 receptor antagonists on the responses originating
from hindpaws which received a noxious mechanical or noxious thermal stimulus.
The study compared the results from naive animals with those which had received an
intraplantar injection of carrageenan 3 hours earlier; a previously determined model
of inflammation (Iadorola etal, 1988a; 1988b).
When saline, or 0.5% DMSO in saline (vehicle) were intrathecally
applied a transient rise in latency/threshold to noxious thermal/mechanical stimuli
was observed. Stress-induced analgesia may be evoked by a number of stimuli, both
noxious and non-noxious (Bodnar et al, 1978; Hayes et al, 1978; Grau et al, 1981;
Hamm et al, 1985), and there appear to be both opioid and non-opioid (including
noradrenergic) components of this phenomenon (Chance & Schechter, 1979; Terman
et al, 1984; Chance & Nelson, 1986). It is therefore feasible that the protocol in the
current experiments was accompanied by a transient stress-induced endogenous
analgesia. Due to this apparent procedure-evoked analgesia, all drug-induced
alterations in responses were compared to the effects of vehicle, and not the pre-drug
levels.
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When mGluR antagonist (S)-CHPG was applied to animals with non-
inflamed ('normal') paws there was a significant delay in the response to both noxious
mechanical and thermal stimulation. However, the second antagonist used, L-AP3
(and its isomer D-AP3), had no such effect. Both of these antagonists act at Group I
mGluRs, though (S)-CHPG is invariably more potent than L-AP3, and acts
preferentially at mGluR 1 (Pin & Duvoisin, 1995). This would suggest that the effects
observed due to (S)-CHPG application were a result of the prevention of mGluR 1
activation. Although L-AP3 was ineffective on responses from the non-inflamed paw,
it was effective in inflamed paws (see below). Since the only cloned mGluR against
which L-AP3 has been reported to be effective (but of low potency) is mGluR 1 (Pin
& Duvoisin, 1995) this is consistent with an involvement of mGluRl in nociceptive
inputs following carrageenan treatment.
Lambda-carrageenan has been used in previous studies to induce an acute
state of inflammation, which peaks at around 3-4 hours and persists for several days
(Iadorola et al, 1988a; 1988b). In the present study, animals received an intraplantar
injection 3 hours prior to drug testing, following which the foot was observed to be
red and swollen. Mechanical and thermal hyperalgesia in the sensitised animal were
assessed by re-measuring withdrawal responses to noxious stimulation. Following the
development of this inflammation, an intrathecal injection of both (S)-CHPG and
L-AP3 resulted in a significant rise in withdrawal responses to both noxious
mechanical and noxious thermal stimulation. The effect observed can be presumed to
be mediated by mGluRs, as the stereoisomer of L-AP3, D-AP3, was still ineffective,
compared to vehicle. Furthermore, the difference in responses between the two
isomers was also statistically significant. Since (S)-CHPG was effective in both
models assessed here, there appears to be a role for mGluR 1 at least, in mediating
brief noxious inputs under both normal and inflamed conditions. This is in agreement
with the studies discussed earlier in Chapter 3, as both (S)-CHPG and L-AP3
attenuated the elevated activity evoked in dorsal horn neurons by topically
administered mustard oil. On the basis of the present modestly-selective antagonists,
it is not possible to exclude some additional contribution of mGluR5 and other
mGluRs. Similarly, electrophysiological studies on thalamic nuclei have highlighted a
nocispecific role for mGluRs, as antagonists did not affect responses induced by
innocuous air jet stimuli, though they did reduce responses to noxious heating of the
skin (Eaton et al, 1993a; 1993b). Furthermore, a study by Neugebauer et al, (1994b)
provides congruent evidence in support of the inflammation-specific role for L-AP3
observed in the present study. In this electrophysiological investigation they found L-
AP3 could attenuate responses elicited by pressure application to the knee, but only
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following the induction of inflammation.
In contrast to the present work, no such role was found for L-AP3 in
behavioural studies by Coderre's group (Coderre & Melzack, 1992; Coderre &
Empel, 1994). Since the doses in the current experiments were based on the earlier
study (Coderre & Melzack, 1992), dose differences are not the reason for the
variances, although drug access could differ between the studies. The difference in
timing is far more probable a cause, as Coderre & Melzack, (1992) tested animals
some 15 minutes after the intrathecal injection. Clearly the current investigation
provides evidence that the analgesic effect of L-AP3 (and (S)-CHPG) is very short-
acting. This may be somewhat discouraging when considering the possibility of
novel analgesic compounds. However, if a role for the receptors at which these drugs
act can be elucidated, then identification of the target itself is a valuable tool for the
further development of more longer-lasting analgesic compounds. In order to
substantiate this evidence for mGluR involvement in nociception, further studies
would be useful: electrophysiological experiments to assess the effect of mGluR
antagonists on responses to brief noxious and non-noxious stimuli, preferably both
before and after the application of mustard oil to define their role in specific
sensitisation.
As well as glutamate, SP and NKA are found in some fine primary
afferent fibres (Hokfelt, 1980; Ogawa et al, 1985). The role of both of these
transmitters in nociception has been under much investigation over the past few
decades. In the current investigation the effect of antagonists to NKj and NK2
receptors (preferentially activated by SP and NKA respectively, (Regoli et al, 1987))
was assessed on brief noxious inputs, both before and after carrageenan-induced
inflammation. When the NK2 receptor antagonist L659,874 was administered
intrathecally, there was a highly significant rise in withdrawal latency to the noxious
thermal stimulus, though no such effect was observed on the threshold to pressure
applied to the paw. This L659,874-mediated reflex depression was maintained for
the duration of testing in the normal paw, and for the first two tests in the inflamed
paw. These results are in complete agreement with previous electrophysiological
experiments which have highlighted a selective role for NK2 receptors in mediating
brief noxious thermal inputs to thalamic and spinal cord dorsal horn neurons
(Fleetwood-Walker et al, 1990; 1993; Santucci et al, 1993).
There have been very few published studies on the role of NK2 receptors
in behavioural testing. Lack of effect by intrathecally administered NK2 receptor
antagonist GR115211, on brief (tail flick and hot plate) and sustained (formalin)
nociceptive inputs was observed by Birch et al, (1993). However, in that same study
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GR115211 also failed to antagonise the effect of an intrathecally applied NK2
agonist, indicating that the evidence does not reflect the genuine activity of NK2
receptors. A more recent investigation, employing the non-peptide NK2 receptor
antagonist SR48968 found that NK2 receptors appeared to be involved in formalin-
evoked behaviours, though not brief nociceptive testing such as the tail flick test
(Seguin et al, 1995) It is important to note however, that systemic administration of
these compounds implies that they are not necessarily inducing their effect by acting
at spinal cord receptors. Although this evidence is contrary to the current
investigation, in that here a role for NK2 receptors was observed in the brief paw-
flick response, this is not entirely surprising as the tests utilised two different skin
types. There is evidence that the glabrous side of the foot displays a somewhat
different, lesser response to noxious stimulation, at least in the case of mustard oil, a
selective C-fibre activator (Harris & Ryall, 1988; F.E. Munro PhD thesis, 1995).
This may indicate that a different population of nociceptive afferent fibres innervate
the two skin types, and that stimulus modality/intensity is a crucial factor in
activating subpopulations of fibres.
The present investigation found no data to support a role for NK]
receptors in the mediation of brief noxious inputs in either the normal animal, or
carrageenan-treated animals. In further support of the data here, Schaible et al,
(1990) demonstrated in an antibody microprobe study that SP could not be detected
in the spinal cord of animals with a normal joint. Interestingly, even after a
carrageenan/kaolin-induced inflammation, the average time that elapsed before SP
was detected was 6.5 hours. In light of this evidence, it is hardly surprising that the
current study found no effect of GR82334. It would appear that SP requires not only
an inflamed state for release, but also quite some time under those inflammatory
conditions. In addition to these studies, there are several electrophysiological
experiments which are in agreement with the present data. Ionophoretic application
of NK] antagonists do not appear to alter the firing evoked in dorsal horn neurons by
either brief or medium-term noxious cutaneous stimulation (Fleetwood et al, 1987;
1990; Munro et al, 1993). Other electrophysiological studies have claimed that non-
peptide NK] antagonist CP96,345 blocks spinal cord neuronal responses to "brief"
noxious mechanical stimulation (De Koninck & Henry, 1991; Radhakrishnan &
Henry, 1991). However, the stimulus used in these experiments was, arguably, far
from short-lived and may have been subsequently tissue-damaging. A role for SP in
nociceptive inputs following other forms of sensitisation, though not in normal
preparations, is heavily supported by much electrophysiological data (Kellstein et al,
1990; Xu et al, 1992; Chapman & Dickenson, 1993; Laird et al, 1993; Thompson et
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al, 1994). However, behavioural studies have yielded mixed results. There is a large
body of evidence supporting the current data in that NKj receptors are not implicated
in acute nociceptive tests (Garces et al, 1992; Malmberg & Yaksh, 1992a;
Yamamoto & Yaksh, 1992a; Couture et al, 1993; Picard et al, 1993; Seguin et al,
1995). However, antagonists to NK] receptors are antinociceptive following some
sustained noxious cutaneous inputs (Garret et al, 1991; Murray et al, 1991; Birch et
al, 1992; 1993; Yashpal et al, 1993; Seguin et al, 1995), but not others (Yamamoto
& Yaksh, 1992a). Undoubtedly the stimulus is a major factor in these contradictory
reports, particularly if there is a possibility that each model is activating a different
population of C- and A8-afferent fibres (Treede et al 1992; see Fleetwood-Walker,
1995).
As there was no evidence for a role of SP in mediating brief noxious
inputs in the present study, several considerations should be highlighted: firstly,
there is evidence that the time required for SP release was inadequate following
carrageenan administration (see Schaible et al, 1990). Secondly, recent single fibre-
labelling studies have emphasised a lack of SP-LI in C polymodal fibres, in the
guinea pig at least (Lawson et al, 1994). Since the existence of C polymodal afferent
fibres in glabrous skin in dubious (see Treede et al, 1994), this may explain why
other studies have previously detected a role for SP in the transmission on
nociception from glabrous surfaces, i.e. the ventral paw and the tail. The current
investigation has further drawn attention to the possibility that the innervation of
these skin types may be crucially different, as the results obtained differ from the data
available on glabrous skin.
Taken together, the results obtained using NKj and NK/) receptor
antagonists would suggest that, although SP and NKA are co-localised in the
majority of instances (Dalsgaard et al, 1985) their roles upon release are really quite
distinct. Studies of the effect of various stimuli on the detectable release of these
peptides are highly supportive of such separate roles in sensory processing (Duggan
et al, 1988; Duggan et al, 1990). NKA would appear to mediate a modality-specific
nociception, in that it plays a role only in noxious thermal inputs to the spinal cord,
under normal and sensitised conditions. On the other hand, SP seems to require a
very much more prolonged input, or some form of sensitisation before it mediates
nociceptive information. It is possible that upon the co-release of SP and NKA,
initial events involve NKA in the process of inducing sensitisation in dorsal horn
neurons, whereas SP then mediates the subsequent events which occur as a result of
this phenomenon.
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Some of the most fascinating results observed in this study were those
elicited by the co-application of an mGluR antagonist and a NK antagonist. In short,
the previously seen analgesic effects of the mGluR antagonists were occluded when
either GR82334 or L659,874 were concurrently injected. Since the compounds were
co-injected simultaneously, the results cannot be explained by re-setting of the
baseline by one compound acting to pre-empt effects of the second. Furthermore, the
phenomemon was seen both with compounds which were analgesic (NK2) and non-
analgesic (NKj) in their own right. Previous electrophysiological intracellular
recording studies investigating NMDA/NK receptor interactions have found the co-
adminstration of agonists results in mixed effects (Randic et al, 1990; Rusin et al,
1992; 1993a; 1993b), though no such investigation has been done with antagonists.
One study did however find that alone an NMDA or NK2 antagonist partially
abolished a capsaicin-evoked DRG response, but together they could almost
completely attenuate it (Nagy et al, 1993). No such interactions with mGluRs and the
tachykinins have yet been studied. The most likely explanation for the present data
requires that a small amount of SP be released upon noxious stimulation. This SP is
normally inadequte to mediate noxious inputs in the current model (perhaps due to
rapid degradation) however it could be enough to act at other sites, for example a
hypothetical inhibitory interneuron. Therefore, if the NK] receptor on this
interneuron was blocked, the observed effect would be an increase in neuronal firing,
which may be, at least partially, attenuated by the application of (S)-CHPG or L-AP3,
thus manifesting as no change in the overall response. However, this would indicate
that GR82334 alone should result in hyperalgesia, an effect not observed. A second
possibility is that an intracellular interaction may be occurring. It is however difficult
to envisage such an event that would lead to occlusion of analgesia, because both
mGluR 1/5 and NK]/2 receptors work primarily though the same signal transduction
cascades. It is possible that additional signals (which may be activated to different
extents by the two receptor classes) are responsible. In general however, such
explanations seem unlikely as the mGluR antagonists alone were analgesic, and why
should cessation of NK] receptor activity negate this role? The case with NKA is
somewhat different, as it is the L659,874-induced analgesia to noxious thermal
stimuli, in the normal paw, which is reduced when either mGluR antagonists is co¬
administered. This may indicate that the input from the carrageenan-treated paw is
too substantial to be altered. Interestingly though, L659,874 alone did not affect the
withdrawal latency to noxious mechanical stimulation, but when co-injected with
either mGluR antagonist in these carrageenan-treated animals, their previously
analgesic effect was prevented. A further possibility is, of course that the drugs used
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in this study interact themselves. If, for example, GR82334 is ineffective alone and
then binds to, or interacts with L-AP3 or (S)-CHPG, then the overall observed
response is equal to no injection at all. Further studies should be carried out, not only
with antagonists, but also agonists, using a number of compounds with the greatest
available specificity. These studies would aim to characterise (and if possible explain
the mechanism of) the phenomenon and would ideally be carried out at behavioural,
electrophysiological and biochemical levels. Whatever the mechanism, there appears
to be a highly complex interaction occurring in the spinal cord when mGluR and NK
receptors are simultaneously inhibited. These observations also underlie the point that
problems can arise when using cocktails of drugs as analgesics, despite the fact that
each is a wholly rational therapeutic stratagem in its own right.
In summary, it would appear that mGlu and NK2 receptors are involved
in the mediation of brief noxious inputs in both normal and carrageenan-treated
animals. The role of NK] receptors in this model of inflammation appears to be





Many previous studies have implicated both EAA and NK receptors in
the mediation of sensory neurotransmission. The current investigation has, by means
of electrophysiological recording experiments and, behavioural testing together with
pilot experiments using a molecular biology approach; see Appendix 1, aimed to
further elucidate the specific role of certain receptor subtypes activated by these
primary afferent transmitters, and the cellular mechanisms by which they may act.
The NMDA type of EAA receptor has been extensively studied, and there is a large
body of evidence implicating it in the mediation of prolonged synaptic events, such
as wind-up in the spinal cord (Davies & Lodge, 1987; Dickenson & Sullivan, 1987;
1990; Haley et al, 1990) and LTP in the hippocampus (see Collingridge, 1992).
However, the role of mGluRs in sensory processing has not yet been adequately
addressed. In the current study this was initially assessed by observing the effect of
several mGluR antagonists on the responses of dorsal horn neurons evoked by
sensory stimulation in vivo. Following this, several signal transduction pathways
were investigated to reveal possible mechanisms through which mGluRs may
operate. This study simultaneously addressed the role of the various second
messengers in the neurotransmission of both innocuous and noxious information. In
a further investigation, behavioural experiments were carried out to assess the effect
of intrathecally applied mGlu, NK] and NK2 receptor antagonists on withdrawal
responses to noxious thermal and mechanical stimuli. Glutamate and SP are
co-existing transmitters in fine primary afferent terminals (DeBiasi & Rustioni,
1988), suggesting that it is important to consider their effects in conjunction.
Furthermore, evidence from previous electrophysiological experiments has
highlighted the possibility of an interaction between EAA and NK receptors (Randic
et al, 1990; Dougherty & Willis 1991b; 1993; Rusin et al 1992; 1993a; 1993b; Song
& Zhao, 1994; Urban et al, 1994). Therefore, subsequent to an analysis of the effect
of the individual compounds, the effect of co-injecting mGluR antagonists with each
of NK] and NK2 antagonists on the responses to noxious stimuli was monitored.
(a) Metabotropic Glutamate Receptors and Nociception
The results obtained from the electrophysiological experiments in this
thesis provide substantial evidence for a role of mGluRs in the mediation of noxious
cutaneous inputs. Furthermore, it would appear that non-noxious inputs are not
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mediated by this subtype of EAA receptors. The compounds used in the current
study implicate group I mGluRs in the mediation of such nociceptive inputs to dorsal
horn neurons. It would now be useful to observe the effects of the newer mGluR
antagonists which have since become available (see Watkins & Collingridge, 1994;
Pin & Duvoisin, 1995). Previous investigations have indicated a similar selective
role for mGluRs in the transmission of noxious, but not non-noxious sensory inputs
to thalamic nuclei (Eaton et al, 1993a; 1993b). The present data obtained from
behavioural testing has highlighted that such a role for mGluRs in nociceptive
processing is far more substantial when spinal cord neurons have been subjected to
some form of sensitisation, in this instance a carrageenan-induced inflammation.
These data are highly reflective of the role which the NMDA receptor plays in
sensory neurotransmission, as NMDA receptors are similarly implicated in
nociceptive processing in a sensitised state. Indeed, it is likely that these two
receptor groups operate in concert to elicit the final output from dorsal horn neurons.
Recent LTP investigations have hypothesised that mGluRs are involved in a
conditional switch mechanism (Bortolotto & Collingridge, 1994), which could result
in prolonged molecular events that gate the functional involvement of other
receptors, for example the NMDA receptor.
The mechanisms which are instigated downstream of mGluR activation
appear to be numerous. The present investigation found that at least three signal
transduction targets, namely CamKII, PLA2 and PKC, play specific roles in the
mediation of high intensity inputs to the spinal cord. These pathways all
demonstrated a clear link with group I/H mGluRs, as (lS,3R)-ACPD-evoked activity
could be attenuated by their inhibitors, though the exact receptor subtype involved is
not certain. CamKII and PKC have both been demonstrated to participate in LTP
(Lovinger et al, 1987; Malinow et al, 1988; 1989; Malenka et al, 1989), a
phenomenon with many analogies to the sensitisation which occurs in dorsal horn
neurons, following the cutaneous application of mustard oil. It therefore seems likely
that these signalling mediators will play comparable roles in the mediation of high
intensity sensory inputs to the spinal cord, in this case via an mGluR. In addition to
this, a role for PKC in nociception has been hypothesised on the basis of several
experiments: this kinase has been shown to be involved in the modulation of NMDA
receptor currents in the spinal cord and the hippocampus in vitro (Gerber et al, 1989;
Ben-Ari et al, 1992) Ionophoresis of the same PKC inhibitors utilised in the current
investigation markedly reduced the sustained activity in dorsal horn neurons elicited
by the cutaneous application of mustard oil (Munro et al, 1994a). Also, [^HjPDBu
binding assays have demonstrated how sustained noxious stimulation results in the
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translocation of PKC to the membrane compartment, in the spinal cord (Mao et al,
1992; 1993; Munro et al, 1994a; Yashpal et al, 1995). Thus the present investigation
supports the hypothesis that PKC is a crucial mediator of the cellular signalling
involved subsequent to a nociceptive input to the dorsal horn. Several other studies
have highlighted the possibility that PLA2 and consequently formed eicosanoids may
also be an important mediator of nociception in the central nervous system, as well as
in the periphery (Chapman & Dickenson, 1992; Malmberg & Yaksh, 1992a; 1992b;
Coderre & Yashpal, 1994; Boyce et al, 1994). The present study supports such a
central role for this signalling mediator, particularly in the mediation of sustained
noxious inputs. The work presented here could not provide any conclusive evidence
as to the nature of the role which PKA or non-receptor tyrosine kinases may play in
sensory inputs to the spinal cord.
(b) NK2 Receptors and Nociception
Previous electrophysiological studies have demonstrated the specific
mediation of noxious thermal, but not mechanical inputs to thalamic and spinal
neurons by NK2 receptors (Fleetwood-Walker et al, 1990; 1993; Santucci et al,
1993). Since the NK2 receptor antagonist L659,874 was analgesic in the thermal
paw flick, but not paw pressure test, the current work similarly concludes that NK2
receptors, and thus probably NKA, are involved in a modality-specific mediation of
both brief and sustained thermal and chemical, but not mechanical noxious inputs to
the spinal cord.
(c) NKj Receptors and Nociception
The present investigation found no behavioural evidence for a role for
NK] receptors in mediating the inflammatory inputs induced by intraplantar
carrageenan. This is somewhat surprising given that there is a large body of literature
supporting a role for SP in mediating chronic noxious input (Kellstein et al, 1990;
Birch et al, 1992; 1993; Xu et al, 1992; Chapman & Dickenson, 1993; Laird et al,
1993; Yashpal et al, 1993; Thompson et al, 1994). There is a possibility that the
hairy skin type which was tested may be innervated by a distinct population of fibres
which do not contain SP. This is unlikely however, as NK2 antagonist L659,874 was
observed to be analgesic and NKA is highly localised with SP in DRG cells
(Dalsgaard et al, 1985). Therefore, if SP is indeed being released it would appear to
be either metabolised or degraded too quickly to exert an obvious effect in the current
investigation. Previous antibody microprobe investigations support this conclusion,
as SP is not detected for an average of 6.5 hours after a carrageenan/kaolin-induced
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inflammation (Schaible et al, 1990) and a study which utilised peptidase inhibitors
demonstrated how SP could be detected more quickly and widespread if its
degradation was prevented (Duggan et al, 1992). The current model could of course
be inappropriate to invoke a substantial amount of NK] receptor involvement.
Results similar to the present experiments were obtained in an electrophysiological
study in which NK2, but not NK] receptor antagonists could inhibit the sustained
activation of dorsal horn neurons elicited by mustard oil (Munro et al, 1993),
therefore several stimuli are apparently insufficient to observe the involvement of SP
in nociception.
(d) Metabotropic Glutamate and NK Receptor Interactions in
Nociception
Although previous electrophysiological studies have hypothesised an
interaction between EAA and NK receptors (Randic et al, 1990; Rusin et al, 1992;
1993a; 1993b; Urban et al, 1994), none of them have had sufficient data to elucidate
the mechanism by which such an interaction may be occurring. The current
behavioural study also suggests that there is some form of interaction taking place,
(though it is impossible to ascertain the mechanism without further experiments)
since concurrent blockade of mGlu and NK receptors leads to a loss of mGluR-
mediated analgesia.
The work presented here has highlighted many features of nociception.
Metabotropic glutamate receptors, particularly mGluRl/5, appear likely to mediate
(at least in part) A8- and C-fibre inputs to the spinal cord, especially in a sensitised
state. Furthermore, this may be accomplished through several signal transduction
mechanisms, likely to include PKC, CamKII and PLA2 as downstream mediators.
Neurokinin2 receptors are apparently involved in brief and sustained noxious thermal
but not mechanical inputs, whereas NK] receptors appear to require a very
substantial, sustained noxious input before their role is appreciated.
The current study does highlight the possibility of an interaction between
EAA and NK receptors, but the complex nature of this means the likelihood of drug
combinations as efficient analgesics still requires many years of study.
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APPENDIX 1:
INVESTIGATION OF THE EFFECT OF METABOTROPIC GLUTAMATE
RECEPTOR ANTAGONISTS ON COMPLETE FREUND'S ADJUVANT-
INDUCED C-FOS mRNA EXPRESSION IN THE SPINAL CORD
A.l. AIMS
Following the induction of inflammation due to a subcutaneous injection of
complete Freund's adjuvant (CFA), c-fos expression is known to increase in the spinal
cord. In order to assess the role of mGluRs in this increased gene expression,
antagonists were applied intrathecally during the first four hours of inflammation. The
effect of CFA on c-fos mRNA expression and ultimately any changes induced by mGluR




Adult male Wistar rats (320-770g) were anaesthetised and cannulated as in section 3.2.2.
An incision was made into the dorsal surface of the neck, over C2/C3 and a minor
laminectomy was performed in order to expose C2 - C3. After the dura was carefully cut
a, polyethylene cannula (2 French Gauge: outer diameter of 0.70mm, inner diameter of
0.38mm, with green luer fitting; Portex, Hythe, UK) was filled with saline or drug and
inserted into the intrathecal space between C2 and C3. It was then eased along the spinal
cord until the caudal tip reached the region of L2 - L3. This position was determined by
a mark made on the cannula prior to its insertion, and usually confirmed by reflex
twitching of the hindlimbs. At this point (designated as time 0), two injections were
given simultaneously. Firstly, a 150|ll subcutaneous injection of complete Freund's
adjuvant (CFA; 1 .Omg/ml killed Mycobacterium tuberculosis suspended in 85% paraffin
oil / 15% mannide monooleate; Sigma Chemical Company, Poole, UK) was given to
both feet. This particular CFA was used since it produces an inflammation very quickly
and is known to induce c-fos expression in the spinal cord after only 4 hours (Lanteri-
Minet et al, 1993b). The peripheral response to CFA was monitored in part by
measuring the circumference of the animal's paw at 0,1 and 4 hours. Secondly, 50pl of
saline or drug were given via the cannula into the intrathecal space. Inflammation was
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allowed to develop for a further 4 hours, with the intrathecal injection repeated at hourly
intervals. During this time anaesthesia was maintained with a-chloralose using the same
criteria described in section 3.2.2. After 4 hours a laminectomy at L1-L5 was carried out
and two pieces of spinal cord (L1-L2 midway and L2 midway-L5) were removed
bilaterally, each weighing approximately lOOmg. They were immediately frozen in
liquid nitrogen, where they were stored until required for RNA extraction.
A.2.2. Drugs
Two metabotropic glutamate receptor antagonists were given intrathecally:
L-AP3 and (S)-CHPG, 30mM in aqueous solution, pH7.0.
A.2.3. RNA Extraction
The extraction of RNA was carried out using a QuickPrep® Micro mRNA purification
kit (Pharmacia Biotech, St Albans, UK). All procedures were carried out under RNase
free conditions. This entailed either autoclaving or washing equipment in absolute
alcohol followed by several washes in diethyl pyrocarbonate (DEPC)-treated water. All
solutions were at room temperature, unless otherwise stated. The tissue was removed
from liquid nitrogen and immediately homogenised in a buffered aqueous solution
containing guanidinium thiocyanate (GTC) and N-lauroyI sarcosine. The extract was
then diluted three-fold with lOmM Tris-HCl (pH 7.5)/ ImM EDTA and homogenised
further. The sample was centrifuged (13,000g, 3 minutes) and the supernatant added to
oligo(dT)-cellulose in a microcentrifuge tube. The tube was manually inverted for 3
minutes to allow poly (A)+RNA to bind to the oligo(dT)-cellulose. Following a 10
second centrifugation this supernatant was removed and 1ml of a high salt buffer (lOmM
Tris-HCl (pH 7.5)/ ImM EDTA/ 0.5M NaCl) was added. Five sequential batch washes
with this buffer and then two with a low salt buffer (lOmM Tris-HCl (pH 7.5)/ ImM
EDTA/ 0.1M NaCl) took place. Each wash was accomplished by a process of
resuspension and 10 second recentrifugation. After the last low salt wash, the pellet was
resuspended in 0.3ml of low salt buffer then transferred to a MicroSpin Column and
washed a further 3 times with 0.5ml low salt buffer. Finally, the polyadenylated material
was eluted with two applications of 0.2ml of lOmM Tris-HCl/lmM EDTA which had
been warmed to 65°C.
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A.2.4. Quantitation and Precipitation of RNA
Concentration and purity of the RNA samples was evaluated by comparing
spectrophotometer readings at 260nm and 280nm. Samples were placed in RNase free
quartz cuvettes and readings were taken from a Shimadzu UV-1201 spectrophotometer
(VA Howe & Co. Ltd., Banbury, UK). Before storing the RNA at -70°C it was
necessary to precipitate it. This was done by adding lOpg of glycogen in DEPC-treated
water and 40|il of 2.5M potassium acetate, then storing under ethanol at -20°C for a
minimum of 30 minutes. Finally after 5 minutes of centrifugation (13,000g, 4°C) the
samples were stored under ethanol at -70°C until needed.
A.2.5. Slot Blot Assay
A.2.5.1 3' Labelling of the Oligonucleotide Probe
c-fos antisense 48 base oligomer: 5' GAG CGT ATC TGT CAG CTC CCT
CCT CCG ATT CCG GCA CTT GGC TGC AGC. This c-fos oligomer is
complementary to the base sequence 582-630 of rat c-fos mRNA (Curran et al, 1987)
which corresponds to the conserved DNA binding site in Fos proteins. This means that
proteins closely related to c-fos could also be detected. For the P-actin controls (see
section A.2.7.) the following sequence, complimentary to amino acids 135 - 150 of rat p-
actin mRNA, was used: 5' GCC AGT GGT ACG ACC AGA GGC ATA CAG GGA
CAA CAC AGC CTG GAT CCG (Nudel et al, 1983; see Figure A.2).
The following reaction mixture was warmed in a sterile eppendorf tube at
32°C for 15 minutes: 3pl of DEPC treated water containing 0.68pg (38pmol) of
antisense c-fos probe, 5pl of terminal deoxynucleotidyl transferase (TdT, 15 units/pl), 10
pi potassium cacodylate tailing buffer, 5pl [35s]dATPaS (70pmol; 1-1.3 x 10^
Ci/mmol) and 38pl of DEPC treated water to make a final volume of 61 pi. This volume
was calculated to ensure the TdT was diluted at least 1 in 10. The mixture was briefly
vortexed for before being spun down (13,000g, 2-3secs) and then incubated with gentle
248
Figure A.l.
Nucleotide sequence of rat c-fos
The nucleotide sequence reads in the 5' to 3' direction (from Curran et al, 1987). The
oligomer probe used was complimentary to the base sequences 582-629, as shown in


































Nucleotide sequence of rat (3-actin
The nucleotide sequence reads in the 5' to 3' direction (from Nudel, et al, 1983). The
oligomer probe used was complimentary to amino acids 135-150, as shown in italics



















agitation for 1 hour at 32°C. To optimise conditions, a further 5(_il of 35s-labelled ATP
and 2|il of TdT were added at the end of the first hour, this combination was then
allowed another hour's incubation period. The reaction was stopped by cooling on ice
for 15 minutes.
At this time two l|ll samples were removed from the tube. These were
compared with two later samples taken after the remainder of the mixture had been
purified from unincorporated nucleotide using a Nu-Clean D25 disposable spun column
(International Biotechnologies Inc, New Haven, USA). This was done by placing the
sample onto the surface of the gel in the column and then centrifugation for 4 minutes at
1,1 OOg, with collection into a fresh tube. 1ml of scintillation fluid was added to the lpl
test samples in sterile eppendorf tubes and counts per minute were read using a Wallac
1450 Microbeta Plus liquid scintillation counter with customised software (Department
of Veterinary Pathology, University of Edinburgh). The difference between the pre-spun
and post-spun samples allowed the percentage incorporation of the radiolabel to be
estimated. The labelled probe was stored at -70°C until required, for a maximum of 14
days.
A.2.5.2. Denaturation and Fixation
A 48 well Bio-dot Slot Format Microfiltration unit (Biorad Laboratories,
Inc., Hemel Hempstead, UK) was used in which each well was 7mm by 0.75mm. Before
using the apparatus it was washed once in 95% alcohol followed by two rinses in DEPC
water. The apparatus was assembled according to the manufacturer's recommendations,
with a Zeta-Probe nylon membrane (9cm by 12cm) which had been pre-wetted in DEPC-
treated water. The outer wells were not used, to avoid any potential loss of sample
through uneven vacuum effects. These wells had buffer applied when the others had
samples placed in them. Since the samples contained such variable levels of RNA, each
was adjusted to contain the amount known to be in the least concentrated sample. This
was accomplished by diluting the stronger samples with ImM EDTA. Such uniformity
was necessary for true comparison at the grey scale analysis stage.
Following their removal from the freezer, samples were re-centrifuged (5
minutes, 13,000g) and the ethanol was removed using a sterile glass pipette. They were
then redissolved in 0.5ml of ice cold lOmM NaOH/lmM EDTA, and diluted where
necessary (see above). To prepare the membrane, 0.5ml of DEPC water was placed in
each well, then a vacuum applied. Next the 0.5ml samples themselves were added to the
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wells and a vacuum applied until drying could be seen. The samples were washed
through with 0.5ml of buffer and a final vacuum. Upon removal the membrane was
immediately washed in 2 x standard sodium citrate (1 x SSC = 150mM NaCl, 15mM
trisodium citrate)/ 0.1 % sodium dodecyl sulphate (SDS) and blotted lightly.
A.2.5.3. Hybridisation
The membrane was carefully placed in a sterile plastic container with 200ml
of a prehybridisation buffer consisting of lOx Denhardt's Solution, (1 x Denhardt's
Solution = 0.02% each of bovine serum albumin, polyvinylpyrrolidone and Ficoll) 5 x
SSC, 20mM NaH2P04, 7% SDS and 100|ig/ml denatured salmon sperm DNA (all final
concentrations) and left in a shaking water bath at 68°C overnight (a temperature derived
from standard calculations which consider both the base-pair content and the type of
probe used). The following day the buffer was removed and replaced with a fresh, but
identical, solution. 55-60pl of the 3' end 35s_]a5enecj oligonucleotide probe
complementary to c-fos was added (4.5 - 5.8 x 105 c.p.m./ml buffer) and allowed to
hybridise with the membrane, 68°C, overnight. The membrane was then washed twice
in 3 x SSC, 10 x Denhardt's, 5% SDS and 25mM NaH2P04 and once in 1 x SSC, 1%
SDS, (30 minutes each wash, 50°C).
A.2.6. Autoradiography
The blot was allowed to dry naturally (2-3 hours, room temperature) before
being apposed to X-ray film (Kodak XAR-5, Biorad Laboratories, Inc., Hemel
Hempstead, UK), with two intensifying screens, at -70°C for 12 - 14 days. It was
developed using a standard X-ray developing machine (Small Animal Clinic,
Summerhall, Edinburgh).
A.2.7. Controls
In order to determine the levels of c-fos mRNA expressed under various
conditions, several controls were necessary for these experiments. Firstly, a
surgery/vehicle control whereby the animal underwent an intrathecal cannula insertion
and received hourly injections of saline. Secondly, for direct comparisons with drug-
effects, further animals received the same treatment as above along with a bilateral
injection of CFA into their feet. A third group had only intravenous and tracheal
cannulae inserted, then were left for 4 hours. This was to determine levels of c-fos under
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the influence of minimal noxious inputs. Finally, to observe the effect of the CFA alone,
one animal was given the bilateral injections into the feet, but did not undergo back
surgery.
In order to compare one slot with another, controls for levels of mRNA
bound to the membrane were also carried out. This entailed stripping the membrane
immediately after the exposure which determined levels of c-fos mRNA expression.
This was accomplished by washing it 2 times, for 30 minutes each in a 0.1 x SSC/0.5%
SDS solution at 95°C, followed by overnight exposure at -70°C. The membrane was
subsequently re-assayed and treated in the same manner as before (section A.2.5.), but in
this case was probed for [3-actin, a standard cellular gene which should have uniform
expression, regardless of treatment (Iadorola et al, 1988a). Should the levels of [3-actin
expression differ, they should be taken into account when analysing the levels of c-fos,
i.e. if one slot contains twice as much mRNA than the next then the levels of c-fos
expression should be halved for comparison.
A.2.8. Analysis of Results
Initial attempts were made to analyse the autoradiographs by means of an
image analysis programme, customised to detect grey levels from silver grain
autoradiographs. Using Image 1.44 VDM-F (in an Apple Macintosh Ml298) a 'live'
image from a camera above the autoradiograph allowed each slot to be captured as an
image. A region of interest (ROI), usually encompassing the entire slot, was analysed
for grey levels. An identical ROT immediately adjacent to the slot was then measured in
the same manner for background levels. This method proved unsuitable for the
measurements required, as it relied too much on human judgement of the slot position.
Therefore, a further program was used, Image 1.49, which utilised a scanned and
magnified image of the autoradiograph and counted pixels per ROI. An ROI was set and
used for each slot in turn, and the background adjacent to each slot was likewise
measured. To minimise the margin of error a mean of all 23 background measurements
was used to compare with the levels from each slot.
Unfortunately although the [3-actin mRNA controls could be analysed in this
manner the levels of c-fos which were expressed throughout the blot in these pilot
studies were too low to evaluate quantitatively, even with a magnified scanned image.
As the slots were discernible by eye, it was decided that each slot would be given an
empirical rank from 0 to 3 in order to determine any trends in c-fos expression. From
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the (3-actin levels which were expressed, all of the control measurements were calculated
as a ratio of the slot containing the most mRNA, this being assigned as 1 (see column of
Table A.l). This level of c-fos (0-3) was then multiplied by the inverse of the ratio of (P
-actin) mRNA contained in the slot. This resulted in values which were directly
comparable for inflammation- and drug-induced changes in c-fos expression.
In this short study there was no time permitted to construct a calibration
curve for the relationship between pixel levels and silver grain density (this could have
been done with the use of commercial standard strips which emit a known amount of
radioactivity). Therefore it should be noted that a linear relationship has been presumed,
though further experiments would be needed to ascertain the correct nature of this
relationship.
A.3. RESULTS
The values which are quoted are those from Table A.l., these are
comparative levels of c-fos mRNA expression (calculated with consideration to the
amount of control (3-actin contained in the relevant slot).
A.3.1. Controls
(a) mRNA content - |3-actin expression
In order to ensure comparability in the c-fos blots the membrane was
stripped of radiolabel and then re-examined for the expression of P-actin, a gene which
is considered to be expressed equally throughout cells regardless of treatment (Iadorola,
1988a). The levels of p-actin which were detected can be seen in Figure A.3. They were
not entirely uniform, but did show that every slot contained a more than detectable level
of mRNA. Table A.3. shows the pixel counts in each autoradiograph slot, as a ratio of
the maximum amount of mRNA detected. The slots which contained the control tissue
appear to have far more bound mRNA than the others.
(b) Vehicle Control
Four hourly injections of saline were administered via an indwelling
intrathecal cannula in order to evaluate the effect the experimental procedure had on the
expression of c-fos mRNA. Unfortunately, technical problems meant that the results
obtained were not adequate in this pilot study.
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Figure A.3.
These are photographic images of examples of the slot-blot autoradiographs. The top
photograph represents the control assay, in which (3-actin mRNA was detected.
Adequate levels of mRNA can be seen in all slots. The lower photograph is from the
test assay, showing the very poor detection of c-fos mRNA in all slots.
The table below describes the treatment received by the tissue in the appropriate slot
shown opposite.
CFA/no cannula L-AP3 (S)-CHPG (S)-CHPG
(S)-CHPG (S)-CHPG (S)-CHPG (S)-CHPG
(S)-CHPG (S)-CHPG L-AP3 (no tissue)
L-AP3 L-AP3 L-AP3 CFA/cannula
L-AP3 L-AP3 (S)-CHPG (S)-CHPG




This is a summary of the mean results obtained from the autoradiographs in Figure A3
following c-fos and (3-actin detection. A rating was assigned to each of the slots
containing c-fos mRNA, based on the experimenter's visual assessment of the
autoradiograph. Following this, each rating was multiplied by the inverse of the
proportion of control (3-actin mRNA detected in the slot. The numbers in the final






l/(3-actin ratio 1/P-actin ratio
X
c-fos
CFA, no cannula 1 3 1 1 3
CFA, cannula 1 1 0.73 1.37 1.37
no CFA, no cannula 1 1 0.86 1.16 1.16
no CFA, cannula 1 0 0.72 1.39 0
(S)-CHPG 11 1.7 0.53 1.89 3.21
L-AP3 8 1.5 0.56 1.79 2.69
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(c) CFA-induced c-fos expression
Tissue from a rat which did not receive a CFA injection, but was left for 4
hours with an in-dwelling cannula, showed no induced c-fos expression (slot 22; Figure
A.3. and Table A.3.). A rat which did not receive either a CFA injection or any back
surgery showed an expression level of 1.16, a small rise compared to the previous
control.
The level of c-fos mRNA expressed following a CFA injection can be seen
in slot 1 (Figure A.3. and Table A.3.). This treatment, 4 hours post-CFA injection
resulted an apparent inflammation with a 30-50% increase in paw circumference. This
CFA-evoked inflammation seemed to induce a clear rise in the level of c-fos mRNA
detected from the spinal cord, with the adjusted measurement being 3. However, the
tissue from an animal which also had an in-dwelling cannula did not appear to contain as
much detectable c-fos (slot 15, Figure A.3. and Table A.3.), with the level being only
1.37. Further replication of samples and administration of experimental procedures
would be required before any conclusions could e drawn from studies like this.
Nevertheless, values were obtained from a number of drug-treated samples before
shortage of time prevented any further experiments from being carried out.
A.3.2. Metabotropic Glutamate Receptor Antagonists
Tissue from rats which had received intrathecally applied (S)-CHPG
expressed a mean level of c-fos mRNA of 3.21 (n=ll). The mean level of c-fos
expression from tissue which had had L-AP3 applied was 3.21 (n=8). Clearly, these
values were consistent with the idea that CFA-induced increases in c-fos mRNA
expression were not markedly diminished by the mGluR antagonists. This could reflect
inadequate access or an authentic lack of involvement.
Nevertheless, these preliminary observations can only be considered as a
technical trial, requiring improvements in c-fos mRNA hybridisation/detection
conditions and an adequate usage of both control and experimental samples, before any
valid conclusions could be drawn.
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A.4. DISCUSSION
A number of problems arose in this pilot study. Firstly, insufficient controls
were available since a lot of tissue was lost during initial experiments, mainly at the
mRNA-purification stage. This loss of data was increased due to problems which arose
in the process of developing the technique and optimising conditions for the assay itself.
There was inadequate time left at the end to repeat the control experiments in which
much tissue had initially been lost. Furthermore, although it was relatively convenient
for processing a large number of samples the slot blot technique appeared to be
sufficiently sensitive only when there were large amounts of the target mRNA present,
i.e. in the case of (3-actin, but not c-fos. Apart from technical improvements increased
levels of c-fos expression could have perhaps have been accomplished with a more
prolonged stimulus, such as 6-8 hours of CFA-induced inflammation. Lanteri-Minet et
al (1993b) observed maximal Fos expression in the superficial dorsal horn after only 4
hours, using immunocytochemistry. Although the aim of this study was to investigate in
a simple fashion the effect of mGluR antagonists on c-fos expression in a population of
cells, immunocytochemistry or in situ hybridisation histochemistry (ISHH) allowing the
detection of c-fos in individual dorsal horn neurons would have perhaps been more
successful. This would overcome the signal to noise problem undoubtedly associated
with attempts to measure responses to a relatively small number of cells in combined
extracts from both these and a large number of unresponsive cells. ISHH was employed
by another member of our laboratory (F.E. Munro PhD thesis, 1995) to observe the
effect of cutaneously applied mustard oil on c-fos mRNA expression. Levels of c-fos
mRNA were observed to increase significantly on the side ipsilateral to the
administration of the irritant, after only 45 minutes. This evidence, along with that from
Lanteri-Minet et al (1993b), would imply that there should be significant levels of c-fos
expression in the spinal cord with the current model, and therefore the difficulties
experienced in these pilot experiments are primarily of a technical nature. Therefore,
since these initial experiments time has been spent, along with another colleague, on
refining this protocol. The use of a more sensitive hyperfilm and a wider range of
stimulus-response times may well lead to a substanital improvement in the results.
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299.6/0.
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brief nociceptive inputs to rat dorsal horn (laminae III - V) neurons, European
Journal of Pharmacology 242: 173-181
5. Munro F.E., Young M.R., Fleetwood-Walker S.M., Parker R.M.C. & Mitchell R
(1993) Receptor and cellular mechanisms involved in mustard oil - induced
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P82 The Role of NKi and NK2 Receptors in
Nociceptive Inputs to Rat Dorsal Horn Lamina
I and Laminae IV/V Neurons
S. Fleetwood-Walker, R. Parker, F. Munro,
M. Young and R. Mitchell*
Royal (Dick) School of Veterinary Studies,
Summerhall, Edinburgh and *MRC Brain Metabolism
Unit, George Square, Edinburgh, UK
Single neurons of chloralose/urethane anaesthetised rats
were extracellularly-recorded and drugs applied by
ionophoresis.1 In lamina I, [Met-OMe"]SP (NKi agonist)
had no effect in 9/10 cells whereas NKA and GR 64349
(NIG) produced a marked but transient excitation in nearly
all cases. However, in laminae IV/V, [Ac-Arg6, Sar',
Met(02n]SP6-u(NKi), NKA and GR 64349 were all effec¬
tive excitants. In experiments with antagonists on lami¬
nae IV/V neurons, L-659874 (NK2) selectively inhibited
brief thermal nociceptive responses in 9/9 cases but L-
668169 (NKi) had no effect in 7/9. Similar results were
obtained in models of sustained neuronal activation by
mustard oil2 or induction of preprodynorphin mRNA by
intraplantar carrageenan.3 Our results suggest that NIG but
not NKi receptors may be - important in nociceptive
responses of laminae I and IV/V neurons to brief thermal
and modest inflammatory stimuli. NKi receptors may be
more important in profound inflammatory conditions,
since in contrast to NKA, SP is released only by damag¬
ing levels of thermal stimuli.
1. Fleetwood-Walker, S. M., Hope, P. J., Parker, R. M. C. and
Mitchell, R. (1991). Effects of antagonists selective for NKi
and NK receptors on somatosensory responses of rat dorsal
hom neurons. Br. J. Pharmacol. 104: 472P.
2. Munro, F. E., Fleetwood-Walker, S. M., Parker, R. M. C. and
Mitchell, R. Mustard oil-evoked activation of rat dorsal hom
neurons is inhibited by NKz but not NK. receptor antagonists.
Br. J. Pharmacol (in press).
3. Parker, R. M. C., Fleetwood-Walker, S. M., Rosie,R., Munro,
F. E. and Mitchell, R. Effects ofNK receptor antagonists on
carrageenan-induced expression of preprodynorphin mRNA
in rat dorsal hom lamina I neurons. Br. J. Pharmacol, (inpress).
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EVIDENCE FOR THE INVOLVEMENT OF NKj RATHER THAN NKi RECEPTORS IN BOTH ACUTE AND
SUSTAINED NOCICEPTIVE INPUTS TO DORSAL HORN NEURONS
FLEETWOOD-WALKER, S„ PARKER, R.. MUNRO, F„ YOUNG. M. and MITCHELL, R.*
Department of Preclinical Veterinary Sciences, Royal Dick School of Veterinary Sciences, University of Edinburgh. Edinburgh EH9 1QH.
and *MRC Brain Metabolism Unit. University Department ofPharmacology, 1 George Square, Edinburgh EH8 9JZ. UK
Both substance P (SP) and neurokinin A (NKA) are present in fine somatosensory afferents and can be released into spinal dorsal horn by
noxious cutaneous stimuli. However, for thermal stimuli, detectable release of SP is not measured until skin temperatures reach levels
likely to cause inflammatory damage. Here we assessed the role of NK1/NK2 receptors in acute and sustained (inflammatory) nociceptive
inputs to dorsal hom neurons, using ionophoresis of NIC receptor drugs. In acute experiments, the NK2 antagonist L-659874 but not L-
668169 (NKi) inhibited thermal nociceptive responses of extracellularly-recorded cells without modifying responses to pinch or brush.
Agonists for both NKi and NK2 receptors activated laminae IV/V neurons however, suggesting that under some circumstances SP is likely
to play some role in nociception. Interestingly, only NKj and not NKt agonists excited lamina I neurons. The sustained activity of laminae
IV/V neurons wound-up' by repeated application of mustard oil to the periphery (over 10-30 mini was inhibited by L-659874 but not L-
668169 or GR 82334 (NKi). Neuronal activation elicited by intraplantar carrageenan (6 h) was assessed by in situ hybridisation for
preprodynorphin (PPD) mRNA. The increased expression of PPD mRNA in superficial dorsal horn neurons was inhibited by L-659874 but
not L-668169 or GR 82334. It is clear that NKj receptors are important in acute thermal nociception and in sustained inflammatory






EVIDENCE FOR A ROLE OF NK, RECEPTORS IN
MEDIATING ACUTE AND SUSTAINED NOCICEP¬
TIVE INPUTS TO DORSAL HORN NEURONS. 5,
Fleetwood-Walker. R. Parker, F. Munro, M. Young and
R. Mitchell (SPON: A. Iggo), Dept. of Preclinical
Veterinary Sciences, Royal (Dick) School of Veterinary
Studies, Summerhall, Edinburgh EH9 1QH and *MRC
Brain Metabolism Unit, 1 George Square, Edinburgh
EH8 9JZ.
Aim of Investigation: In view of reports that tachy¬
kinins with selectivity for NK( and NK, receptors (sub¬
stance P and neurokinin A respectively} are contained in
fine somatosensory afferents and can be released upon
noxious stimulation, we assessed the role of these recep¬
tors in nociceptive processing.
Methods: The activation of single dorsal horn neu¬
rons during cutaneous stimulation was investigated in
two models (i) acute natural stimuli to the peripheral
receptive field (over 10-30 s) and (ii) peripheral inflam¬
mation induced by intraplantar injection of carrageenan
(over 6 h). Experiments were carried out in anaesthetised
rats. Neuronal responses were measured in model (i) by
extracellular electrical recording and in model (ii) by in
situ hybridisation histochemistry for preprodynorphin
(PPD) mRNA. Antagonists selective for NK^ or NK,
receptors were delivered by ionophoresis into the spfnal
dorsal horn.
Results: Acute sensory responses to noxious heat but
not innocuous brush or noxious pinch were inhibited by
the NK, antagonist L-659874 (9/9 cells) but not by L-
668169"(NKjj no effect in 7/9 cells), confirming earlier
work in cats. In 3 out of 3 animals with bilateral carra¬
geenan inflammation, unilateral L-659874 inhibited the
increased expression of PPD mRNA in ipsilateral super¬
ficial dorsal horn whereas L-668169 or GR 82334 were
ineffective.
Conclusion: These results indicate that dorsal horn
NK2 receptors piay a more important role than NKj in
the present modeis of acute and sustained nociception.
However, since laminae IV/V (although not lamina I)
cells are excited by NK( as weil as NK2 agonists it seems
likely that NKj receptors do play some role in nocicep¬
tive processing, perhaps under circumstances of more
profound inflammation than assessed here.
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Evidence for a role of tachykinin NK2 receptors in mediating brief
nociceptive inputs to rat dorsal horn (laminae III-V) neurons
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Since the NK2 receptor-selective tachykinin, neurokinin A is present in fine primary afferent neurons in addition to the NKj
Kcptor-selective tachykinin, substance P, we have addressed the relative role of NKj and NK2 receptors in somatosensory
processing in spinal dorsal horn. Recording extracellularly from rat laminae III-V neurons whilst ionophoresing drugs nearby,
fcselective NK] receptor antagonists L 688,169, GR 82334 and [D-Pro4,D-Trp7'910Phen]substance P-(4—11) failed to influence
leuronal responses to cutaneous pinch or noxious heat but often enhanced responses to innocuous brush. In contrast, the highly
selective NK2 receptor antagonist L 659,874 profoundly inhibited responses to noxious heat but not pinch or brush. Highly
selective synthetic agonists for both NKj and NK2 receptors ([N-acetyl-Arg6,Sar9,Met(02)n]substance P-(6-ll) and GR 64349,
respectively) and also NKA showed the inverse effects on sensory responses to those brought about by their antagonists. At
iigher ionophoretic currents, both NKt and NK2 receptor agonists increased spontaneous activity. This increased basal firing
induced by GR 64349 and neurokinin A (but not that due to [N-acetyl-Arg6,Sar9,Met(02)11]substance P-(6—11) appeared to
partially pre-empt further excitatory responses to noxious heat. It is concluded that although both NKj and NK2 receptors can
dearly mediate excitation of dorsal horn neurons, it is not NKj, but rather NK2 receptors that are important as the physiological
iltansducer of brief thermal nociceptive inputs in this model.
Tachykinins; Neurokinins; Pain; Analgesia; Spinal cord
L Introduction
The tachykinins substance P and neurokinin A
(which display selectivity for NKj and NK2 receptors
s respectively) are both present in fine somatosensory
Wferents (Hokfelt et al., 1975; Sundler et al., 1985) and
,;for some time substance P has been a candidate trans¬
mitter of nociception (Henry, 1976). There is consider¬
able evidence from electrophysiological, behavioural,
.' biochemical and transmitter release experiments that
D substance P is involved in nociception (see Fleetwood-
ipWalker and Mitchell, 1989, for review). Nevertheless,
E!lie crucial experiments with antagonists have provided
«mixed results. Early substance P antagonists [D-
E1fro2,D-Trp7'9]substance P and [D-Pro2,D-Phe7,D-
RV]substance P failed to reliably reverse the excita-
t®respondence to: S.M. Fleetwood-Walker, Department of Preclin-
tal Veterinary Sciences, Royal (Dick) School of Veterinary Studies,
University of Edinburgh, Summerhall, Edinburgh EH9 1QH, UK.
Tel- 031 650 6091, fax 031 650 6576.
tory effects of substance P on trigeminal neurons (Hill
et al., 1985) and [D-Arg1,D-Trp7,9LeuI1]substance P
(spantide) failed to antagonise the substance P facilita¬
tion of the nociceptive flexor reflex in vivo (Wiesen-
feld-Hallin and Duranti, 1987) and only inhibited noci¬
ceptive reflexes in vitro at rather high concentrations
(Otsuka and Yanagisawa, 1988; Brugger et al., 1990).
However, recent NKj receptor antagonists spantide II
[D-NicLys1,3-Pal3,D-Cl2Phe5,Asn6,D-Trp7'9,Nle1 ^sub¬
stance P (Maggi et al., 1991b) and CP 96,345 (Snider et
al., 1991) have been described to block the facilitation
of the flexor reflex and the excitation of dorsal horn
neurons brought about by electrical stimulation of af-
ferents at C-fibre intensity (Wiesenfeld-Hallin et al.,
1990; De Koninck and Henry, 1991). In behavioural
reflex experiments only certain of the early substance P
antagonists effective elsewhere on smooth muscle
preparations, elevated response thresholds to nocicep¬
tive stimuli (Post and Folkers, 1985; Piercey et al.,
1986), although several newer NK, receptor antago¬
nists were effective in models of inflammatory pain
(Yamamoto and Yaksh, 1991; Murray et al., 1991;
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Garret et al., 1991; Birch et al., 1992; Boyce et al.,
1992).
Little has been done to address any possible role of
NK2 receptors in dorsal horn, but ionophoretic admin¬
istration of two early NK, receptor antagonists [D-
Pro4,Lys6,D-Trp7'9'10,Phen]substance P-(4—11) and [D-
Tyr4,D-Trp7'9,Nlen]substance P-(4-ll) (Regoli et al.,
1985) but not an NKt receptor antagonist, spantide,
into the substantia gelatinosa, specifically inhibited the
responses of cat dorsal horn neurons to noxious ther¬
mal, but not other, cutaneous stimuli (Fleetwood-
Walker et al., 1990).
Whilst several reports have described direct excita¬
tory effects of substance P on dorsal horn neurons
(Henry, 1976; Murase et al., 1989; Urban and Dray,
1992), not only the selective NK2 receptor agonist
[Met-OMe1 ^substance P (Fleetwood-Walker et al.,
1990) but also the NK2 receptor agonist neurokinin A
(Salter and Henry, 1991) have been reported to excite
dorsal horn lamina IV/V neurons when ionophoreti-
cally ejected nearby.
The present experiments were carried out with a
range of recently developed agonists and antagonists
which are highly selective for NKX and NK2 receptors
in order to further address their relative contribution
to mediating spinal nociceptive transmission.
2. Materials and methods
2.1. General
Experiments were carried out, broadly as described
previously (Fleetwood-Walker et al., 1991), on male
rats (270-350 g), anaesthetised with intravenous a-
chloralose (60 mg kg"1) and urethane (1.2 mg kg"1),
after induction with halothane. Supplementary doses
of a-chloralose were given as required. Core tempera¬
ture was maintained at 37-38°C with a thermostatically
controlled heated blanket, and in the majority of exper¬
iments carotid blood pressure was monitored through¬
out the experiment. Oxygen (0.1 1 min"1) was passed
over the end of the tracheal cannula to enrich the
inspired air. The thoraco-lumbar spinal column was
supported by three pairs of clamps. A laminectomy
(segments L1-L4) was then carried out and agar in¬
jected under the most rostral clamped vertebra and
then over the whole area of the laminectomy. A core of
agar was removed from above the recording region, the
dura carefully cut and a pool of liquid paraffin applied
to the region.
2.2. Electrophysiological methods and ionophoresis
Extracellular recordings were made via the central
barrel (4 M NaCl, pH 4.0-4.5) of a 7-barrelled glass
microelectrode. Electrode tip sizes were 4.0-4.5 ^
and DC resistances were 5-8 Mil. The band-width of
the recording amplifier was 1 Hz-7 kHz. One side
barrel contained 1 M NaCl (pH 4.0-4.5) for automatic
current balancing and current controls (Neurophore
Ionophoresis System, Medical Systems Corporation)
Another side barrel contained Pontamine Sky Blue dye
(2% in 0.5 M sodium acetate for marking recording
sites by ejection for 100 p. A min). The locations of
recording sites in laminae III-V verified histologically
in 15 jum cryostat sections lightly counterstained with
neutral red. Other barrels contained the following neu¬
rokinin receptor agonists and antagonists: neurokinin
A; L 659,874 (acetyl-Leu,Met,Gln,Trp,Phe-NH2), L
668,169 (cyclo(Gln,D-Trp,Me-Phe,(R)Gly[ANC-
2]Leu,Met)2), L 659,877 (cyclo(Gln,Trp,Phe,Gly,Leu,
Met)) (all from Cambridge Research Biochemicals);
[D-Pro4,D-Trp7'9'10,Phe11]substance P-(4-ll) (from
Bachem UK); GR 82334 ([D-Pro9[spiro-y-lactam]-
Leu10,Trpn]physalaemin-(l-ll) and GR 64349
([Lys3,Gly8-R-y-lactam-Leu9]neurokinin-(3-10) (gifts
from Glaxo Group Research) and [N-acetyl-Arg6,Sar9,
Met(02)n]substance P-(6-ll) (a gift from Professor D.
Regoli). Solutions were either 1 mM in distilled water
(GR 82334, neurokinin A and GR 64349) or 0.1 mMin
0.3% dimethylformamide, diluted from concentrated
stocks in pure dimethylformamide (other compounds)
and were, adjusted to pH 4.5 with HC1. All peptide
solutions were either freshly made or stored at -20°C
in small (100 ^.1) aliquots which once thawed were not
refrozen, or used again. All drugs were applied with
cathodal currents. Retaining currents of -10 nA were
used to minimise drug leakage between tests. Action
potentials of the recorded cells were clearly discrimi¬
nated from other field potentials throughout the test.
Neuronal firing was recorded on FM tape (Racal) and
firing rates were plotted on-line by computer (IBM
PS/2-70-121) together with stimulator and ionophore¬
sis markers.
All the neurons recorded were selected as having
cutaneous excitatory receptive fields on the hairy skin
of the ipsilateral hind limb that were multireceptive
(i.e. mediated responses to both noxious and innocuous
stimuli). Receptive fields were initially located by brief
manual brush/pinch stimuli, prior to characterisation
with timed and quantified stimuli, including also nox¬
ious heat. Controlled stimuli were applied to adjacent
cutaneous areas within the receptive field on the dorsal
surface of the paw or the hind limb were regularly
repeated over 3-4 min cycles. The innocuous stimulus
used was a motorised, rotating brush. Noxious stimuli
were provided by a calibrated pinch (serrated forceps
with a graduated controlled displacement) or a thermo¬
couple-controlled radiant heat lamp (giving a skin sur¬
face temperature ramp of 30-48°C). Like the other
stimuli, the noxious heat stimulus was set routinely for
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I s at 48°C, but in occasional examples for 15 s to
ensure a more robust response. Skin temperatures
,ever exceeded the 45°C definition of noxious levels
(Duggan et al., 1988) for longer than 1.5 s beyond the
10 or 15 s duration of the pre-set 48°C stimulus. The
marker bars in the figures indicate the period of skin
temperature in excess of 45°C. The cycle of stimuli was
repeated every 3 min, with the ejection of the drugs
initiated 1 min before the start of a cycle and continu¬
ing through that cycle. The different responses and
epochs of spontaneous activity prior to each cycle of
stimuli were integrated over 10-15 s periods as appro¬
priate and compared to pre-drug control values,
meaned from at least two consecutive tests. The stimu-
Ins-evoked responses were always submaximal and ap¬
proximately matched in terms of neuronal firing rates.
Duplicate or triplicate control responses were required
tovary by less than 15-20%.
J, Results
The present results were obtained from a total of 61
neurons which were all located in laminae III-V of the
dorsal horn. Peptide antagonists highly selective for
NKl and NK2 receptors (L 668,169/GR 82334/[D-
Pro4,D-Trp7,9'10Phen]substance P-(4-ll) and L
659,874, respectively; Regoli et al., 1987; McKnight et
al, 1988; Hagan et al., 1991) were tested by ionophore-
sis close to the recorded cells. The vehicle (0.3%
dimethylformamide in water) had no effect on 3 out of
keurons when ejected at up to 80 nA for 12 min. The
rather more potent cyclic analogue of L 659,874, L
659,877, could not be tested because of its low solubil¬
ity in acceptable vehicles.
Fig. 1 shows typical results (displayed as raw activity
records) obtained with the NK, receptor antagonist L
668,169 in 6 out of 8 neurons tested. There was little
effect of this antagonist on spontaneous activity or any
sensory-evoked response apart from a small but consis¬
tent enhancement of activity evoked by innocuous brush
(fig-1, table 2). In the remaining 2 cells there were no
detectable changes. In 4 cells where recovery was as¬
sessed there was 50% (n = 1) and over 85% (n = 3)
reversal of the effect of L 668,169 on brush responses
6y 4 and 9-24 min respectively, after cessation of
ionophoresis. Entirely similar results were obtained
Wh GR 82334 in 5 out of 6 cells, showing a small
ncrease in responses to brush, but no effect on those
te noxious heat (fig. 2, Table 2). In 2 neurons tested
Wh [D-Pro4,D-Trp7A10,Pheu]substance P-(4-ll) (30-
® nA, 6 min) brush responses were increased by 33
aid 41% with no consistent change in other activity,
'cnophoretic currents up to 50, 45 and 80 nA were
fcsted for L 668,169, GR 82334 and [D-Pro4,D-
V'9'10,Phe11]SubStanCe P-(4—11) respectively, until ei¬
Q.
Brush Pinch Noxious heal
R1089N1 10 s
Fig. 1. Ongoing firing frequency records showing typical effects of
the NK[ receptor antagonist L 668,169 on somatosensory responses
of a laminae 1II-V neuron. A modest facilitation of responses to
innocuous brush was observed in 6 out of 8 neurons tested, with no
other consistent changes. Recovery from drug effects was not exam¬
ined closely, but in 3 out of 4 cells examined, responses to brush had
recovered to within +15% of control levels within 9-24 min after
stopping ionophoresis of the drug. The fourth cell showed approxi¬
mately 50% recovery within 4 min. The inset shows the position of
the cutaneous receptive field on the ipsilateral hind limb. The
duration of each of the stimuli is indicated, in the case of noxious
heat, this representing the period for which the skin temperature
exceeded the generally accepted noxious threshold of 45°C.
ther spike reduction or technical factors prevented
further study. The effects on sensory responses at these
currents were similar to those at lower currents, no¬
tably there still being no consistent inhibition of re-
ponses to noxious heat.
The NK2 receptor antagonist L 659,874 produced a
quite different result: a highly selective inhibition of
responses to noxious thermal stimuli without altering
responses to noxious pinch, innocuous brush or sponta¬
neous activity (fig. 3, table 2). This was seen in 8 out of
10 neurons tested at just 10 nA of L 659,874 (mean
49% inhibition), with no detectable effect in the others.
At a higher ejection current (20 nA) the selective
inhibition was seen in all cells tested (9 out of 9) and
was of a greater degree (mean 66% inhibition) (this
was particularly clear in 4 cases where both currents
were tested on the same cell). In 3 neurons where
recovery was investigated, the inhibition of heat re¬
sponses by L 659,874 had partially recovered (to 50-
85% of controls) within 6-15 min after cessation of
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TABLE 1
Time dependence of the effects of neurokinin receptor antagonists on thermal nociceptive responses.
All values represent evoked activity (corrected for background) and are shown as percentages of the mean stimulus-induced activity occurring
during the stimulus. Values are expressed as mean + S.E.M.
Noxious heat-induced increase in neuronal firing rate (% of control response during stimulus)
During stimulus 0-10 s after stimulus 10-20 s after stimulus
(a) L 668,169 (n = 6)
Control
Drug (20 nA for 6 min)
(b) GR 82334 (n = 5)
Control
Drug (32 ±4 nA for 6 min)
(c) L 659,874 (n = 9)
Control
Drug (20 nA for 6 min)


















ionophoresis. In the majority of cells tested here, re¬
sponses to noxious heat declined rapidly on cessation
of the stimulus (to less than 20% of the response
during the stimulus, within the subsequent 10 s). For
each of the drugs tested there were, however, examples
of relatively prolonged after discharges, retaining
around 50% of the peak activity during the first post-
stimulus period. There was no evidence that effects of
any of the drugs were greater (or in any way different)
in post-stimulus periods than during application of the
heat stimulus (table 1).
A number of NKj and NK2 receptor agonists were
also examined (table 2). The highly selective NK[ re¬
ceptor agonist [N-acetyl-Arg6,Sar9,Met(02)n]sub-
stance P-(6—11) (Regoli et al., 1988) was tested either
on neuronal responses to cycled cutaneous stimuli ei¬
ther at low or higher ionophoretic currents. In 9 out of
13 cells [N-acetyl-Arg6,Sar9,Met(02)"]substance P-(6-
11) (when ejected at relatively low currents: mean
31+4 nA) caused an inhibition of the activity evoked
by innocuous brush with no apparent effect on sponta¬
neous activity or nociceptive responses. In 6 out of 6
cells, higher ejection currents (mean 57 + 5 nA) of
[N-acetyl-Arg6,SarlJ,Met(02)n]substance P-(6-ll) in¬
creased spontaneous activity, causing marked and sus¬
tained rises to around 5-fold of pre-drug controls.
Recovery was observed in all 5 cases examined within
5-10 min after terminating ionophoresis and the drug
effect was not replicated in current (NaCl) or vehide
control tests.
TABLE 2
Summary of the effects of neurokinin receptor antagonists and agonists on laminae III—V neurons.
All values are calculated as a percentage of the mean pre-drug control value and are expressed as the mean + S.E.M. Responses were designated
as being essentially unchanged if they remained within 20% of the mean control value. Neurons in the population tested which were not
influenced in the characteristic predominant fashion illustrated, all showed no (or no consistent) changes in their responses. For the
subpopulations of neurons affected by the drugs, the statistical significance of changes was assessed by Wilcoxon test.
Drug and conditions Stimulus-evoked neuronal firing rate (% of mean pre-drug control)




L 668,169 (NKj) 20 nA for 6 min 95 ± 7 141± 9 a 105 ± 10 82 ± 9 6 8
GR 82334 (NK[) 32 + 4 nA for 6 min 103 ± 8 131± 8 a - 91 ±11 5 6
L 659,874 (NK2) 10 nA for 6 min 93+ 7 103 ± 9 99 ± 8 51 ± 6 a 8 10
20 nA for 6 min 95 ±12 SO+1o 85 ±11 34 ± 5 a 9 9
Agonists
[Ac-Arg6,Sar9, Met(02)n]-
substance P-(6-ll) (NKj) 31 + 4 nA for 5 +1 min 121 ±13 52± 5 a 98 ± 5 92 ± 6 9 13
57 + 5 nA for 6 + 2 min 536 ±88 a 67+ 9 a 91 ±14 106 ±11 6 6
Neurokinin A (NK2) 11 + 5 nA for 7 + 1 min 112+10 89 ±11 108 ±10 155 ±13 a 6 6
44 + 4 nA for 6+1 min 354 ±61a 79 ±19 120 ±21 64+16 a 6 8
GR 64349 (NK2) 66 + 6 nA for 7 + 1 min 398 + 54 a 111 ± 13 88 ±20 75± 11a 5 5
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Fig. 2. Ongoing firing frequency records showing typical effects of
Ihe NK! receptor antagonist GR 82334 on somatosensory responses
of a laminae III—V neuron. Facilitation of responses to innocuous
tosh (with no other consistent change) was observed in 5 out of 6
cells examined. The lower trace shows recovery 3 min after termina¬
tion of ionophoresis. Similar effects were observed in 3 further cells
there recovery was assessed. The inset shows the position of the
cutaneous receptive field on the ipsilateral hind limb.
tude of reduction in heat responses. In all other cases
this magnitude of reduction was greater (mean 3-9-
fold) than the actual increase in spontaneous activity.
Recovery was observed within 6-12 min after terminat¬
ing ionophoresis and none of the effects was repro¬
duced in current control tests. In 4 cells where [N-
acetyl-Arg6,Sar9,Met(02)u]substance P-(6-ll) and
neurokinin A were each tested, clear excitatory re¬
sponses to both the NK, and NK2 receptor agonist
were seen.
Fig. 4 (representative of 3 out of 3 neurons) shows
the selective facilitation of thermal nociceptive re¬
sponses by a low current of neurokinin A and a reduc¬
tion in those facilitated responses when L 659,874 was
additionally applied. This is consistent with reversal of
the effect of exogenous neurokinin A by the selective
NK2 receptor antagonist but cannot be unequivocal,
since the antagonist alone had inhibitory effects on
thermal nociceptive responses (fig. 3). Analogous re¬
sults were obtained in 3 experiments when the effect of





The NK2 receptor agonists, neurokinin A and the
novel highly selective compound GR 64349 (Hagan et
al., 1991) also increased spontaneous activity of lami¬
nae III—V neurons in a consistent manner. Neurokinin
A (44 + 4 nA) and GR 64349 (66-6 nA) produced
marked and sustained excitation of spontaneous activ¬
ity in 6 out of 8 and 5 out of 5 cases respectively. When
neurokinin A was tested at low currents (mean 11 + 5
nA) which did not raise spontaneous activity in the
recorded neuron, there was a selective facilitation of
the responses to noxious thermal stimuli (in 6 out of 8
cells). Responses to innocuous brush and noxious pinch
were essentially unaltered. Although one cell showed a
30% increase in the noxious pinch response, this was
not reproduced in the other examples. At the higher
ionophoretic currents of neurokinin A and GR 64349
that increased spontaneous activity, noxious heat-
evoked responses were attenuated when corrected for
the elevated baseline. Other responses were essentially
unaltered. In 2 cases with neurokinin A, the increment












Fig. 3. Ongoing firing frequency records showing typical effects of
the NK2 receptor antagonist L 659,874 on somatosensory responses
of a laminae III-V neuron. A marked attentuation of responses to
noxious heat but not other stimuli or spontaneous activity was seen
in all 11 neurons tested at currents of 15-20 nA. Recovery from drug
effects was not examined closely, but in 3 out of 3 cells examined
there was recovery of the noxious heat response to within 50-85% of
control at 6-15 min after terminating ionophoresis of the drug. The
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Fig. 4. Ongoing firing frequency records showing typical effects of
the NK2 receptor agonist neurokinin A, in the absence or presence
of the NK2 receptor antagonist L 659,874 on the somatosensory
responses of a laminae III-V neuron. Neurokinin A caused a selec¬
tive facilitation of responses to thermal but not mechanical noxious
stimuli. Responses to innocuous brush (not shown here) were also
unaltered (see table 2). Results were typical of 6 neurons tested with
low currents of neurokinin A. After the middle trace had been
recorded, ionophoresis of L 659,874 was begun in addition to neu¬
rokinin A. A marked attenuation of the neurokinin A-amplified
response to noxious heat to below control levels was observed in all 3
cells so tested. The inset shows the position of the cutaneous
receptive field on the ipsilateral hind limb.
brush responses induced by low currents of [N-acetyl-
Arg6,Sar9,Met(02)n]substance P-(6—11). Effects of an¬
tagonists on the increases in spontaneous activity
brought about by high ejection currents of NK, and
NK2 receptor agonists were not investigated in the
present study.
4. Discussion
These experiments provided no clear evidence that
NK, receptors participate in transducing brief nocicep¬
tive inputs to laminae III-V neurons of rat spinal
dorsal horn under the present conditions. Since the
potency of some NK, receptor antagonists, including L
668,169, is reduced in rodent bioassays compared to
those in other species (Pattachini et al., 1992), we also
tested GR 82334 (which retains high potency at rat
NK, receptors; Beresford et al., 1992) and [D-Pro4,D-
Trp7'9'10,Phen]substance P-(4— 11) (which is effectively
antinociceptive in the mouse formalin model; Murray
et al., 1991). The NK, receptor antagonists L 668,169,
GR 82334 and [D-Pro4,D-Trp7,9,10Pheu]substance P-
(4-11) had no significant effect on nociceptive re¬
sponses in any neurons tested, but in contrast caused a
modest facilitation of their responses to innocuous
brush in the majority of cells. This suggests that their
lack of effect on nociceptive responses was not due to
failure to reach relevant sites at effective concentra¬
tions. Conviction that this effect of L 668,169, GR
82334, and [D-Pro4,D-Trp7'9'10,Phe"]substance P-(4-
11) was due to NK, receptor antagonism is strength¬
ened by that being the common property of structurally
quite distinct compounds, by the low ionophoretic cur¬
rents required, by the observation that NK, receptor
agonists produce precisely the inverse effect (table 2)
and by the apparent reduction in the effect of [N-
acetyI-Arg6,Sar6,Met(02)"] substance P-(6—11) in the
presence of GR 82334.
The simplest interpretation of the facilitation of
brush responses by NK, receptor antagonists seems to
be that NK, receptors are responsible for an attenuat¬
ing influence on non-nociceptive inputs to these cells
and that the antagonist is acting to reverse the action
of the endogenous NK, receptor agonist, substance P,
which has been released during the course of our
experimental procedure. The factors leading to sub¬
stance P release here are unclear (see below), but
substance P does not appear to be responsible for
acutely mediating the increased activity elicited by brief
thermal or mechanical noxious stimuli. It is of course
possible that the antagonists have unknown side effects
or that more complex interactions are occurring. The
NK, receptor agonist [N-acetyl-Arg6,Sar9,Met(02)n]
substance P-(6—11) clearly increased the spontaneous
activity of laminae III-V neurons here (table 2), indi¬
cating that NK, receptors can exert a direct (or at least
a general modality-independent) influence on activity
of these cells. The data indicating that NK, receptor
activation can excite these cells, but seems not to
participate in nociceptive responses and instead atten¬
uates non-nociceptive tactile responses (in at least a
subpopulation of cells) are entirely consistent, in our
hands, between rat and cat. Somewhat in contrast to
the present results, Radhakrishnan and Henry (1991)
reported inhibition by CP-96,345 of the after-discharge
following brief noxious mechanical or thermal stimuli.
There was little effect on the initial phase of excitatory
responses to brief heat stimuli and inconsistent effects
on pinch-evoked excitation. It is possible that CP-96,345
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is effective only on late components of nociceptive
responses or that actions of this compound other than
on NK, receptors may be involved. Indeed, there is
new evidence that CP-96,345 is a potent antagonist of
'L'-type Ca2+ channels (Schmidt et ah, 1992) and fur¬
thermore that such compounds are effective antinoci¬
ceptive agents (Miranda et ah, 1992). Although both
peptide and non-peptide NK, receptor antagonists
have been reported to block the late prolonged but not
the brief excitatory postsynaptic potentials induced in
dorsal horn neurons by C-fibre activation or by noxious
stimuli (Urban and Randic, 1984; De Koninck and
Henry, 1991), in our experiments, there was no evi¬
dence that NK, receptor antagonists were any more
effective in the 20 s of afterdischarge following a nox¬
ious heat stimulus than they were during the response
itself (table 1).
In experiments designed to examine adequate stim¬
uli for the release of substance P into spinal cord, it
las been reported that noxious pinch, intraplantar
formalin, topical methylene chloride and flexion of a
laolin/carrageenan-inflamed knee-joint were effective
(Duggan et ah, 1988; Kuraishi et ah, 1989; Schaible et
al., 1990). Thermal cutaneous stimuli, however, were
only effective at skin temperatures considered to result
in inflammatory cutaneous lesions (Duggan et ah, 1988;
Kuraishi et ah, 1989). In contrast, both noxious me¬
chanical stimuli and noxious thermal stimuli (at skin
temperatures below those producing inflammatory
damage) were effective in releasing neurokinin A
(Duggan et ah, 1990). Behavioural reports have de¬
scribed inhibition by CP-96,345 of the second (in¬
flammation-supported) phase of the response to intra¬
plantar formalin (Yamamoto and Yaksh, 1991) and
inhibition by [ArgI,D-Pro2,D-Phe7,D-His9]substance P
of the secondary contralateral hyperalgesia following
heat injury (Coderre and Melzack, 1991). Correspond¬
ingly, only the facilitation of nociceptive flexor reflex
by substance P or C-afferent conditioning stimuli (and
not the reflex itself) was inhibited by the NK, receptor
antagonist spantide II (Wiesenfeld-Hallin et ah, 1990).
Thus, our evidence and the data from behavioural and
release experiments point towards the involvement of
substance P in mediating inflammation-supported noci¬
ception rather than responses to brief noxious stimuli.
In contrast to the results concerning NK, receptors,
Ihe NK2 receptor antagonist L 659,874 caused a
marked and highly consistent inhibition of nociceptive
responses without affecting spontaneous activity or re¬
sponses to innocuous brush. Inhibition by the NK2
receptor antagonist showed a striking selectively for
Ihermal rather than mechanical nociceptive stimuli, a
result also noted in cat with the moderately selective
NK2 receptor antagonist [D-Pro4,Lys6,D-Trp7'9-10,
Phe"]substance P-(4-ll) (Fleetwood-Walker et ah,
1990). The mechanistic basis for this is unclear, since
polymodal C-afferents are likely to contribute greatly
to both responses. Nevertheless, small dorsal root gan¬
glion cells are very heterogeneous in terms of their
neuropeptide content and there is evidence that ther¬
mal/mechanical noxious stimuli can differentially elicit
release of neuropeptides into spinal perfusates
(Kuraishi et ah, 1989). Consistent with a role of an
NK2 receptor agonist such as neurokinin A in thermal,
but not mechanical nociception is its selective facilita¬
tion of thermal nociceptive responses (fig. 4, a result
also seen in cat with neurokinin A and other agonists
with NK2 receptor selectively (Fleetwood-Walker et
ah, 1990). In the current experiments, both neurokinin
A and the highly selective NK2 receptor agonist GR
64349 further caused marked and consistent increases
in spontaneous activity of laminae III-V neurons, con¬
sistent with the idea that NK2 receptor activation is an
important element in the transduction of thermal noci¬
ceptive inputs. It is of course possible that co-factors
may also subserve an important role. Interestingly,
although both NK, and NK2 receptor agonists in¬
crease the spontaneous activity in laminae III-V cells,
the situation is quite different in lamina I where only
NK2 but not NK, receptor agonists are effective
(Fleetwood-Walker et ah, 1992).
There is increasing biochemical evidence that NK2
receptors (although generally at much lower abun¬
dance than NK, or NK3 receptor sites) are present in
the CNS and in particular in the dorsal horn of the
spinal cord (Yashpal et ah, 1990; Poosch et ah, 1991;
Takeda and Krause, 1991). Additionally functional
studies from other groups are now beginning to sup¬
port a role for NK2 receptors in spinal nociception. Xu
et ah (1991) described that the NK2 receptor antago¬
nist, [Tyr5,D-Trp6A9,ArgI0]neurokinin A-(4-10) (MEN
10207) selectively reversed the facilitation by neu¬
rokinin A (but not substance P) of the spinal nocicep¬
tive flexor reflex. Furthermore, a congener with further
reduced partial efficacy [Tyr5,D-Trp6'8,9,Lys10]neuro-
kinin A-(4-10) (MEN 10376; Maggi et ah, 1991a) inhib¬
ited the synaptic excitation of dorsal horn neurons
evoked by capsaicin administration to the dorsal root
ganglia (but not that evoked by an NK, receptor ago¬
nist) in a spinal cord slice with attached dorsal roots
(Urban et ah, 1992).
The pharmacological properties of the small, but
functionally important population of NK2 receptors in
dorsal horn remain to be investigated in detail.
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1RECEPTOR AND CELLULAR MECHANISMS
INVOLVED IN MUSTARD OIL-INDUCED ACTIVA¬
TION OF DORSAL HORN NEURONS. F. Munro. M.
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Edinburgh EH9 1QH and MRC Brain Metabolism Unit,
1 George Square, Edinburgh EH8 9JZ.
Aim of Investigation: The C-fibre-seiective chemical
irritant mustard oil produces sustained activity of dorsal
horn neurons upon repealed peripheral application and
long-lasting changes in receptive fields and responsive¬
ness. We addressed the possible role of NK^ NK7 and
metabotropic excitatory amino acid receptors and'of
protein kinase C (PKC) in responses to mustard oil.
Methods: Mustard oil was applied to restricted distal
areas of one hindlimb of rats. In some experiments tissue
was taken for biochemical assay of the
translocation/activation of PKC assessed by movement of
[3Hlphorbol dibutyrate ([3H]PDBu) binding sites from
cytosolic to membrane fractions. Extracellular recordings
of single dorsal horn neurons were made in anaesthetised
rats and drugs applied by ionophoresis.
Results: Selective antagonists for NK7 and metabo¬
tropic receptors, L-659874 and 1-AP3 reliably inhibited
neuronal activity 'wound-up' by repeated application of
mustard oil (in 19/21 and 6/9 cases respectively). The
NK antagonists, L-668169 and GR 82334 had no effect
in 13/17 cases. The selective PKC inhibitors cheleryth-
rine and GF 109203X caused marked, yet recoverable,
inhibition of activity in 8/9 and 8/8 cases respectively. In
corresponding spinal segments, significantly greater
proportions of [ HIPDBu binding sites were associated
with the membrane fraction on the side ipsilateral to
mustard oil application.
Conclusion: Both NK7 and metabotropic receptors
appear to play a role in the sustained activation of dorsal
horn neurons elicited by mustard oil. There is good
evidence that PKC is a cruciai mediator of this cellular
activation. NK receptors appear to be of less importancettOkl IUUV/II, i 1 1
in this model of sustained nociception.
Proceedings of the 7th World Congress on Pain,
Progress in Pain Research and Management, Vol. 2,
edited by G.F. Gebhart, D.L. Hammond, and T.S.
Jensen, IASP Press, Seattle, © 1994.
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INTRODUCTION
For many years substance P (SP) has been a prominent candidate for the
transmitter of primary afferent nociceptive fibers (Henry 1976). Although
considerable evidence suggests a role for SP (and NKi receptors) in nocicep¬
tive transmission (Coderre et al. 1993; Maggi et al. 1993), it is unlikely to be
the only relevant transmitter. SP together with neurokinin A (NKA) and
excitatory amino acids (EAAs) are released into the dorsal horn by noxious or
high-intensity stimulation of afferents (Duggan et al. 1990; Skilling et al.
1988; Petermann et al. 1986). Evidence from both electrophysiological and
reflex studies suggests that transmitters such as NKA and EAAs also may be
crucial to nociception through their actions at NK2, NMDA, and non-NMDA
receptors (Coderre et al. 1993).
Several lines of evidence point to a role for NKA in nociceptive transmis¬
sion. Ligand binding (Yashpal et al. 1990) and mRNA hybridization studies
(Takeda and Krause 1991) have confirmed that there are NK2 receptors in the
spinal cord. NKA is present in primary sensory neurons (Ogawa et al. 1985)
and is released by capsaicin from primary afferent terminals (Saria et al.
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1986). In a model of acute nociception, we have previously shown that the
responses of dorsal hom neurons to brief thermal (but not mechanical) nox¬
ious cutaneous stimuli are inhibited by selective NK2 but not NKj receptor
antagonists (Fleetwood-Walker et al. 1990, 1992a). Also in an in vitro spinal
cord/dorsal root preparation, neuronal activity evoked by brief application of
capsaicin to the dorsal root ganglion is inhibited by a selective NK2 antagonist
(Urban et al. 1992). Following both noxious mechanical and noxious thermal
stimuli, release of NKA-immunoreactive material is detected throughout the
dorsal horn in a diffuse pattern (Duggan et al. 1990; Hope et al. 1990) and
intrathecal administration of NKA gives rise to behavioral responses indica¬
tive of pain (Cridland and Henry 1986; Fleetwood-Walker et al. 1990).
The EAA glutamate is present at high levels in local interneurons of the
dorsal hom (Rizzoli 1968; Fagg and Foster 1983; Storm-Mathisen and Ottersen
1987) as well as in primary afferent terminals, as demonstrated by
immunolabeling of granular vesicles following rhizotomy (DeBiasi and Rustioni
1988). Upon noxious cutaneous stimulation or low- or high-intensity electri¬
cal stimulation to peripheral nerves, glutamate is released (Skilling et al.
1988), where it may act via several receptors (Schoepp et al. 1990a; Watkins
et al. 1990). The ionotropic group of receptors, including a-amino-3-hydroxy-
5-isoxazole-4-propionate (AMPA) and N-methyl-D-aspartate (NMDA) types,
have been extensively studied and it is now well established that the NMDA (
receptor is involved in hypersensitized states such as long-term potentiation ;
(LTP) in the hippocampus (Collingridge 1992) and wind-up in the spinal cord -
(Davies and Lodge 1987; Dickenson and Sullivan 1987, 1990; Thompson et
al. 1990). A metabotropic group of glutamate receptors (mGlu), linked to
G-proteins, also may be involved in such transmission. Studies have demon¬
strated a role for mGlu receptors, including a role in an NMDA receptor-
independent model of LTP (Bortolotto and Collingridge 1993). Previous studies
have demonstrated that l-amino-cyclopentane-l,3-dicarboxylic acid (ACPD), ^
a metabotropic glutamate receptor agonist (Irving et al. 1990), can augment ^
the actions of ionotropic agonist-induced activity in spinal cord preparations^
(Ceme and Randic 1992; Bleakman et al. 1992), although the cellular mecha--^
nism responsible has yet to be elucidated.
In our study, we used a prolonged noxious chemical stimulus to investi- |j
gate the involvement of NK,, NK2, mGlu receptors, and protein kinase £.|jj
(PKC) in the sustained activation of dorsal hom neurons. The model used is |
topical cutaneous application of mustard oil (allyl isothiocyanate), a c^em?c^|
irritant that selectively activates C (and occasionally some A-delta) affere® |j
fibers (Heapy et al. 1987).
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METHODS
ELECTROPHYSIOLOGY
We conducted experiments on male Wistar rats (250-340 g) anaesthetized
with intravenous a-chloralose (60 mg/kg) and urethane (1200 mg/kg) after
induction with halothane. Supplementary doses of a-chloralose were given as
required. Rectal temperature was continuously monitored and maintained be¬
tween 37-38°C. The rats respired spontaneously, but oxygen was supplied to
the area of the tracheal cannula to enrich the inspired air.
The thoraco-lumbar spinal column was supported by clamps under the
lateral processes and a laminectomy (segments L1-L4) was performed. To
increase the recording stability, a 2% agar solution was injected under the
spinal bone at the rostral end of the laminectomy and then poured over the
exposed cord. A core of agar was removed from above the recording region,
the dura carefully cut, and a pool of liquid paraffin applied to the region.
Extracellular recordings were made via the central barrel (4 M NaCl pH
4.0-4.5) of a seven-barreled glass microelectrode. One side barrel contained
1 M NaCl (pH 4.0-4.5) for automatic current balancing and current controls.
Another side barrel contained Pontamine Sky Blue (2% in 0.5 M sodium
acetate) for determination of neuronal location by ejection at the recording
site followed by histological examination. The other barrels of the electrode
contained NKt, NK2 or mGlu receptor antagonists or PKC inhibitors, which
were applied locally by ionophoresis over a range of currents (10-80nA) for
several minutes. NK, (L668,169) and NK2 (L659.874) antagonists were pre¬
pared as 0.15 mM solutions in distilled water with 0.3% dimethylformamide,
and the NK[ antagonist GR82334 was a 1 mM aqueous solution; all were pH
4.5-5.0. Metabotropic glutamate (mGlu) antagonists (L- and D-2-amino-3-
phosphoproprionate, L- and D-AP3) and (RS)-4-carboxy-3-hydroxyphenylglycine
(CHPG) were 10 mM aqueous solutions pH 8.0-8.5. PKC inhibitors
chelerythrine (1 mM aqueous solution) and GF109203X (0.2 mM aqueous
solution with 0.2% dimethylformamide) were pH 4.0.
All neurons were located in dorsal horn laminae IV/V, had excitatory
receptive fields on the ipsilateral hindlimb (excluding glabrous skin), and
were multireceptive (i.e., displayed responses to both noxious and innocuous
stimuli). Neurons were initially found by their responsiveness to widespread
manual brushing of the ipsilateral hindlimb. Cutaneous receptive fields of the










Fig. 1. Typical inhibitory effects of the NK2 antagonist L659.874 on mustard oil-evoked
activity of laminae IV/V dorsal horn neurons. Ionophoretic application of NaCI had no
effect, whereas L659.874 consistently caused greater than 50% inhibition of evoked
activity.
neurons were first localized by responses to manual brush, then the more
restricted pinch and noxious heat fields were identified. The mustard oil (5-20%
in paraffin oil) was applied topically with a paintbrush to the receptive fields.
BIOCHEMISTRY
To examine the subcellular translocation of protein kinase C (PKC, a
facet of its activation in response to external stimuli), we performed the fol¬
lowing [3H]PDBu binding assay in spinal cord tissue ipsilateral/contralateral
to mustard oil stimulation.
Male Wistar rats (273-330 g) were briefly anaesthetized with halothane,
and mustard oil (7-20%) was applied three times to the left hindfoot and leg
over a 15-minute period. This treated leg was bandaged to avoid cross-
contamination and after one hour the rats were killed and the spinal cords
removed and hemisected.
Each side of the spinal cord was separately homogenized in 0.4 ml of ice-
cold buffer containing 20 mM Tris-HCl at pH 7.5, 50 mM 2-mercaptoethanol,
2 mM EDTA and 1 mM phenylmethylsulphonylfluoride with 0.01% leupeptin
and 20 pM trans-epoxysuccinyl-L-leucylamido-(4-guanidino)butane (E-64).
The samples were then centrifuged at 25,000 X g for 20 minutes at 4°C. The
supernatant and pellet were carefully separated and the pellet was
rehomogenized in 0.3 ml Tris-BSA (50 mM Tris HC1, pH 7.4), with 4 mg/ml
essential fatty acid-free bovine serum albumin. While membrane binding was
carried out in Tris-BSA, cytosolic binding assays additionally contained
1 mM CaCl2 and 75 mM magnesium acetate and 1.35 mg/ml sonicated
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Fig. 2. An example of the inhibition of mustard oil induced firing of a dorsal horn neuron
by the metabotropic glutamate receptor antagonist CHPG. In this case recovery was
observed within two minutes of termination of ionophoresis of the antagonist.
phosphatidylserinc, sodium salt. Assays were conducted in a total volume of
275 pi (30 min, 37°C), with 5 nM [3H]PDBu (approximately 0.03 pCi per
tube) and dimethylformamide (0.5% final) or 10 pM PDRtt in dimethylformamide
for total and nonspecific binding measurements, respectively. Tissue samples
gave a total binding of less than 10% of total radioactivity present. Protein
was precipitated at 4°C by the addition of 100 pi of 12 mg/ml bovine gamma
globulin and 300 pi of 24% polyethyleneglycol 8000 in 50 mM Tris-HCl
(pH 7.4). After 20 minutes on ice, assay tubes were centrifuged (12,000 X g,
5 min, 4°C), the supernatant aspirated, and the [3H] radioactivity in each
pellet determined after solubilization.
All laboratory chemicals were from Sigma Chemical Co., Poole, Dorset,
UK, except phosphatidyl serine from Lipid Products Ltd., Nuffield, Sussex,
UK. Radioligand was from Du Pont NEN, Stevenage, Herts., UK. Drugs
were from Cambridge Research Biochemicals Ltd., Northwich, Cheshire, UK;
Calbiochem-Novabiochem, Nottingham, Notts., UK; Tocris Neuramin,
Churchill Building, Langford House, Langford, Bristol, Avon, UK; or were
gifts from Merck, Sharp and Dohme and Glaxo Group Research.
RESULTS
After application of the C-nociceptor-selective chemical algogen mustard
oil, virtually all the multireceptive neurons showed a large and prolonged
increase in activity (149 ± 36-fold of background, mean ± S.E.M.). In most
cases, the steady elevated firing rate was achieved by repeated application of
mustard oil 3-5 times to the same site over a period of 10-15 minutes.
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Fig. 3. The selective PKC inhibitors (A) chelerythrine and (B) GF109203X caused
marked, yet recoverable inhibition of mustard oil-evoked activity.
The selective NK2 antagonist L-659,874 (10-80 nA) caused a clear and!
maintained inhibition of the elevated activity, to 50 ± 7% mean ± S.E.M., of
prior control level in 23 of 24 cells (Fig. 1). Recovery was observed in 13 of
17 cases examined after terminating ionophoresis of L659.874. In contrast,'
the two selective NK, antagonists L668,169 and GR82334 (20-80 nA) rarely]
inhibited mustard oil-evoked activity (in 1 of 11 and 3 of 11 cases, respectively).]
The mustard oil-evoked activity in many cells (n = 15) was unaffected by;
NK[ antagonists but was inhibited by the NK2 antagonist L659,874 (Munro et
al. 1993). d
Selective antagonists for mGlu (L-AP3 and CHPG) and NK2 (L659,874)^j
receptors also reliably inhibited the mustard oil-induced wind-up of neuronal;
activity. L-AP3 (-15 to -50 nA) and CHPG (-15 to -55 nA) inhibited thej
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Tabic I
Mustard oil-induced translocation of specific [5H] PDBu binding sites
(% of total specific binding on control contralateral side)
Cystolic Fraction Membrane Fraction
Control (contralateral to mustard oil) 73.7 ± 2.5 26.2 ± 2.4
Test (ipsilateral to mustard oil) 37.6 ± 5.0 40.5 ± 4.8
Note: The proportion of [3H1 PDBu binding sites in the membrane fraction was significantly greater on
the test side (mean 52%) than on the control side (mean 26%) P < 0.05, Wilcoxon test). Values are the
means ± S.E.M. from nine separate experiments.
mustard oil-evoked activity (by 68 ± 7% and 56 ± 9% mean ± S.E.M.) in 11
of 16 and 7 of 8 cells, respectively (Fig. 2). Recovery was sometimes but not
always observed. The stereoisomer of L-AP3, D-AP3 (which has a much
lower affinity for mGlu receptors; Schoepp et al. 1990b) (-15 to -55 nA) had
no effect in 5 of 5 cells.
The selective PKC inhibitors chelerythrine and GF109203X caused marked
inhibition of mustard oil-induced activity in 8 of 9 and 8 of 8 cases respec¬
tively (Fig. 3). Rapid recovery was seen in the majority of cases after removal
of the PKC inhibitor. In contrast, activity evoked by continuous innocuous
brushing was completely unaffected by the PKC inhibitors (data not shown,
n = 5).
In rats treated with mustard oil to one distal hindlimb, a significant trans¬
location of specific [3H]PDBu binding sites from the cytosolic to membrane
fraction was observed in ipsilateral spinal segments L1-L5 in comparison
with the contralateral (control) side (Table I).
DISCUSSION
These results indicate that both NK2 and mGlu receptors play a crucial
role in mediating the sustained excitation of lamina IV/V dorsal horn neurons
elicited by cutaneous application of mustard oil. As mustard oil excites largely
C-fibers (Heapy et al. 1987), this implies a role for NK2 and mGlu receptors
in the transmission of nociceptive information. For tachykinins, this finding
agrees with our previous studies showing that ionophoretic administration of
NK2 but not NK, receptor antagonists inhibited the responses of both rat and
cat dorsal hom neurons to brief noxious thermal stimuli applied to their cuta¬
neous receptive fields (Fleetwood-Walker et al. 1990, 1991, 1992a,b).
This evidence for a role of mGlu receptors in sustained cutaneous noci¬
ceptive inputs that lead to hyperalgesia is novel and contrasts with data from
Thompson et al. (1992) who found no evidence for inhibition by L-AP3 of
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ventral root potentials evoked by high-intensity stimulation of dorsal roots in
an in vitro spinal cord preparation. Despite several reports of the attenuation
of wind-up by NMDA receptor antagonists (Davies and Lodge 1987; Dickenson
and Sullivan 1987, 1990; Thompson et al. 1990), we found no evidence for
attenuation of mustard oil-evoked responses by the D-isomer of AP3 (which
is a weak antagonist at the NMDA receptor [Schoepp et al. 1990b]). This
may simply be a consequence of low potency of the antagonist or it may
indicate a genuine mechanistic difference in the present case.
We also carried out a preliminary investigation of the intracellular mecha¬
nisms underlying the sensitization of spinal dorsal hom neurons brought about
by the repeated application of mustard oil. The role of PKC in this model was i
clearly indicated by two separate approaches: (1) the inhibition of electro-7
physiological responses by ionophoretic administration of selective PKC in-r
hibitors, and (2) translocation/activation of PKC in response to mustard oil. \
Although many other mechanisms may contribute to the processing of sus- •]
tained nociceptive inputs and the integral sensitization of dorsal horn neurons ;
which they bring about, this preliminary evidence clearly identifies a crucial
role of PKC. Since both NK2 and some mGlu receptors bring about hydrolysis *|
of phosphoinositides, it seems likely that either or both of these receptors
could well contribute to PKC activation by means of elevation of cellular |
diglyceride contact.
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Summary
Since not only substance P (SP) but also neurokinin A (NKA)
appears to be released from fine primary afferents upon
noxious cutaneous stimulation we have addressed the role of
their preferential targets (NK, and NK, receptors respec¬
tively) in mediating nociceptive responses of spinal dorsal
horn neurons. By making extracellular recordings of neurons
in anaesthetised rats (and cats) whilst applying drugs locally
by ionophoresis it was shown that NK. agonists facilitate and
NK, antagonists prevent responses to brief thermal noxious
stimuli in a highly selective manner. NK, receptor drags had
no marked effect, although NK, agonists could readily excite
laminae IV/V but not lamina I neurons. NK, agonists excited
both deep and superficial cells, apparently producing a selec¬
tive desensitising block of thermal nociception in lamina I.
NK, and NK. receptor drugs were also assessed in two
models of sustained C-afferent input associated with periph¬
eral inflammation, hyperalgesia and increased responsive¬
ness of dorsal hom. Neuronal activity wind-up over tens of
minutes by cutaneous application of mustard oil was inhibited
by NK, but not NK, antagonists. Expression of mrna for
preprodynorphin elicited over 6 hours by intraplantar injec¬
tion of X-carrageenan was similarly affected.
Experiments with another peptide released from fine noci¬
ceptive afferents. somatostatin (SS) indicated that just like
NK. receptors, the SS, subtype of SS receptor may well be an
essential component in mediation of brief thermal nocicep¬
tive inputs.
The interrelations between the roles played by NK.. SS.
and NK, receptors (and indeed receptors for other factors co-
released from nociceptive afferents) will be important to
elucidate.
Introduction
For a number of years there has been strong interest in the
possibility that substance P (SP) is a transmitter mediating the
input from fine primary afferent C fibres to dorsal horn
neurons. In support of this hypothesis there is a body ofearlv
work describing prominent excitatory effects of SP on dorsal
horn neurons, especially those responding to nociceptive
inputs (see [I] for review). More recent work with in vitr
preparations describes facilitation by SP of responses ~
excitatory amino acids [2], In behavioural experiments
intrathecallv-applied SP and NK, receptor agonists elicit
localised biting'scratchine response, perhaps consistent wit:
irritation or pain [3] while some but not ail NK, antagonist,
produce behavioural analgesia [4.5], However, when the
release of tachykinins into dorsal horn has been examined b'
antibody microprobe or push-pull cannula techniques, it .
clear that SP is released by noxious levels of mechanic::
stimulation but surprisingly not by noxious thermal stimula¬
tion at temperatures which selectively activate polvmodai C-
afferents [6.7], Higher skin temperatures however which are
likely to cause inflammatory damage, do release SP [8], In
contrast, both noxious pinch and heat cause release of neuro¬
kinin A (NKA) which originates in dorsal hom very largely
from primary afferents [9] where it is generated by alternative
splicing of the mRNA for the SP precursor [10],
At the level of sensory responses of single neurons or
nociceptive reflexes there has been relatively little decisive
data implicating tachykinins as mediators of nociception; due
ill large part to the low specificity and potency of the earls
antagonists. Although SP was reported [I I] to excite oniy
those neurons that received nociceptive inputs, this has not
been observed by other workers [12]. Only recently with the
advent of non-peptide NK, antagonists has solid evidence
been presented for an actual role of NK. receptors in mediat¬
ing responses of single neurons to high intensity afferent
stimulation or peripheral noxious stimuli [13.14], More ex¬
tensive studies are needed because these new agents have
been found to exert prominent and very relevant effects on
Ca:' channels [15]. Facilitation of a flexor reflex elicited
either by SP or by conditioning stimulation of sural nerve was
prevented by an improved peptide antagonist. Spantide II la
more potent blocker of NK, than NK. or NK, receptors) [ 161.
Our earlier studies, carried out on single neurons of anaes¬
thetised cats, pointed clearly to a role of NK, rather than NK.
receptors in mediating brief responses to noxious thermal
stimuli [17], NKA and other NK. agonists specifically facili¬
tated such responses, whereas the early NK. antagonists
[D-Pro'.Lys".D-Trpr" ,".Phe"]SPJ ,, and [D-Tyr.D-
Trp:".NIc"]SP,,, abrogated thermal nociceptive responses,
reversed the effect of NKA on these responses and demon¬
strated behavioural analgesia in rat tail flick and hot plate
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tests. Interestingly, selective NK, agonists had no effect on
dorsal horn neurons in those studies whereas NK, agonists
merely inhibited nonnociceptive responses, without modify¬
ing thermal or mechanical nociceptive responses: despite
clear evidence [6] that noxious pinch releases SP into dorsal
hom.
The experiments described here were carried out to further
investigate the relative importance of NK, and NK. receptors
in spinal nociceptive processing. There is evidence that ligand
binding sites and mRNA corresponding to both NK, and to a
lesser extent NFC receptors are present in superficial dorsal
hom [18-20].
Methods
Experiments were carried out in chloralose/urethane-anaes-
thetised rats examining the responses of single dorsal hom
neurons during localised ionophoresis ofNK receptor antago¬
nists and employing a range of sensory stimuli. Some experi¬
ments. particularly comparing the effects of tachykinins and
somatostatin (SS: shown to be released into dorsal hom by
noxious, but not damaging levels of thermal stimuli [6.7])
were carried out in cats. The detailed methods, and sources
and specificity of the relevant pharmacological agents are
described in the publications indicated.
Results
In the first series of experiments, novel and highly selective
NK, and NK. antagonists were tested on the nociceptive'non-
nociceptive responses of rat laminae IV/V neurons [21.22]. In
17 out of 19 neurons tested with the NK, antagonist L-659874
there was clear and selective inhibition of thermal (but not
mechanical) nociceptive responses. In contrast, the NK, an¬
tagonists L-668169 and GR 82334 were without effect on
nociception in 6 out of 8 and 4 out of 6 cases respectively, yet
caused facilitation of non-nociceptive responses in over 75%
of the cells. It seems clear that not only in cat but also in rat.
NK. receptors play an important role in thermal (if not
mechanical) nociception.
One possible reason for the lack of forthcoming evidence
for a role of NK, receptors is that they are not present at a
location accessible to the drugs as applied. To address this
issue we carried out experiments with agonists. Drugs were
applied ionophoreticaily close to laminae IV/V neurons and
as a comparison, lamina I neurons [22.23]. The ascending
ceils of lamina I were of interest for two reasons: (i) they are
reported to show a greater predominance of nociceptive cells
and (ii) they are reported to receive direct synaptic contacts
from tine primary afferents (including some SP reactive
terminals). In laminae IV/V. selective NK, and NK. agonists
produced clear excitatory effects of a similar order of magni¬
tude which gradually declined despite continued ionoplioresis.
In lamina I. NfC^agonists reliably produced a marked ver
transient excitation and the declining phase of this (desensi-
tisation?) coincided remarkably with a selective diminution
of responses to noxious heat. NK, agonists were without
detectable effect in lamina I cells (Table I).
Fr*ctio« of cells excited










2/! I (<0.6 fold)
9/|| (xl 1.2 fold)





5/5 fx4 0 fold)
Expemnenw were earned out in anaesthetised rats and drags were applied bv
| rmcromnonnoresH (10-80 nA for 3-12 mm) from side barrels of the muitibsrreiled
i extracellular recording cicctroae.
Tahle I. Effects ofNK receptor agonists on spontaneous electncai
activity of multireceptive neurons in lamina I and laminae IV/V.
Since the sensory models investigated relied on very brief
(10 sec) cutaneous stimuii. we carried out further experiments
utilising models of sustained inflammatory nociceptive input
to ascertain whether these in contrast would provide evidence
for a role of NK, over NK. receptors. Two models were
selected: (i) electrical recording of cells during topical appli¬
cation of mustard oil (a C-fibre selective chemical irritant) to
the cutaneous receptive field, and (ii) measurement of the
expression of preprodynorphin (PPD) mRNA in dorsal horn
neurons (using in situ hybridisation histochemistry) follow¬
ing localised inflammation induced by intraplantar injection
of X-carrageenan. These models provide sustained C-afferent
input for relatively prolonged periods and covered the experi¬
mental time domains of tens of minutes and six hours respec¬
tively. NK receptor antagonists were administered locally to
the spinal dorsai hom by ionophoresis in each case (Table 2).
In the mustard oil model, several NK. but not NK, antagonists
again prevented mustard oil-induced excitation of spontane¬
ous neuronal activity [24.25]. In the carrageenan model, the
same profile was apparent [26.27] with no discernible evi¬
dence for a role of NK, receptors. It is possible that more
profound or qualitatively different inflammatory stimuli would
reveal a contribution from NK, receptors, but (at least in the
present experimental conditions) it appears that NK. receptors
have a more prominent role in mediating nociception. Thus,
there is evidence mainly from release studies to suggest that
NK. receptors may play a greater role in nociception elicited
by prolonged mechanical stimuli, noxious cold or formalin
[6.7.28.29],
Since release experiments [6.7] have shown that in contrast
to SP. SS (as well as NKA [9]) is released into dorsai hom by
noxious heat, we compared (he effects of agonists and antago¬
nists for neurokinin [17.21.22] and somatostatin [30] receptors
on brief sensory responses of laminae IV/V neurons (Table 3).
Whilst SS-14 had broad antinociceptive effects on responses
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Antagonist Proportion of nearons Mean percentage inhibition
inhibited in affected ceib(±s.e. mean|
L 668169 (NK.) i/ll
GR 82334 <NK,) 3/11 (31 ± 14)
L 659874 (NK.) 23/24 50 ±7
MEN 10376 (NK.) 4/4 J8±6
R 396 (NK.) 3/3 44 ± 10
Electncal activity of multireceptive iamtrae IV/V neuron* was recorded (is m Tabic 11
dunnc topical application of mustard oii (5-20*'. in paraffin otit a C-fihre selective
chemical irritant (24.25). One to five repeated applications over 10-15 mm caused
marked increases in tiring rate (138 */• 33 fold ofbackground, mean «-• *.e. mean»which
were sustained for more than 20 min and allowed tcsnne of NK antagonist* by
ionophorests (10-80 nA for 1-6 mini.
a) Mustard oil-induced electrical activity.
Antagonist Number of PPO mRNA
expressing laminae I cells
(°/o ofcontralateral controls:
mean ± s.c.meant
L 668169 (NK.) 98 ± 7
GR 82334 (NK.) 103 ±3




The expression of preprodynorphm mRNA in lamina I neurons of anaesthetised rats ;
subjected (o bilateral intraplantar injection of the inflammatory agent X-cartaecenan \
(150ul of 1.4% in saline: n-12) was measured by in situ hybridisation histochemistry
(26.27). Neurokinin receptor antagonists were continuously ionophoresed unilaterally
into the superficial dorsal horn of spinal segments shown to display corresponding
receptive field areas. Drugs were ejected (5OnA) for I hour prior to and then throughout
the 6 hours of canageenan stimulation. Drug effects were observed over aboui70()um
centred on the ejection site: the data shown are for the 200um in closest proximity to the j
electrode.
I
J b) Carrageenan-indticed PPD mRNA expression
Table 2. Effects of NK receptor antagonists on the responses




Predominant effects on sensory responses




SS-14 (SS, > SS.) >(9'll) «5/5) Of10/12)
SS-28 (SS. > SST "(5-'6) 0(5/5) 0(6'6)
(D-Trp'.D-Cysi4 jsS-14 "(5/6) 0(5/6) 0(5.6)
(SS. > SS.?)
(Met-Ome"]SP 0(13/16) 0(6/9) >t 12/16)
(NK, > NK.)
NKA "(17/18) 0(11/14) 0(16/18)
(NK, > NK,)
b) Antagonists
cyclo-{7-amtnoheptanoyl. >(7/10) 0(8/10) 0(10/11)
Phe.D-Trp.Lys.O-benzyl-Thr
(SS./SS.?)
[D-Arg'.D-frp:\Leu"]SP 0(10/12) 0(9/10) 0(10/12)
(NK, > NK.)
(D- ProJ.Lys\D-Trp; * >111/13) 0(8/9) 0(11/13)
Phe"]SPwl
(NK. > NK,)
Experiments were earned out as described previously (17_30| on anaesthetised cats,
applying drugs by miaoionoohoresis from a muliibanclled electrode located in lamina
II immediately dorsal to the recording electrode. Since the required diffusion distances
in the cat are much greater than in the rat lonophorests was at higher currents (350-400
nA for 6-15 mm 1. which in ejection of" IM NaCl were shown to have no discernibleeffect
alone on neuronal activity.
to both themi.nl and mechanical noxious stimuli (just as in r.
[30]). SS-2J! and [D-Trp*. D-Cysu]SS-l4 selectively fac::
tated felelv thermal nociceptive responses. This is anaiogoc
to the effect of the NK. agonist NKA and the parallel berwesr
effects of NKA and SS-28 is further indicated by the identicc
effects of their antagonists ([D-ProJ.Lys*.D-Trpr-"".Phe;']SP.
and cyclo-[7-aminoheptanoyl.Phe.D-Trp.Lys-0-benzyl-TT:r
respectively) in selective abrogation of thermal nociception
As in the other experimental models described above, there
was little evidence for a significant role of NK, recemors.
PPD mRNA silver grain denufxj
in expressing cell*
i o/ contralateral controls: j
Discussion
The present results provide strong support for a functionally-
important role of dorsal horn NK. receptors in thermal
nociception. Although present at much lower levels than NK
receptors, both ligand binding sites and mRNA for NK.
receptors are present in spinal cord [ 18.20]. In support of our
contention, the flexor reflex facilitation elicited by NKA or by
conditioning stimulation of the gastrocnemius nerve is pre¬
vented by selective NK. antagonists [31]. Furthermore, the
excitation of dorsal horn neurons brought about by capsaicin
applied to ihe dorsal roots of an in vitro spinal cord/dorsai root
preparation is similarly prevented by NK, and not NK.
antagonists [32].
NK, receptors may be more important in nociception which
may rely more on different classes of fine afferent inputs, for
example high threshold meclianoreceptive afferents in pro¬
longed and severe pinch-mediated responses. Both noxious
cold [7] and profoundly damaging inflammatory stimuli such
as intraplantar formalin [29] or ultraviolet radiation-induced
burning [33] may invoke a greater NK, contribution.
It is clear that the two main processing variants from
preprosomarostatin (SS-14 and SS-28) exert quite different
effects on somatosensory processing. Both are present in
dorsal horn [34], show selectivity for the two subtypes of SS
receptor (SS, and SS.. respectively [35]) and have been shown
in other CNS regions to exert quite distinct electrophysiological
effects [36], it appears that just like NKA, SS-28 may act as
a transmitter of thermal nociceptive afferents. Whilst the
antagonist experiments show each is necessary for main¬
tained mediation of inputs, the full range of consequences of
a thermal nociceptive input may not be felt by dorsal horn
neurons unless they receive combined signals from NKA. SS-
28 and possibly other co-released factors.
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Evidence for a Role of Metabotropic Glutamate
Receptors in Sustained Nociceptive Inputs to Rat
Dorsal Horn Neurons
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Summary—Several antagonists at metabotropic glutamate (mGlu) receptors, when applied ionophoretically,
inhibited the excitation of single dorsal horn neurons elicited by cutaneous administration of the C
fibre-selective algogen, mustard oil. The selectivity and stereospecificity of AP3 isomers at mGlu, compared
to NMDA receptors was confirmed on responses to agonists and matched by their effects on mustard
oil-evoked activity.
Keywords—Metabotropic glutamate receptors, dorsal horn neurons, spinal cord, nociception.
loth primary afferent neurons and local neurons of the
pinal dorsal horn contain excitatory amino acids
EAA), the release of which can be elicited by noxious
utaneous stimuli or low- as well as high-intensity electri-
al stimulation of peripheral nerves (see refs in:
lougherty et al., 1992). A number of studies have
implicated NMDA receptors in nociceptive inputs from
resumed A<5 and C fibres, whereas AMPA-type, non
NMDA receptors may be important both there and in
aputs from large myelinated fibres (Dougherty et al.,
992). It is now well-established that NMDA receptors
lay a crucial role in the central neuronal sensitization
reduced by repetitive C-fibre stimulation ('wind-up') or
>y sustained noxious stimuli (Davies and Lodge, 1987;
laley et al., 1990). Relatively little attention has been
laid to the role of metabotropic glutamate (mGlu)
eceptors in synaptic responses in dorsal horn, although
he mGlu receptor agonist (IS,3R)-l-amino-cyclo-
ientane-l,3-dicarboxylic acid (ACPD) potentiates
(inotropic responses to AMPA and to NMDA in dis¬
persed dorsal horn neurons (Bleakman et al., 1992;
"erne and Randic, 1992).
The present experiments were carried out to assess any
(ole of mGlu receptors in sustained activation of dorsal
horn neurons by the C nociceptor-selective chemical
ilgogen, mustard oil (allyl isothiocyanate) which causes
l long-lasting sensitisation of neurons to subsequent
'To whom correspondence should be addressed.
inputs (see refs in: Munro et al., 1993). Experiments
were carried out as described previously (Munro et al.,
1993) in adult male Wistar rats, anaesthetized with
a-chloralose (60 mg kg-1) and urethane (1.2 g kg-1).
Extracellular recordings were made from multireceptive
neurons in dorsal horn laminae III-V of segments L,-L4
using the central barrel of 7-barrelled glass micro-
electrodes. The remaining barrels contained 1M
NaCl for automatic current balancing (Neurophore
Ionophoresis System), 2% Pontamine Sky Blue in 0.5 M
sodium acetate for histological marking of recording
sites and combinations of the following drugs for
ionophoresis: L-l-amino-3-phosphopropanoic acid (L-




1 -aminocyclobutane-ds -1,3-dicarboxylic acid (ACBD);
(Tocris Neuramin); all 10 mM solutions in distilled water
(adjusted pH 8.0-8.5 with NaOH).
Neuronal receptive fields were initially located by
brushing of the ipsilateral hindlimb and then further
examined with noxious heat (48°C, 10 sec). All neurons
tested displayed a low basal firing rate of 0-1 Hz. The
mustard oil experiments were carried out on a total of
28 multireceptive cells which responded to both brush
and noxious heat. Repeated applications of mustard oil
(7.5% in paraffin oil) were made to an area of about
3 cm2 covering the receptive field, and after 2-5 appli¬
cations separated by 5 min intervals, a steady elevated
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firing rate (5-13 Hz) was maintained. Antagonists were
then tested by ionophoresis at currents of ( —)15 to
( —)55nA. In agonist experiments, they were usually
applied alone at ( — )10 to ( — )30nA until a response
occurred (within 1 min) and then, especially in the case
of ACBD, currents were decreased to low levels in order
to maintain a steady firing rate of around 5-11 Hz before
antagonists were tested. The inhibitory effects of antag¬
onists were calculated as the mean evoked activity
through the 20 sec period encompassing greatest inhi¬
bition compared to the mean evoked activity in the
10 sec period immediately prior to antagonist adminis¬
tration.
Mustard oil-evoked activity was markedly inhibited
(by 68 ± 7%, mean + SEM) in 11 out of 16 cells by
L-AP3 [( — )15 to ( —)50nA] which acts as a selective
antagonist at a number of mGlu receptor subtypes
compared to the ionotropic EAA receptors (Schoepp
and Conn, 1993). In some, but not all cases, recovery
was observed. In contrast, its stereoisomer D-AP3
[( —)15 to ( —)55 nA], which displays an inverse selectiv¬
ity for NMDA over mGlu receptors, had no effect in 5
out of 5 cells which had all shown inhibition by L-AP3
[Fig. 1(A)]. The racemic mixtures of two other mGlu
receptor antagonists CHPG and aMeCPG [( — )15 to
( —)55 nA] caused clear inhibition in 7 out of 8 cells (by
56 + 9%, mean + SEM) and 1 out of 4 cells respectively
[Fig. 1(A, B)]. In five of the cells tested with CHPG,
L-AP3 was also examined and caused inhibition in each
case, whilst in three of these examples, D-AP3 was also
tested and had no effect. aMeCPG was not tested in
conjunction with other antagonists. In two cases with
aMeCPG, modest excitation (by no more than 20%)
was observed. This may reflect the properties of the
(R)-isomer in the racemic mixture, influencing other
receptors in the preparation or a genuine characteristic
of the mGlu receptor subtype involved here.
(RS)aMeCPG has been demonstrated to inhibit ACPD-
induced ventral root depolarization in vitro and the
responses of ventrobasal thalamic neurons to noxious
(52°C) heat (Eaton et al., 1993). We did not reach the
ionophoretic currents required in the latter experiments
(in the order of 150nA) so the relative inactivity of
aMeCPG here may simply be due to a failure to reach
adequate concentrations.
In order to confirm the selectivity of some of the
antagonists under the present conditions they were also
tested on responses to the mGlu receptor agonist, ACPD
and the NMDA receptor agonist, ACBD. These were
different neurons from those tested with mustard oil so
as to avoid any possibility of agonist administration
modifying mustard oil responses. Fourteen out of 37
cells tested responded to ACPD and 16 out of 23
responded to ACBD. Of the neurons responding to
ACPD or ACBD, 9 out of 12 and 7 out of 12 tested
respectively, had also previously shown vigorous excit¬
atory responses to noxious heat. In 20 cells tested with
both agonists, six gave clear responses to both, three
responded selectively to ACPD, nine responded selec¬
tively to ACBD and two were unaffected. In each
category there were examples of cells which either did or
did not respond overtly to noxious heat. The effects of
agonists on subsequent sensory responses were not
examined in these experiments. In cells considered as
failing to respond to agonists, ACPD was tested at
currents to ( — )90nA and ACBD at currents up to
( —)80 nA. In several cells agonist responses were tested
comparatively with L-AP3 and D-AP3. In 4 out of 6
neurons activated by ACPD at ( —)7 to ( —)25nA,
L-AP3 [( — )15 to ( — )30 nA] caused marked inhibition of
activity by 67 ± 12% (mean + SEM) whereas in all cases
D-AP3 had either no effect or caused slight excitation
[Fig. 1(C)]. In contrast, D-AP3 [(-)15 to (-)30nA]
inhibited the activity elicited by ACBD [( —)1 to
( —)6nA] in 4 out of 6 neurons by 58 + 17%
(mean + SEM), whereas L-AP3 had no effect in any of
them [Fig. 1(D)]. In one example we were able to record
the expected selectivity of AP3 isomers on activity
evoked by ACPD and then, after recovery, the inverse
selectivity on activity evoked by ACBD. In 3 out of 3
further cells, L-AP3 [( — )15 to ( — )30nA] inhibited
ACPD-evoked activity by 76 ±11 % (means ± SEM).
CHPG [(-) 30 to (-) 50 nA] caused 46% and 97%
inhibition in two of these cells. aMeCPG was not tested.
These results demonstrate that a number of mGlu
receptor antagonists inhibit the sustained activation of
dorsal horn neurons elicited by repeated application of
a selective chemical stimulant of C-nociceptors. Stereo¬
selectivity of inhibition was observed in the effectiveness
of L-AP3 but not D-AP3. Pharmacological selectivity of
L-AP3 and D-AP3 for mGlu and NMDA receptor
responses respectively was demonstrated in the majority
of cells under the present experimental conditions using
exogenous selective agonists.
Examples where no effect was seen may have resulted
from inadequate access or conceivably from contri¬
butions of different subtypes of these receptor classes.
Indeed the cells sampled for the agonist experiments may
represent in part a different population from those in the
mustard oil experiments. Notably, however, we never
observed blockade of ACPD responses by D-AP3 or of
ACBD responses by L-AP3.
Although D-AP3 had no effect on mustard oil-evoked
activation in these experiments, it is a weak NMDA
receptor antagonist and we have not attempted to
investigate effects of more potent and selective NMDA
receptor antagonists. There is good evidence that in
other models of sustained C-afferent activation of dorsal
horn neurons (Davies and Lodge, 1987; Haley et al.,
1990) NMDA receptors play an important role. The
contribution of NMDA receptors to mustard oil-
induced activation here is thus not clear and in the
present study we have sought only to elucidate whether
mGlu receptors may play a role. The present evidence
for involvement of an L-AP3-sensitive mGlu receptor
contrasts with observations on long duration ventral
root potentials evoked by dorsal root stimulation in
neonatal rat spinal cord in vitro, which are sensitive to
2-amino-5-phosphonopentanoic acid but not L-AP3


















Fig. 1. Inhibition of mustard oil-evoked activity of dorsal horn neurons by metabotropic glutamate (mGlu)
receptor antagonists. Action potentials of recorded cells were clearly discriminated from other field potentials
and the ongoing firing frequency in Hz (Responses/sec, R/S) was displayed continuously. Basal activity in all
records was less than 1 Hz. Records (A) and (B) show activity evoked by prior application of 7.5% mustard oil
on 2-5 occasions at 5 min intervals to the cutaneous receptive field of the neurons. (C) Shows activity evoked
by ionophoresis of the mGlu receptor agonist ACPD (1-2 nA for 7 min prior to and during the test). (D) Shows
activity evoked by ionophoresis of the NMDA receptor agonist ACBD (1 nA for 10 min prior to and during
the test). In each record, antagonists were tested at the currents and durations indicated. The inhibitory effect
of L-AP3, CHPG and aMeCPG (but not D-AP3) seen on mustard oil-evoked activity (A, B) was paralleled by
the inhibitory effect of L-AP3 (but not D-AP3) on ACPD-evoked, but not ACBD-evoked activity (C, D).
>dels of nociception and different cell populations may
fate the extent to which particular EAA receptors
ltribute to sustained nociceptive responses. Whilst
iminent activation by ACPD and inhibition by L-AP3
pear to preclude some subtypes of mGlu receptors
ihoepp and Conn, 1993), it is not yet possible to define
: particular species of mGlu receptor involved here.
Dther mediators are likely to contribute additionally
mustard oil-induced activation and sensitization of
rsal horn neurons, since we have shown previously
it NK-2 receptor antagonists also inhibit this neuronal
ivation (Munro et ah, 1993). There is reason to
suspect that mGlu receptors may interact functionally
with ionotropic Glu receptors during sustained nocicep¬
tive responses since ACPD augments and mGlu antag¬
onists prevent tetanus-induced long-term potentiation in
hippocampal CA1 neurons (Bashir et ah, 1993) while
ACPD augments the effects of exogenous ionotropic
receptor agonists on isolated dorsal horn neurons
(Bleakman et ah, 1992; Cerne and Randic, 1992).
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The Involvement of Metabotropic Glutamate
Receptors and Their Intracellular Signalling
Pathways in Sustained Nociceptive Transmission in
Rat Dorsal Horn Neurons
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Summary—The excitatory responses of individual dorsal horn neurons to cutaneous brush, repeated application
of the C-fibre-selective chemical algogen, mustard oil, or to ionophoretic (lS,3i?)-ACPD [a metabotropic
glutamate receptor (mGluR) agonist] were monitored by extracellular recording. We have previously shown
that the responses ofdorsal horn neurons to mustard oil are inhibited by several selective antagonists ofmGluRs.
Effects of ionophoresis of the mGluR antagonists (R,S")-CHPG and L-AP3 and a range of selective inhibitors
of intracellular signalling pathways were examined on evoked responses here. The results suggest that protein
kinase C, phospholipase A2 and perhaps Ca2+/calmodulin kinase II play a role in mediating the sustained
elevated activity of dorsal horn neurons that is incrementally elicited by repeated application of mustard oil,
but probably make little contribution to sustained brush-evoked activity. Concurrence in the sensitivity of
mustard oil- and (15",3R)-ACPD-evoked activity to (R,Sj-CHPG, L-AP3 and to inhibitors of intracellular
signalling pathways, suggests that mGluRs are an important origin of these intracellular signals required for
sustained nociception.
Keywords—Metabotropic glutamate receptors, nociception, spinal cord, intracellular signalling, protein kinase
C, phospholipase A2.
he possible role of metabotropic glutamate receptors
iGluRs) in spinal sensory processing has been
vestigated relatively little. Their potential importance is
ghlighted by evidence for their role in gating NMDA
ceptor-dependent and -independent forms of the
nsitization phenomenon in the hippocampus known as
ng-term potentiation (LTP) (Bortolotto and
ollingridge, 1993; Bortolotto et al., 1994) and by the
cilitation by mGluR agonist [(1S,3R)-ACPD] of
MPA and NMDA responses in dorsal horn neurons
ileakmane/fl/., 1992; Cerneand Randic, 1992).Wehave
:eviously provided evidence for a mediatory role of
GluRs in the sustained activation of dorsal horn
lurons elicited by repeated cutaneous application of the
•fibre selective chemical algogen, mustard oil (Young
al., 1994), which is known to bring about central
'nsitization of dorsal horn neurons to afferent inputs,
he repeated cutaneous application of mustard oil elicits
i increasingly powerful and sustained activation of
To whom all correspondence should be addressed.
dorsal horn neurons (analogous to "wind-up") until a
state of persistent elevated activity is reached (Munro
et al., 1993). This persistent mustard oil-evoked activity
was inhibited by ionophoretic application of the
selective mGluR antagonists l-(but not d-)-l-amino-3-
phosphonopropanoic acid (l-AP3), (/?,S)-4-carboxy-3-
hydroxyphenylglycine (R,S-CHPG) and, more variably,
by (R,S)-a-methyl-4-carboxyphenylglycine (R,S-a-
MeCPG) (Young et al., 1994). In behavioural analgesia
experiments, intrathecally-applied (5")-CHPG, which is
the enantiomer with activity at mGluRs, produces
antinociceptive effects in thermal and mechanical paw
withdrawal tests (Young et al., 1995). In animals treated
by unilateral intraplantar injection of carrageenan, these
effects are amplified and an antinociceptive influence of
l-AP3, but not d-AP3, is also apparent (Young et al.,
1995). Co-administration ofAMPA and mGluR agonists
is reported to bring about behavioural hyperalgesia in
acute mechanical nociceptive tests (Meller et al., 1993).
The sensitization of dorsal horn neurons brought about
by intra-articular inflammation is also inhibited by the
mGluR antagonist l-AP3 (Neugebauer et al., 1994).
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While these data provide compelling evidence that
mGluRs play some role in spinal processing of
nociceptive inputs (most likely in the sensitization of
dorsal horn neurons to sustained high intensity C-fibre
input), any evidence is lacking as to their intracellular
mechanism of action. We have previously reported that
neuronal activity evoked by repeated mustard oil
application is profoundly inhibited by antagonists of
protein kinase C (PKC) (Munro et al., 1994a). This
corresponds to the attenuation ofbehavioural nociceptive
responses to subcutaneous formalin injection (and of
their facilitation by glutamate) seen with PKC inhibitors
(Coderre, 1992; Coderre and Yashpal, 1994). Since the
intracellular signals leading to PKC activation are likely
to also involve elevation of Ca2+ levels, it is possible that
the Ca2+-activated enzyme, Ca2+/calmodulin-dependent
protein kinase II [which has been implicated in LTP (Silva
et al., 1992)], may also play a role here. Additionally,
evidence for the involvement of prostanoids in the
nociceptive responses to formalin (Malmberg and Yaksh,
1992a,b; Chapman and Dickenson, 1992) and the
facilitation of such behavioural responses by the
prostanoid precursor arachidonic acid (Coderre and
Yashpal, 1994), suggests that the arachidonic acid-gener¬
ating enzyme, phospholipase A2 (PLA2) may play a role
in sensitization. Further transduction mechanisms which
could potentially play a role are cAMP-dependent protein
kinase (PKA), since PKA activation can potentiate
NMDA responses of dorsal horn neurons (Cerne et al.,
1993), and non-receptor tyrosine kinases, which can be
activated by a number of phosphoinositide-hydrolysing,
G protein-coupled receptors (Zachary et al., 1991).
The present experiments utilized a range of selective
inhibitors applied by ionophoresis, to assess the role of
these various signal transduction pathways in neuronal
responses to repeated application of mustard oil, to
activation by the mGluR agonist (lS,3/?)-l-aminocy-
clopentane-l,2-dicarboxylic acid [(15',3R)-ACPD] and to
light innocuous brushing of the cutaneous receptive field.
Whilst these reagents were all chosen for their reported
high degree of selectivity, it is not possible to say with
certainty that their expected effects represent the actual
mechanism of action in the present experiments. For this
reason, pairs of reagents (with quite different structures,
but with the common property of selectively blocking
particular signal transduction pathways) were tested in
each case.
METHODS
Experiments were carried out on 43 male Wistar rats
(240-420 g). Following an initial halothane anaesthesia,
animals were given intravenous a-chloralose (60 mg
kg~') and urethane (1.2 g kg"'). Supplementary doses of
a-chloralose were given when required. Core body
temperature was maintained at 37-38°C by means of a
thermostatically controlled heat blanket. A light flow of
02 (0.1 1 min"1) was passed over the end of a tracheal
cannula to enrich the inspired air. Once the thoraco-lum
bar spinal column was supported, using 3 pairs o
swan-necked clamps, a laminectomy (L,-L4) was carrier
out. To provide stability, agar was injected under the mos
rostrally clamped vertebra, then over the whole area o
the laminectomy. An agar core was removed to expose the
recording region. The dura was then cut and a pool o
37°C liquid paraffin applied to the region.
Extracellular recordings were made from neurons ii
the deeper dorsal horn of spinal segments L|-L4, using the
central barrel of 7-barrelled glass microelectrodes. The
remaining barrels contained 1 M NaCl for automatic
current balancing (Neurophore lonophoresis System)
2% Pontamine Sky Blue in 0.5 M sodium acetate foi
histological marking of recording sites and combination;
of the following drugs for ionophoresis: (1S,3R)-ACPE
(Irving et a!., 1990), 10 mM aqueous, pH 8.0-8.5
(R,S)-and (S)-CHPG (Watkins and Collingridge, 1994)
10 mM aqueous, pH 8.0-8.5; L-AP3 (Schoepp et al.
1990), 10 mM aqueous, pH 8.0-8.5; calmidazoliurr
(Silver et al., 1986), 50 /cM in 0.5% dimethylformamide
pH 4.0^4.5; KN62 (Tokumitsu et al., 1990), 50 /,<M ir
0.5% dimethylformamide, pH 4.0-4.5; GF109203X
(Toullec et a!., 1991), 100 /cM in 0.5% dimethylfor-
mamide, pH 4.0-4.5; chelerythrine (Herbert et al., 1990)
1 mM aqueous, pH 4.0—4.5; ONO-RS-082 (Banga et al.
1986), 100 /(M in 0.5% dimethylformamide, pH 4.0-4.5
benzenesulphonamide 4 (BS4; Oinuma et a!., 1991), 5C
/<M in 0.5% dimethylformamide, pH 4.0-4.5; KT572C
(Kase et a!., 1987), 50 /tM in 0.5% dimethylformamide
pH 4.0-4.5; H89 (Chijiwa et a!., 1990), 100 ;uM in 0.5°/t
dimethylformamide, pH 4.0%.5; lavendustin A (Hsi
et al., 1991), 200 /eM in 0.2% dimethylformamide, pH
4.0-4.5; and piceatannol (Geahlen and McLaughlin
1989), 300 /;M in 0.3% dimethylformamide, pH 4.0%.5
(lS^/G-ACPD, (R,S)-, (S)-CHPG and L-AP3 were frotr
Tocris Neuramin, calmidazolium was from Sigma
piceatannol was from Boehringer Mannheim and al
other compounds were from Calbiochem, except BS4
which was a gift from Mike Clark (Schering-Plougl
Research, Kenilworth, NJ, U.S.A.), and ONO-RS-082
which was a gift from Dr Tsuboshima (ONC
Pharmaceuticals, Osaka, Japan). The signal transductior
reagents were dissolved at the maximum concentratior
that could be achieved in an acceptable vehicle (0.5%
dimethylformamide) that did not affect neuronal activity
(see below). With certain reagents it was possible to use
lower concentrations of the solvent in ionophoretic
solutions.
Neuronal receptive fields were initially located bj
brushing of the ipsilateral hindlimb and then furthei
examined with noxious heat (48°C, 10 sec). All neuron;
tested displayed a low basal firing rate of 0-1 Hz. The
mustard oil experiments were carried out on a total of 31
multireceptive cells which responded to both brush anc
noxious heat. Repeated applications of mustard oil (Ally
isothiocyanate, Aldrich Chemical Company, 7.5% ir
paraffin oil) were made to an area of about 3 cm2 covering
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n_ie receptive field, and after 2-5 applications separated by
3f,min intervals, a steady elevated firing rate (4-37 Hz) was
■maintained. The inhibitory effects of antagonists were
stimulated as the mean evoked activity through the 20 or
5f0 sec period encompassing greatest inhibition, compared
Iei the mean evoked activity in the 20 or 30 sec period
^mediately prior to antagonist administration. Analysis
as routinely over 20 sec, but was occasionally for the
nmger period of 30 sec if spurious variations occurred in
eie control sampling period, so that more truly
eipresentative values were obtained. The effects of
ciitagonists, over a similar current range to that used on
i,rustard oil-evoked activity, were also tested on responses
rfcells to a motorized brush applied continuously to the
siitaneous receptive field and to ionophoretically-applied
)IS,3/?)-ACPD. The ionophoretic current ranges used
; fere the lowest found to cause > 50% reduction of
, nustard oil-evoked activity without any detectable spike
Jstortion; equivalent currents were then tested on brush-
iind (l.S,3/?)-ACPD-evoked responses. The statistical
, ignificance of drug-induced changes from control
tsponses was assessed by the Wilcoxon test on the mean
.voked raw firing rate in the sampling periods before and
luring drug administration. All analysed activity data are
poted as mean + SEM values.
RESULTS
The majority of the neurons examined were multirecep-
live (i.e. responded to both innocuous brushing and
noxious pinch or noxious heating to 48°C, of the
cutaneous receptive field). As described previously
(Munro et al., 1993; Young et al., 1994), the majority of
these were vigorously excited by cutaneous adminis-
iration ofmustard oil, with several successive applications
resulting in sustained elevated activity. The majority of
Pontamine Sky Blue spots recovered from neuronal
recording sites were within laminae 111—V of the dorsal
lorn. Of the population of neurons recorded in the
present study, approximately one-fifth (47 out of 244)
ivere overtly excited by ionophoresis of (1S',37?)-ACPD
(0—60 nA). Ionophoresis of 0.5% dimethylformamide-
tontaining vehicle or saline at up to 80 nA, had no
letectable or consistent effect on basal, mustard oil-,
(IS^Rl-ACPD- or brush-evoked responses (n = 5). For
:ach mGluR antagonist or signal transduction reagent,
.vhenever recovery of responses was examined, full
ecovery was seen in most cases by 10 sec-15 min after
onophoresis was stopped.
Figure 1 extends the previously reported observations
Young et al., 1994; Munro et al., 1994b) that mGluR
intagonists inhibit mustard oil-evoked neuronal acti-
'ation, by demonstrating that the potent mGluR
intagonists (R,5)-CHPG and L-AP3 act selectively to
nhibit mustard oil-evoked activity without affecting that
voked by innocuous brush. Mustard oil-evoked activity
ras significantly inhibited by (R,5)-CHPG [( — )15 to
— )55 nA] and L-AP3 [( —)15 to ( —)50 nA] in 7 out of 8
cells (56 + 9% inhibition, P < 0.05) and 11 out of 16 cells
(68 + 7% inhibition, P < 0.05), respectively (Wilcoxon
test on raw data) (Fig. 1; Young et al., 1994; Munro et al.,
1994b). In contrast, brush-evoked activity was never
altered by more than 15% in 5 out of 5 cells by
(R,S)-CHPG and 9 out of 9 cells tested with L-AP3
(not statistically significant). Furthermore, 12 out of
12 cells tested with (Sl-CHPG [( —)15 to ( —)55 nA] also
showed negligible effects (<15% inhibition on brush-
evoked activity (not statistically significant). Similar to
their effect on mustard oil-evoked activity, (R,S)-CHPG
and L-AP3 inhibited (15,3R)-ACPD-driven activity in
5 out of 5 and 4 out of 6 cells, respectively (Fig. 1;
Young et al., 1994). The effect of (R,S)-CHPG on
(lY,3R)-ACPD-evoked activity was a mean inhibition of
64 + 6% (5/5 neurons) at currents of (—) 15 to (— )40 nA
[P < 0.05). When the percentage inhibition values of
brush-, mustard oil- and (lS,3R)-ACPD-evoked activity
caused by (R^l-CHPG were compared by the
non-parametric Mann-Whitney t/-test, effects on each of
the other responses were significantly greater than those
on brush (P < 0.05). As a consequence of the lasting
nature of activation caused by mustard oil, it was not
possible to test drug effects in a side-by-side comparison
of brush-, mustard oil- and (lS,3R)-ACPD-evoked
responses on individual cells. Comparisons of a drug
effect on brush/mustard oil, brush/(lS,3R)-ACPD or
(lS,3R)-ACPD/mustard oil were however made in a
number of cases. In individual examples of each
combination, both (R,S)-CHPG and L-AP3 caused
similar inhibition (by > 50%) of mustard oil/(l5",37?)-
ACPD responses, but in examples of sequential
brush/mustard oil and brush/(lS,3R)-ACPD tests the
antagonists inhibited brush responses by < 15%, if at all,
despite causing > 50% reduction in mustard oil and
(15,3R)-ACPD responses.
When a range of selective inhibitors of signal
transduction pathways was tested on activity evoked by
brush, mustard oil or (15",3R)-ACPD, there was general
concurrence in the effects of each inhibitor on mustard
oil- and (lS,3R)-ACPD-evoked responses. These re¬
sponses were significantly inhibited by ionophoresis of
each of the agents tested (P < 0.05, by Wilcoxon test, in
each case; Table 1). However, in the case of certain
inhibitors of Ca2+/calmodulin kinase II, PKC and PLA2,
but not the other agents, there appeared to be a lesser
effect on brush-evoked activity than on the other
responses. The Ca2+/calmodulin kinase II inhibitor,
calmidazolium, the PKC inhibitor GF 109203X, and the
PLA: inhibitor ONO-RS-082 had no significant effect on
brush-evoked activity. The mean percentage inhibition of
mustard oil- and (lS^Rl-ACPD-evoked responses by
calmidazolium, ONO-RS-082 and a further PLA:
inhibitor, BS4, was consistently at least 2-fold greater
than their effect on brush responses (and in the case of
GF109203X, many fold more). In the case of
GF109203X, the percentage inhibition of mustard oil and
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ban that of brush responses (P < 0.05, Mann-Whitney
J-test). The effect of ONO-RS-082 on (15,3/?)-ACPD-
voked activity was also significantly greater than that on
rush (P < 0.05), but no other such "between-response"
omparisons revealed differences that were significant
(ith the present samples. Figure 2 shows examples of the
fleet of the Ca2+/calmodulin kinase II inhibitor KN62
pd of the PLAi inhibitor BS4, illustrating concurrent
nhibition of mustard oil- and (lS^Rf-ACPD-evoked
ictivity with little or no effect on brush responses. In the
iverall populations, however, both KN62 and BS4
:aused a relatively small, but significant, inhibition of
jrush as well as the other responses, with each drug
towing no marked effect ( < 20% change) in approxi-
nately 50% of the cells (as in the examples illustrated)
Fig. 2; Table 1). In the case of the PKA inhibitors,
!(T5720 and H89, and the tyrosine kinase inhibitors,
lavendustin A and piceatannol, each reagent tested
:aused a significant inhibition of all types of evoked
ictivity (Table 1). It was not possible to make direct
iequential comparisons of a drug's effects on brush,
nustard oil and (15,3/?)-ACPD responses of the same
jell. However, comparisons between two types of evoked
response were possible in a number of cases. For example,
h the case of a single neuron tested with BS4, direct
:omparison of effects on brush/(15",37?)-ACPD responses
revealed selective inhibition of the latter, in accordance
with the overall population of neurons investigated.
Similarly, piceatannol caused inhibition of both brush
and mustard oil responses when directly compared on a
single cell, again typical of the overall population
(Table 1). A total of 17 cells were tested sequentially with
several drugs on either responses to brush (6 cells),
mustard oil (6 cells) and (1 S',37?)-ACPD (5 cells). In order
to avoid any possible cumulative drug effects, this
involved drugs considered to act on independent signal
transduction pathways. Time for full recovery was always
allowed between sequential tests on the same neuron (up
to 15 min) and the results from these multiple tests were
always typical of the overall population described in
Table 1.
DISCUSSION
The present experiments extend the evidence for a role
of mGluRs in mediating the prolonged firing of dorsal
horn neurons evoked by repeated application of mustard
oil. Furthermore, they demonstrate modality specificity,
in that neuronal activation caused by mustard oil, but not
that due to continuous innocuous brushing, was inhibited
by the mGluR antagonists (R,5')-CHPG and L-AP3
(Fig. 1). Administration of the single enantiomers
fable 1. Effects of ionophoretically-applied inhibitors of intracellular signalling pathways on the activity of dorsal horn neurons evoked by brush,
mustard oil or (1S,37?)-ACPD
Inhibition of evoked activity (% inhibition compared to
mean pre-drug controls)
Principal target Drug Brush Mustard oil (1S,3R)-ACPD (0-10 nA)




16 + 10 NS
n = 8 (25%)
42 + 13*




n = 5 (80%)
68 + 16*
n = 5 (80%)
83 + 9*





3 + 3 NS
n = 5 (20%)
53 + 10*
n = 9 (89%)
70 + 10*
n = 8 (100%)
86 + 12*
n = 5 (100%)
84+11*





28 + 13 NS
n = 9 (44%)
37 ± 12*
n = 9 (56%)
70+11*
n = 5 (100%)
74+11*
n = 5 (100%)
75 ± 9*
n = 8 (100%)
86 + 6*






n = 10 (70%)
45 + 15*
n = 10 (50%)
73 + 13*
n = l (86%)
66 + 10*




n = 6 (100%)







n = 13 (61%)
58 + 10*
n = 8 (88%)
87 + 7*
n = 6 (83%)
69 + 12*
n = 7 (100%)
84 + 9*
n = 6 (100%)
rhe ranges of ionophoretic currents required for the effects reported, are indicated in parentheses below each drug. In the case of (l.S,3R)-ACPD,
higher currents ( < 60 nA) were sometimes briefly used to initiate firing but, after the first few seconds, the elevated activity could always be
maintained by ^ 10 nA.
rhe effects of the drugs on evoked responses are indicated as the mean + SEM percentage inhibition compared to pre-drug control acitvity. In
each case, the number of neurons contributing to the data is shown below and in parentheses, the proportion (percentage) of those neurons
which individually gave a clear response of > 20% inhibition. The statistical significance of drug-induced changes in firing rate was assessed
using the Wilcoxon test on mean raw firing rate data in action potentials per second (R/sec); comparing the 20 or 30 sec period immediately
prior to drug administration with the 20 or 30 sec period centred on the greatest inhibitory effect of drug (*represents P < 0.05; NS represents
not significantly different, P > 0.05).
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(1S,3R)-ACPD-evokedactivity7nA),respect vely.Threcordsrt kenfromeparaten urons,buantir lyty calfho allp pul tioni ch.Is me ,KN62 andBS4tte uatednotonlymustaril-a(15',37?)-ACPD-evokedcti ity,b talsr hresponses.
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()-CHPG and l-AP3, which display the greater activity
iinGluR antagonists, failed to modify brush responses
[the neurons. Interestingly, Eaton et al. (1993) have
reviously shown that (S)-CHPG affected nociceptive,
at not non-nociceptive, responses of thalamic neurons,
leuronal activity evoked by the mGluR agonist
|S',3R)-ACPD was also significantly inhibited by
s,S)-CHPG or by l-AP3 (Fig. 1; Young et al., 1994).
•MeCPG was not investigated in the present exper-
nents due to the rather variable effects it exerts on dorsal
orn neuron responses to mustard oil (Younger al., 1994)
nd to dorsal root stimulation (Cao et al., 1995).
ilthough the mGluR antagonists inhibited mustard
il-evoked activity in 75% of the neurons tested here,
is,3R)-ACPD only elicited neuronal firing in approxi-
aately 25% of cases. This apparent anomaly may be a
onsequence of the mustard oil-evoked synaptic input
nvolving a number of other mediators beyond mGluRs;
or example AMPA, neurokinin and perhaps NMDA
eceptors. Agonist stimulation of mGluRs alone, in the
bsence of other components, may be insufficient to
egularly elicit overt neuronal firing in the recorded cell.
Ither explanations are of course possible.
The mGluR antagonist used here, (R,S)-CHPG, is a
0tent inhibitor of intracellular signalling responses
licited by the phosphoinositide-hydrolysing mGlu,
eceptor, but not by mGlu2 or mGlu4 receptors (Watkins
iiid Collingridge, 1994). It is likely that the properties of
oG1u5 receptors correspond broadly to those of mGlui,
ind further subtypes to mGlu2/4 receptors, which suggests
hat the receptor subtype involved in the mGlu antagonist
ffects may well be mGlu, or mGlu5. Although the
K)-enantiomer of CHPG displays some NMDA receptor
intagonism (Watkins and Collingridge, 1994) it can be
nferred that the inhibitory effects of (R,S)-CHPG on
nustard oil responses here are mainly due to mGluR
Mockade, since they are mimicked stereoselectively by
.-AP3, but not d-AP3 (effective at mGluR and NMDA
'eceptors respectively; Young et al., 1994).
This evidence for mGluR involvement in a sensitized
lociceptive response is consistent with evidence from
ither studies on the amplification of neuronal responses
)y intra-articular inflammation or carrageenan-induced
Neugebauer et al., 1994; Young et al., 1995). It is clear,
towever, that mGluRs are not the sole mediator of
ensitization, since both NK2 and NK, neurokinin
'eceptors in the dorsal horn can also contribute to the
iustained nociceptive activation and increased neuronal
ssponsiveness (Xu et a!., 1991; Munro et al., 1993;
Thompson et al., 1994). Interestingly, the mGlui and
tiGlu5 subtypes of mGluR, together with NK, and NK2
'eceptors have the common property of signal
transduction by means of phosphoinositide hydrolysis
INakajima et al., 1992; Watkins and Collingridge, 1994).
Correspondingly, neuronal responses to mustard oil, but
tot brush, were significantly reduced by inhibitors of
PKC and by calmidazolium, an antagonist of the Ca2+
binding protein calmodulin (thence Ca2+/calmodulin
kinase II) both classical mediators of phosphoinositide-
hydrolysing receptors (Table 1). Responses to the mGluR
agonist (1S',3R)-ACPD were also significantly inhibited
by these reagents, consistent with the hypothesis that a
phosphoinositide-hydrolysing mGluR may participate in
mediating responses to mustard oil. Both Ca2+/calmod-
ulin kinase II and the Ca2+/calmodulin-activated
phosphatase calcineurin, have been implicated in long
term changes in responsiveness in hippocampal neurons
(Silva etal., 1992; Lisman, 1989). It is not possible to draw
any conclusion from the experiments here with KN62,
since it significantly inhibited all types ofactivity tested in
the overall population of cells and there is thus no
assurance that its effects are other than non-specific.
The prominent blockade ofmustard oil-evoked activity
by PKC inhibitors (Table 1; Munro et al., 1994a) is
consistent with the translocation/activation of dorsal
horn PKC observed in both inflammatory and
loose-ligation neuropathy models of sustained nocicep¬
tion (Mao et al., 1993; Munro et al., 1994a). The
sensitivity of hippocampal LTP to inhibition of PKC
(Bliss and Collingridge, 1993) maintains the analogy
between that phenomenon and the sensitization of dorsal
horn neurons by sustained nociceptive input. Further¬
more, PKC inhibitors attenuate the behavioural
nociceptive responses elicited by subcutaneous formalin
injection (Coderre, 1992; Coderreand Yashpal, 1994) and
also attenuate the enhancement of such responses
brought about by glutamate or substance P. Metabo¬
tropic glutamate, NK, and NK2 receptor agonists can
facilitate neuronal responses to NMDA (Cerne and
Randic, 1992; Bleakman et al., 1992; Rusin et al., 1992)
and, where tested (on the NK| agonist, substance P), these
effects were reversed by a protein kinase inhibitor (Rusin
et al., 1992).
Not only PKC-activating phorbol esters (Gerber et al.,
1989) but also the PKA activator forskolin (Cerne et al.,
1993) can facilitate neuronal responsiveness in the dorsal
horn, but the inhibitory effects of the PKA inhibitors
KT5720 and H89 here are equivocal because all types of
activity were inhibited and the possibility of non-specific
actions cannot be excluded. No evidence was found in
support of the hypothesis that the mGluR subtype here
might be one acting by adenylate cyclase inhibition, in
which case PKA inhibitors might have been expected to
mimic rather than inhibit (1S,3R)-ACPD responses.
The two PLA2 inhibitors tested, ONO-RS-082 and
BS4, significantly inhibited both mustard oil and
(lS,3/?)-ACPD responses, whereas ONO-RS-082 had no
significant effect on brush-evoked activity and BS4
showed at least twice the magnitude of effect on the other
responses than on brush. These agents are reported to
block low and high molecular weight species of PLA2
respectively, and in each case both Ca2+ and PKC have
been implicated in their activation cascades (Banga et al.,
1986; Oinuma et al., 1991; Mayer and Marshall, 1993).
The present results are consistent with observations in
behavioural models implicating PKC and prostanoids in
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the development of hyperalgesic states (Coderre, 1992;
Malmberg and Yaksh, 1992a,b; Coderre and Yashpal,
1994).
Two selective inhibitors of tyrosine kinases (which
could potentially disrupt the effects of either growth
factor receptor tyrosine kinases or of receptor-indepen¬
dent tyrosine kinases operated downstream of phospho-
inositide hydrolysis responses) were also tested. These
agents caused generalized inhibition of all types of evoked
activity and so no clear conclusions can be drawn about
their actions in the context of the present experiments.
In summary, the present results suggest that PKC,
PLAi and perhaps a calmodulin-dependent mechanism,
such as Ca2+/calmodulin kinase II, play a role in the
mustard oil model of sustained and sensitized nociception
in the dorsal horn and that an mGlui or mGlu5 receptor
may be one of the synaptic mediators involved in
triggering these signal transduction pathways.
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THE INTERACTION BETWEEN NEUROKININ, AND METABOTROPIC
GLUTAMATE RECEPTOR ANTAGONISTS IN BEHAVIOURAL
NOCICEPTIVE TESTS IN NORMAL AND CARRAGEENAN-TREATED RATS.
M.R. Young. S.M. Fleetwood-Walker. P.J Birch1. C. Bountra2 and J. Bowers2.
Department of Preclinical Veterinary Sciences, University of Edinburgh, U.K.,
'Department of Molecular Science (Greenford), ^Pharmacology I (Ware), Glaxo
Group Research, U.K. SPON: European Brain and Behaviour Society.
Intrathecal metabotropic glutamate receptor antagonists (S)-4-carboxy-3-hvdroxy-
phenylglycine [(Sj-CHPG, (48nmol)] and L-l-amino-3-phosphopropionic acid (L-
AP3, 60nmol), increase paw withdrawal latencies (PWLs) to both noxious
mechanical and noxious thermal stimulation, in conscious rats. Such elevations were
more profound after carrageenan-induced inflammation in the paw. However, in the
same study the NK, receptor antagonist, GR82334 (3nmol), failed to alter PWLs
(Young er al (1995) Br. I. Pharm. 114:316P). We have addressed the effect of
combined mGlu and NK| receptor antagonists in such behavioural nociceptive tests.
Lister-hooded rats (30-70g), with either normal or carrageenan-inflamed paws,
received a co-injection of GR82334 and either (S)-CHPG or L-AP3 (n=l6 per
group), at doses equivalent to those above (in lOpl). Now, the increases in PWL due
to mGluR antagonists were occluded when GR82334 was given simultaneously,
except the (S)-CHPG-induced increase in PWL to noxious thermal stimulation in the
non-inflamed paw. Statistical significance of effects (% change from pre-drug levels)
was determined compared to mGluR antagonists alone, " - p<0.0l; * - p<0.05
(Mann-Whitney U-test) wi.l the co-injection in the inflamed state!
L-AP3 Co-injection (S)-CHPG Co-injection
MECHANICAL 1 min 123±47 19±8* 13Q±31 54+19"
THERMAL 1 min 97±6 9±9" 71±10 11±7"
These results indicate that in the state of cairageenan-induced hyperalgesia, NK|
receptor antagonism appears to exert an adverse effect on the analgesia normally
elicited by mGluR antagonists.
